cid,chemical,chemical_type,smiles,dosing_guideline
PA166250381,10-desmethyl alpha-dihydrotetrabenazine,Metabolite,,-1
PA166250405,10-desmethyl beta-dihydrodeutetrabenazine,Metabolite,,-1
PA166250403,10-desmethyl beta-dihydrotetrabenazine,Metabolite,,-1
PA166178620,10-formyltetrahydrofolate,Biological Intermediate,,-1
PA166131395,10-hydroxy r-warfarin,Metabolite,,-1
PA166182602,10-monohydroxy oxcarbazepine,Metabolite,,-1
PA166246381,"1-(2,3-dichlorophenyl)piperazine",Metabolite,,-1
PA166271901,"1,2,4-triazole-3-carboxamide",Metabolite,,-1
PA166131247,12-hydroxynevirapine,Metabolite,,-1
PA166131249,12-hydroxynevirapine glucuronide,Metabolite,,-1
PA166165005,12-hydroxy-sirolimus,Metabolite,,-1
PA166131367,"1,3,7-trimethyluric acid",Metabolite,CN1C2=C(NC1=O)N(C(=O)N(C2=O)C)C,-1
PA166131353,"1,3-dimethyl uric acid",Metabolite,CN1C2=C(C(=O)N(C1=O)C)NC(=O)N2,-1
PA166131533,13-O-demethyl tacrolimus,Metabolite,,-1
PA166160599,14-hydroxyclarithromycin,Metabolite,,-1
PA166238901,17-alpha-dihydroequilenin sulfate,Drug,,-1
PA166238881,17-alpha-dihydroequilin,Drug,,-1
PA166238883,17-alpha-dihydroequilin sulfate,Drug,,-1
PA166238882,17-alpha-estradiol sulfate,Drug,,-1
PA166238921,17-beta-dihydroequilenin sulfate,Drug,,-1
PA166238884,17-beta-dihydroequilin sulfate,Drug,,-1
PA166277182,17beta-estradiol glucuronide,Metabolite,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)CCC5=C3C=CC(=C5)O,-1
PA166238961,17-beta-estradiol sulfate,Drug,,-1
PA166131373,"1,7-dimethyluric acid",Metabolite,CN1C2=C(NC1=O)NC(=O)N(C2=O)C,-1
PA165820585,"1,7-dimethylxanthine",Metabolite,CN1C=NC2=C1C(=O)N(C(=O)N2)C,-1
PA166224241,1''-hydroxycannabidiol,Metabolite,,-1
PA166131327,1-hydroxyibuprofen,Metabolite,CC(C)C(C1=CC=C(C=C1)C(C)C(=O)O)O,-1
PA166131541,1-hydroxyibuprofen glucuronide,Metabolite,,-1
PA166131352,1-methyluric acid,Metabolite,CN1C(=O)C2=C(NC(=O)N2)NC1=O,-1
PA166131368,1-methylxanthine,Metabolite,CN1C(=O)C2=C(NC1=O)N=CN2,-1
PA166273182,20alpha-dihydroprednisolone,Metabolite,,-1
PA166273201,20alpha-dihydroprednisone,Metabolite,,-1
PA166273203,20beta-dihydroprednisolone,Metabolite,,-1
PA166273202,20beta-dihydroprednisone,Metabolite,,-1
PA166131511,"2,3-diene valproic acid-coenzyme A",Metabolite,,-1
PA166131512,"2,4-diene valproic acid-coenzyme A",Metabolite,,-1
PA166182310,"2,6-dimethylphenylhydroxylamine",Metabolite,,-1
PA166182227,"2,6-xylidine",Metabolite,,-1
PA164712302,2-amino-1-phenylethanol derivatives,Drug Class,,-1
PA166182231,2-amino-3-methylbenzoate,Metabolite,,-1
PA166233482,"2-chloro-1,1,1-trifluoroethane",Metabolite,,-1
PA166233481,"2-chloro-1,1-difluoroethene",Metabolite,,-1
PA166131288,2-chloroethylamine,Metabolite,C(CCl)N,-1
PA166131572,2-dechloroethyl ifosfamide,Metabolite,,-1
PA166131568,"2'-deoxy-2',2'-difluorouridine monophosphate",Metabolite,,-1
PA166232701,"2-(difluoromethoxy)-2,2-difluoroacetyl fluoride",Metabolite,,-1
PA166246341,2-[[(E)-3-(4-chlorophenyl)prop-2-enoyl]amino]acetic acid,Metabolite,,-1
PA166131246,2-ene valproic acid,Metabolite,,-1
PA166131250,2-ene valproic acid-coenzyme A,Metabolite,,-1
PA166254801,2-ethoxyphenoxyacetic acid,Metabolite,,-1
PA166245462,2-[(hydroxyacetyl)amino]-5- thiazolecarboxylic acid,Metabolite,,-1
PA166247601,2-hydroxyatorvastatin,Metabolite,,-1
PA166247581,2-hydroxyatorvastatin lactone,Metabolite,,-1
PA166224242,2''-hydroxycannabidiol,Metabolite,,-1
PA165817200,2-hydroxycarbamazepine,Metabolite,C1=CC=C2C(=C1)C=CC3=C(N2C(=O)N)C=CC(=C3)O,-1
PA166131468,2-hydroxy-desethylamodiaquine,Metabolite,,-1
PA166131283,2-hydroxydesipramine,Metabolite,CNCCCN1C2=C(CCC3=CC=CC=C31)C=C(C=C2)O,-1
PA166131251,2-hydroxydesipramine glucuronide,Metabolite,,-1
PA166244761,2-hydroxydesmethyltrimipramine,Metabolite,,-1
PA166178655,2-hydroxyestradiol,Biological Intermediate,,-1
PA166131267,2-hydroxyibuprofen,Metabolite,CC(C1=CC=C(C=C1)CC(C)(C)O)C(=O)O,-1
PA166131542,2-hydroxyibuprofen glucuronide,Metabolite,,-1
PA166131287,2-hydroxyiminostilbene,Metabolite,C1=CC=C2C(=C1)C=CC3=C(N2)C=CC(=C3)O,-1
PA166131271,2-hydroxyimipramine,Metabolite,CN(C)CCCN1C2=C(CCC3=CC=CC=C31)C=C(C=C2)O,-1
PA166131277,2-hydroxyimipramine glucuronide,Metabolite,CN(C)CCCN1C2=C(CCC3=CC=CC=C31)C=C(C=C2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,-1
PA166160755,2-hydroxymethyl atomoxetine,Metabolite,,-1
PA166164917,2-hydroxymethyl olanzapine,Metabolite,CN1CCN(CC1)C2=C3C=C(SC3=NC4=CC=CC=C4N2)CO,-1
PA166131275,2-hydroxynevirapine,Metabolite,CC1=CC(=O)NC2=C1NC(=O)C3=C(N2C4CC4)N=CC=C3,-1
PA166131253,2-hydroxynevirapine glucuronide,Metabolite,,-1
PA166244742,2-hydroxytrimipramine,Metabolite,,-1
PA134967247,2-methoxyestradiol,Drug,,-1
PA166131365,2-oxazolidone,Metabolite,C1COC(=O)N1,-1
PA166131290,2-oxo-clopidogrel,Metabolite,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3C(=CC(=O)S3)C2,-1
PA166131532,31-O-demethyl tacrolimus,Metabolite,,-1
PA166246321,3-(4-chlorophenyl)-3-hydroxypropanoic acid,Metabolite,,-1
PA166254461,"3,4-dehydrocilostazol",Metabolite,,-1
PA166245282,"3',4'-dihydroxyflurbiprofen",Metabolite,,-1
PA166181082,"3,4-dihydroxyphenylacetaldehyde","Metabolite,""Biological Intermediate""",C1=CC(=C(C=C1CC=O)O)O,-1
PA166181083,"3,4-dihydroxyphenylacetic acid","Metabolite,""Biological Intermediate""",C1=CC(=C(C=C1CC(=O)O)O)O,-1
PA166181134,"3,4-dihydroxyphenylglycolaldehyde","Metabolite,""Biological Intermediate""",C1=CC(=C(C=C1C(C=O)O)O)O,-1
PA166165008,34-hydroxy-sirolimus,Metabolite,,-1
PA131887008,"3,4-methylenedioxymethamphetamine",Drug,CC(CC1=CC2=C(C=C1)OCO2)NC,-1
PA166247781,"3,5-dihydrodiol simvastatin",Metabolite,,-1
PA165958321,"3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one",Drug,C[C@H]1C(=O)N([C@H](S1)C2=CN=CC=C2)C.Cl,-1
PA166165006,39-o-desmethyl sirolimus,Metabolite,,-1
PA166247921,3'alpha-isopravastatin,Metabolite,,-1
PA166131272,3'-amino-3'-deoxythymidine,Metabolite,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N,-1
PA166131292,3'-amino-3'-deoxythymidine glucuronide,Metabolite,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)N,-1
PA165858618,3-aminopyridine-2-carboxaldehyde thiosemicarbazone,Drug,C1=CC(=C(N=C1)/C=N/NC(=S)N)N,-1
PA451993,3-beta-hydroxy-5-androsten-17-one,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C,-1
PA166123047,3-cyano-7-ethoxycoumarin,Drug,CCOC1=CC2=C(C=C1)C=C(C(=O)O2)C#N,-1
PA166131571,3-dechloroethyl ifosfamide,Metabolite,,-1
PA166131513,3-ene valproic acid-coenzyme A,Metabolite,,-1
PA166178661,3-hydroxy-3-methylglutaryl coenzyme A,Biological Intermediate,,-1
PA166245283,3'-hydroxy-4'-methoxyflurbiprofen,Metabolite,,-1
PA166224243,3''-hydroxycannabidiol,Metabolite,,-1
PA165817197,3-hydroxycarbamazepine,Metabolite,C1=CC=C2C(=C1)C=CC3=C(N2C(=O)N)C=C(C=C3)O,-1
PA166131485,3-hydroxycarbamazepine free radical,Metabolite,,-1
PA166131262,3-hydroxycotinine,Metabolite,CN1[C@@H](CC(C1=O)O)C2=CN=CC=C2,-1
PA166131242,3-hydroxycotinine glucuronide,Metabolite,,-1
PA166163700,3'-hydroxydiclofenac,Metabolite,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC(=C2Cl)O)Cl,-1
PA166131357,3-hydroxyibuprofen,Metabolite,CC(CC1=CC=C(C=C1)C(C)C(=O)O)CO,-1
PA166131543,3-hydroxyibuprofen glucuronide,Metabolite,,-1
PA166181841,3-hydroxylidocaine,Metabolite,,-1
PA166247821,"3""-hydroxy lovastatin",Metabolite,,-1
PA166182232,3-hydroxymonoethylglycinexylidide,Metabolite,,-1
PA166265481,3-hydroxymorphinan,Metabolite,,-1
PA166131276,3-hydroxynevirapine,Metabolite,,-1
PA166131252,3-hydroxynevirapine glucuronide,Metabolite,,-1
PA166131360,3-hydroxyomeprazole,Metabolite,CC1=CN=C(C(=C1OC)CO)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,-1
PA166247881,3-hydroxy-pravastatin,Metabolite,,-1
PA166254201,3'-hydroxysimvastatin,Metabolite,,-1
PA166131384,3-hydroxysulfolane,Metabolite,C1CS(=O)(=O)CC1O,-1
PA166131289,3-hydroxy valproic acid,Metabolite,CCCC(C(CC)O)C(=O)O,-1
PA166131514,3-hydroxy valproic acid-coenzyme A,Metabolite,,-1
PA166265482,3-methoxymorphinan,Metabolite,,-1
PA166181085,3-methoxytyramine,"Metabolite,""Biological Intermediate""",COC1=C(C=CC(=C1)CCN)O,-1
PA166271222,3-methyltriazolophthalazine,Metabolite,CC1=NN=C2N1N=CC3=CC=CC=C32,-1
PA166131354,3-methylxanthine,Metabolite,CN1C2=C(C(=O)NC1=O)NC=N2,-1
PA164712303,3-oxoandrosten (4) derivatives,Drug Class,,-1
PA166131515,3-oxo-valproic acid-coenzyme A,Metabolite,,-1
PA166252522,3'-p-hydroxypaclitaxel,Metabolite,,-1
PA166262141,"(3R,5R)-fluvastatin",Drug,,-1
PA166262142,"(3R,5S)-fluvastatin",Drug,,-1
PA166163701,"4',5-dihydroxydiclofenac",Metabolite,C1=CC(=C(C=C1O)CC(=O)O)NC2=C(C=C(C=C2Cl)O)Cl,-1
PA166122786,"4,6,4'-trimethylangelicin",Drug,CC1=CC(=O)OC2=C3C(=COC3=C(C=C12)C)C,-1
PA166271104,4-acetamidoantipyrine,Metabolite,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C,-1
PA166271102,4-aminoantipyrine,Metabolite,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N,-1
PA166165251,4-beta-hydroxycholesterol,Biological Intermediate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC([C@@H]4O)O)C)C,-1
PA166131238,4-carboxynevirapine,Metabolite,,-1
PA166225461,4-demethyl pantoprazole,Metabolite,,-1
PA166131245,4-ene valproic acid,Metabolite,,-1
PA166131254,4-ene valproic acid-coenzyme A,Metabolite,,-1
PA166271103,4-formylaminoantipyrine,Metabolite,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC=O,-1
PA166160749,4'-hydroxy atomoxetine,Metabolite,CC1=C(C=CC(=C1)O)O[C@H](CCNC)C2=CC=CC=C2,-1
PA166160750,4-hydroxyatomoxetine-O-glucuronide,Metabolite,CC1=C(C=CC(=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)O[C@H](CCNC)C3=CC=CC=C3,-1
PA166247621,4-hydroxyatorvastatin,Metabolite,,-1
PA166247641,4-hydroxyatorvastatin lactone,Metabolite,,-1
PA166170175,4-hydroxybupropion,Metabolite,,-1
PA166224244,4''-hydroxycannabidiol,Drug,,-1
PA166254462,4-hydroxycilostazol,Metabolite,,-1
PA166169930,4'-hydroxyclobazam,Metabolite,,-1
PA166131388,4-hydroxycyclophosphamide,Metabolite,C1COP(=O)(NC1O)N(CCCl)CCCl,-1
PA166265521,4-hydroxydebrisoquine,Metabolite,,-1
PA166163693,4'-hydroxydiclofenac,Metabolite,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=C(C=C2Cl)O)Cl,-1
PA166255181,4-hydroxy duloxetine,Metabolite,,-1
PA166255203,4-hydroxy duloxetine glucuronide,Metabolite,,-1
PA166178986,4-hydroxyestradiol,Biological Intermediate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4O)O,-1
PA166245281,4'-hydroxyflurbiprofen,Metabolite,,-1
PA166131315,4-hydroxyifosfamide,Metabolite,C1COP(=O)(N(C1O)CCCl)NCCCl,-1
PA166169931,4'-hydroxy-n-desmethylclobazam,Metabolite,,-1
PA166131241,4-hydroxy-n-desmethyltamoxifen,Metabolite,,-1
PA166281821,4-hydroxyospemifene,Metabolite,C1=CC=C(C=C1)/C(=C(\CCCl)/C2=CC=C(C=C2)O)/C3=CC=C(C=C3)OCCO,-1
PA166281801,4'-hydroxyospemifene,Metabolite,C1=CC=C(C=C1)/C(=C(/C2=CC=C(C=C2)O)\C3=CC=C(C=C3)OCCO)/CCCl,-1
PA166246801,4'-hydroxyphenprocoumon,Metabolite,,-1
PA166177867,4'-hydroxyphenyl carvedilol,Metabolite,,-1
PA166255261,4-hydroxy-phenyl vortioxetine,Metabolite,,-1
PA166256041,4-hydroxypropofol,Metabolite,,-1
PA166256101,4-hydroxypropofol 1-glucuronide,Metabolite,,-1
PA166256081,4-hydroxypropofol 4-glucuronide,Metabolite,,-1
PA166256102,4-hydroxypropofol sulfate,Metabolite,,-1
PA166176065,4-hydroxypropranolol,Metabolite,,-1
PA166176064,4-hydroxypropranolol glucuronide,Metabolite,,-1
PA166176066,4-hydroxypropranolol sulfate,Metabolite,,-1
PA166127652,4-hydroxytamoxifen,Metabolite,CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,-1
PA166131409,4-hydroxytamoxifen-n-glucuronide,Metabolite,,-1
PA166131362,4-hydroxytamoxifen-o-glucuronide,Metabolite,,-1
PA166131408,4-hydroxytamoxifen sulfate,Metabolite,,-1
PA166280381,4'-hydroxytrazodone,Metabolite,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=C(C=C4)O)Cl,-1
PA166280681,4'-hydroxytrazodone glucuronide,Metabolite,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=C(C=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)Cl,-1
PA166131516,4-hydroxy valproic acid,Metabolite,,-1
PA166159252,4-hydroxyvoriconazole,Metabolite,,-1
PA166159253,4-hydroxyvoriconazole 4-o-glucuronide,Metabolite,,-1
PA166131339,4-hydroxywarfarin,Metabolite,CC(=O)CC(C1=CC=C(C=C1)O)C2=C(C3=CC=CC=C3OC2=O)O,-1
PA166182230,4-hydroxyxylidine,Metabolite,,-1
PA166131320,4-ketocyclophosphamide,Metabolite,C1COP(=O)(NC1=O)N(CCCl)CCCl,-1
PA166131387,4-ketoifosfamide,Metabolite,C1COP(=O)(N(C1=O)CCCl)NCCCl,-1
PA166178648,4-methoxyestradiol,Biological Intermediate,,-1
PA166271101,4-methylaminoantipyrine,Metabolite,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC,-1
PA151958637,4-methylthioamphetamine,Drug,,-1
PA154081778,4-methylumbelliferone,Drug,,-1
PA166271421,4-nitrososulfamethoxazole,Metabolite,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N=O,-1
PA166283861,4-phenylbutyric acid,Metabolite,C1=CC=C(C=C1)CCCC(=O)O,-1
PA166178622,"5,10-methenyltetrahydrofolate",Biological Intermediate,,-1
PA166179139,"5,10-methylenetetrahydrofolate",Biological Intermediate,C1[C@@H]2CN(CN2C3=C(N1)NC(=NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O,-1
PA166131274,5-acetylamino-6-formylamino-3-methyluracil,Metabolite,CC(=O)NC1=C(NC(=O)N(C1=O)C)NC=O,-1
PA164712304,5-androstanon (3) derivatives,Drug Class,,-1
PA166245381,5'-carboxymeloxicam,Metabolite,,-1
PA166255041,5-carboxypirfenidone,Metabolite,,-1
PA166131258,5'-deoxy-5-fluorocytidine,Metabolite,C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=NC2=O)N)F)O)O,-1
PA166131299,5'-deoxy-5-fluorouridine,Metabolite,C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O,-1
PA166131488,5'-glucuronyl zidovudine,Metabolite,,-1
PA166178687,5-HPETE,Biological Intermediate,CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)OO,-1
PA166255182,5-hydroxy-6-methoxy duloxetine,Metabolite,,-1
PA166255201,"5-hydroxy, 6-methoxy duloxetine sulfate",Metabolite,,-1
PA166224245,5''-hydroxycannabidiol,Metabolite,,-1
PA166131243,5-hydroxycotinine,Metabolite,,-1
PA166163694,5-hydroxydiclofenac,Metabolite,C1=CC(=C(C(=C1)Cl)NC2=C(C=C(C=C2)O)CC(=O)O)Cl,-1
PA166163695,5-hydroxy diclofenac benzoquinone,Metabolite,C1=CC(=C(C(=C1)Cl)N=C2C=CC(=O)C=C2CC(=O)O)Cl,-1
PA166255202,5-hydroxy duloxetine,Metabolite,,-1
PA166262161,5-hydroxyfluvastatin,Metabolite,,-1
PA166178629,5-hydroxyindole-3-acetic acid,Biological Intermediate,,-1
PA166178656,5-hydroxyisourate,Biological Intermediate,,-1
PA166225541,5-hydroxylansoprazole,Metabolite,,-1
PA166227301,5-hydroxylansoprazole sulfone,Metabolite,,-1
PA166242202,5'-hydroxylornoxicam,Metabolite,,-1
PA166245382,5'-hydroxymeloxicam,Metabolite,,-1
PA166131281,5-hydroxyomeprazole,Metabolite,CC1=C(C(=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)OC)CO)OC,-1
PA166227323,5-hydroxyomeprazole sulfone,Metabolite,,-1
PA166177868,5'-hydroxyphenyl carvedilol,Metabolite,,-1
PA166227981,5-hydroxypimozide,Metabolite,,-1
PA166255061,5-hydroxypirfenidone,Metabolite,,-1
PA166242201,5'-hydroxypiroxicam,Metabolite,,-1
PA166271501,5-hydroxypyrazinamide,Metabolite,C1=C(N=CC(=O)N1)C(=O)N,-1
PA166271502,5-hydroxypyrazinoic acid,Metabolite,C1=C(N=CC(=O)N1)C(=O)O,-1
PA166261101,5-hydroxy saxagliptin,Metabolite,,-1
PA166131420,5'-hydroxytegafur,Metabolite,,-1
PA166179675,5-hydroxytropisetron,Metabolite,,-1
PA166131517,5-hydroxy valproic acid,Metabolite,,-1
PA166245461,5-methylthiazol-2-ylcarbamoylcarboxylic acid,Metabolite,,-1
PA166131428,5'-O-desmethylomeprazole,Metabolite,,-1
PA166256981,5-oxo pitavastatin,Metabolite,,-1
PA151958362,"6,7-dihydroxybergamottin",Drug,,-1
PA166224246,6alpha-hydroxycannabidiol,Metabolite,,-1
PA166252501,6alpha-hydroxypaclitaxel,Metabolite,,-1
PA166170822,6-alpha-noroxycodol,Metabolite,,-1
PA166170818,6alpha-oxycodol,Metabolite,,-1
PA166170821,6alpha-oxymorphol,Metabolite,,-1
PA166224247,6beta-hydroxycannabidiol,Metabolite,,-1
PA166176697,6beta-hydroxycortisol,Biological Intermediate,,-1
PA166247841,6'beta-hydroxylovastatin,Metabolite,,-1
PA166273181,6beta-hydroxyprednisolone,Metabolite,,-1
PA166273161,6beta-hydroxyprednisone,Metabolite,,-1
PA166170823,6-beta-noroxycodol,Metabolite,,-1
PA166170819,6beta-oxycodol hydrochloride,Metabolite,,-1
PA166170820,6beta-oxymorphol,Metabolite,,-1
PA166254203,6'-carboxy simvastatin,Metabolite,,-1
PA166247922,6'-epipravastatin,Metabolite,,-1
PA166247861,6'-exomethylene lovastatin,Metabolite,,-1
PA166254202,6-exomethylenesimvastatin,Metabolite,,-1
PA166262162,6-hydroxyfluvastatin,Metabolite,,-1
PA166247761,6-hydroxymethyl simvastatin,Metabolite,,-1
PA166254081,6-hydroxymethyl simvastatin acid,Metabolite,,-1
PA166179302,6-hydroxyondansetron,Metabolite,CC1=NC=CN1CC2CCC3=C(C2=O)C4=C(N3C)C=CC(=C4)O,-1
PA166246802,6-hydroxyphenprocoumon,Metabolite,,-1
PA166228041,6-hydroxypimozide,Metabolite,,-1
PA166131394,6-hydroxy r-warfarin,Metabolite,,-1
PA166131393,6-hydroxy s-warfarin,Metabolite,,-1
PA166179676,6-hydroxytropisetron,Metabolite,,-1
PA166160610,6-methylmercaptopurine riboside,Metabolite,CSC1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)O)O,-1
PA166131255,6-O-desmethyl mycophenolic acid,Metabolite,,-1
PA130230922,6-o-phosphoryl inosine monophosphate,Drug,C1=NC2=C(C(=N1)OP(=O)(O)O)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,-1
PA166170918,6-oxo-methylphenidate,Metabolite,,-1
PA166170922,6-oxo-ritalinic acid,Metabolite,,-1
PA166178276,6-phosphogluconate,Biological Intermediate,,-1
PA166178275,6-phosphogluconolactone,Biological Intermediate,,-1
PA166226481,7-carboxycannabidiol,Metabolite,,-1
PA165291924,7-deoxydoxorubicinone,Metabolite,COC1=CC=CC2=C1C(=O)C3=C(C2=O)C(=C4C[C@](CCC4=C3O)(C(=O)CO)O)O,-1
PA166224248,7-hydroxycannabidiol,Metabolite,,-1
PA166131321,7-hydroxyefavirenz,Metabolite,C1CC1C#C[C@]2(C3=CC(=C(C=C3NC(=O)O2)O)Cl)C(F)(F)F,-1
PA166131554,7-hydroxyefavirenz glucuronide,Metabolite,,-1
PA166179304,7-hydroxyondansetron,Metabolite,CC1=NC=CN1CC2CCC3=C(C2=O)C4=C(N3C)C=C(C=C4)O,-1
PA166246803,7-hydroxyphenprocoumon,Metabolite,,-1
PA166267861,7-hydroxyrisperidone,Metabolite,,-1
PA166131397,7-hydroxy r-warfarin,Metabolite,,-1
PA166131399,7-hydroxy s-warfarin,Metabolite,,-1
PA166179677,7-hydroxytropisetron,Metabolite,,-1
PA166131296,"8,14-dihydroxyefavirenz",Metabolite,C1CC1(C#C[C@]2(C3=CC(=CC(=C3NC(=O)O2)O)Cl)C(F)(F)F)O,-1
PA166131556,"8,14-dihydroxyefavirenz glucuronide",Metabolite,,-1
PA166160608,"8,9-anhydroerythronolide b 6,9-hemiketal",Metabolite,,-1
PA152530740,"8-cyclopentyl-1,3-dipropylxanthine",Drug,,-1
PA166265643,8-hydroxyacyclovir,Metabolite,,-1
PA166179269,8-hydroxycarvedilol,Metabolite,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=C(N3)C(=CC=C4)O)O,-1
PA166131334,8-hydroxyefavirenz,Metabolite,C1CC1C#C[C@]2(C3=CC(=CC(=C3NC(=O)O2)O)Cl)C(F)(F)F,-1
PA166131555,8-hydroxyefavirenz glucuronide,Metabolite,,-1
PA166131248,8-hydroxynevirapine,Metabolite,,-1
PA166131257,8-hydroxynevirapine glucuronide,Metabolite,,-1
PA166179303,8-hydroxyondansetron,Metabolite,CC1=NC=CN1CC2CCC3=C(C2=O)C4=C(N3C)C(=CC=C4)O,-1
PA166256961,8-hydroxy pitavastatin,Metabolite,,-1
PA166131396,8-hydroxy r-warfarin,Metabolite,,-1
PA166160631,8-hydroxythioguanine,Metabolite,,-1
PA166153171,8-oxo-dGTP,Biological Intermediate,C1[C@@H]([C@H](O[C@H]1N2C3=C(C(=O)N=C(N3)N)NC2=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,-1
PA166131239,"9,10-dihydrodeoxyartemisinin",Metabolite,,-1
PA166250402,9-desmethyl alpha-dihydrodeutetrabenazine,Metabolite,,-1
PA166250401,9-desmethyl alpha-dihydrotetrabenazine,Metabolite,,-1
PA166250421,9-desmethyl beta-dihydrodeutetrabenazine,Metabolite,,-1
PA166250404,9-desmethyl beta-dihydrotetrabenazine,Metabolite,,-1
PA448004,abacavir,Drug,C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N,1
PA166131333,abacavir 5'-monophosphate,Metabolite,C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)COP(=O)(O)O)N,-1
PA166131344,abacavir carboxylate,Metabolite,C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)C(=O)O)N,-1
PA166131304,abacavir glucuronide,Metabolite,C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)N,-1
PA166131545,abacavir minor metabolites,Metabolite,,-1
PA164754915,abarelix,Drug,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C,-1
PA164747080,abatacept,Drug,,-1
PA448006,abciximab,Drug,,-1
PA166153471,abemaciclib,Drug,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,-1
PA166123407,abiraterone,Drug,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O,-1
PA166272921,abrocitinib,Drug,CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3,-1
PA166104276,ABT-751,Drug,,-1
PA166198581,acalabrutinib,Drug,,-1
PA10344,acamprosate,Drug,CC(=O)NCCCS(=O)(=O)O,-1
PA448010,acarbose,Drug,C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@@H]([C@@H]([C@H]4O)O)O)CO,-1
PA448011,acebutolol,Drug,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,-1
PA166049185,aceclofenac,Drug,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl,1
PA164712305,ACE inhibitors and calcium channel blockers,Drug Class,,-1
PA164712306,ACE inhibitors and diuretics,Drug Class,,-1
PA164712307,"Ace Inhibitors, Combinations",Drug Class,,-1
PA164712308,"Ace Inhibitors, Plain",Drug Class,,-1
PA166049184,acemetacin,Drug,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,-1
PA452632,acenocoumarol,Drug,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,-1
PA164783999,acepromazine,Drug,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C,-1
PA164743727,aceprometazine,Drug,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(=O)C)N(C)C,-1
PA166186245,acetaldehyde,Metabolite,,-1
PA448014,acetamide mea,Drug,,-1
PA448015,acetaminophen,Drug,CC(=O)NC1=CC=C(C=C1)O,-1
PA166246281,acetaminophen / caffeine / dihydrocodeine,Drug,,-1
PA166184061,acetaminophen / codeine,Drug,,-1
PA166131240,acetaminophen-cysteine,Metabolite,,-1
PA165983955,acetaminophen glucuronide,Metabolite,CC(=O)NC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,-1
PA166131355,acetaminophen-glutathione,Metabolite,CC(=O)NC1=CC=C(C=C1)O.C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,-1
PA165290927,acetaminophen/propoxyphene napsylate,Drug,,-1
PA165983956,acetaminophen sulfate,Metabolite,CC(=O)NC1=CC=C(C=C1)OS(=O)(=O)O,-1
PA166184496,acetaminophen / tramadol,Drug,,-1
PA448016,acetanilide,Drug,,-1
PA448018,acetazolamide,Drug,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,-1
PA448021,acetic acid,Drug,CC(=O)O,-1
PA164712309,Acetic acid derivatives and related substances,Drug Class,,-1
PA166178650,acetoacetyl coenzyme A,Biological Intermediate,,-1
PA164777011,acetohexamide,Drug,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,-1
PA164749213,acetohydroxamic acid,Drug,CC(=O)NO,-1
PA448025,acetone,Drug,,-1
PA164781360,acetophenazine,Drug,CC(=O)C1=CC2=C(C=C1)N(C3=CC=CC=C3S2)CCCN4CCN(CC4)CCO,-1
PA448031,acetylcholine,Drug,CC(=O)OCC[N+](C)(C)C,-1
PA166178658,acetyl coenzyme A,Biological Intermediate,,-1
PA448033,acetylcysteine,Drug,CC(=O)N[C@@H](CS)C(=O)O,-1
PA164746246,acetyldigitoxin,Drug,C[C@@H]1[C@H]([C@H](C[C@@H](O1)OC2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)OC4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)OC(=O)C)O,-1
PA166131586,acetylhydrazine,Metabolite,CC(=O)NN,-1
PA166131582,acetylisoniazid,Metabolite,CC(=O)NNC(=O)C1=CC=NC=C1,-1
PA164712311,Acidifiers,Drug Class,,-1
PA164712310,Acid preparations,Drug Class,,-1
PA448039,acitretin,Drug,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C)C)C)OC,-1
PA166260901,acp-5862,Metabolite,,-1
PA164712312,Acridine derivatives,Drug Class,,-1
PA166131366,acrolein,Metabolite,C=CC=O,-1
PA166131350,acrylic acid,Metabolite,C=CC(=O)O,-1
PA166261202,ACT-132577,Metabolite,,-1
PA164712313,Acth,Drug Class,,-1
PA164712314,Actinomycines,Drug Class,,-1
PA448045,acyclovir,Drug,C1=NC2=C(N1COCCO)NC(=NC2=O)N,-1
PA166266341,acyclovir aldehyde,Metabolite,,-1
PA166265642,acyclovir diphosphate,Metabolite,,-1
PA166265621,acyclovir monophosphate,Metabolite,,-1
PA166265641,acyclovir triphosphate,Metabolite,,-1
PA166246421,adagrasib,Drug,,-1
PA10004,adalimumab,Drug,,-1
PA164712315,Adamantane derivatives,Drug Class,,-1
PA448047,adapalene,Drug,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,-1
PA10005,adefovir dipivoxil,Prodrug,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,-1
PA448048,adenine,Drug,C1=NC2=C(N1)C(=NC=N2)N,-1
PA448049,adenosine,"Drug,""Biological Intermediate""",C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,-1
PA166178281,adenosine diphosphate,"Drug,""Biological Intermediate""",,-1
PA164744376,adenosine monophosphate,"Drug,""Biological Intermediate""",C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,-1
PA164743471,adenosine triphosphate,"Drug,""Biological Intermediate""",C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,-1
PA164783813,adinazolam,Drug,CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,-1
PA164712316,Adrenergic and dopaminergic agents,Drug Class,,-1
PA164712318,Adrenergics and other drugs for obstructive airway diseases,Drug Class,,-1
PA164712317,Adrenergics For Systemic Use,Drug Class,,-1
PA10405,"adrenergics, inhalants",Drug Class,,-1
PA165981154,afatinib,Drug,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,-1
PA165981139,afatinib dimaleate,Drug,,-1
PA452609,aflatoxin b1,Drug,,-1
PA166118342,aflibercept,Drug,,-1
PA166182001,AFN911,Metabolite,,-1
PA166122586,afutuzumab,Drug,,-1
PA164746527,agalsidase beta,Drug,,-1
PA164712320,Agents Acting On The Renin-angiotensin System,Drug Class,,-1
PA164712321,Agents Against Amoebiasis And Other Protozoal Diseases,Drug Class,,-1
PA164712322,Agents Against Leishmaniasis And Trypanosomiasis,Drug Class,,-1
PA164712323,Agents For Treatment Of Hemorrhoids And,Drug Class,,-1
PA165958363,agomelatine,Drug,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,-1
PA164776839,ajmaline,Drug,CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H](C2[C@H]5O)N3[C@@H]1O)C6=CC=CC=C6N4C,-1
PA164746058,albendazole,Drug,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,-1
PA166285061,albiglutide,Drug,CC[C@@H](C)[C@@H](C(=O)N[C@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC6=CN=CN6)N,-1
PA165958399,alcaftadine,Drug,CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1,-1
PA164747650,alclometasone,Drug,CCC(=O)OCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2[C@@H](CC4=CC(=O)C=C[C@]34C)Cl)O)C)C)OC(=O)CC,-1
PA166131264,alcoifosfamide,Metabolite,C(CO)COP(=O)(NCCCl)NCCCl,-1
PA166131381,alcophosphamide,Metabolite,C(CO)COP(=O)(N)N(CCCl)CCCl,-1
PA164712324,Aldehydes and derivatives,Drug Class,,-1
PA448081,aldesleukin,Drug,,-1
PA166131301,aldoifosfamide,Metabolite,C(COP(=O)(NCCCl)NCCCl)C=O,-1
PA166131270,aldophosphamide,Metabolite,C(COP(=O)(N)N(CCCl)CCCl)C=O,-1
PA164712325,Aldose reductase inhibitors,Drug Class,,-1
PA164924487,aldosterone,Biological Intermediate,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C=O)O,-1
PA164712326,Aldosterone antagonists,Drug Class,,-1
PA166160050,alectinib,Drug,CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6,-1
PA166182583,alectinib metabolite M4,Metabolite,,-1
PA166182584,alectinib metabolite M6,Metabolite,,-1
PA164748040,alefacept,Drug,,-1
PA164783958,alemtuzumab,Drug,,-1
PA448082,alendronate,Drug,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,-1
PA164746469,alfacalcidol,Drug,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,-1
PA448084,alfentanil,Drug,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,1
PA164774795,alfuzosin,Drug,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,-1
PA164748093,alglucerase,Drug,,-1
PA164754753,alglucosidase alfa,Drug,,-1
PA164712327,Alimentary Tract And Metabolism,Drug Class,,-1
PA166159961,alirocumab,Drug,,-1
PA166165015,alisertib,Drug,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,-1
PA143487910,aliskiren,Drug,CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,-1
PA164746900,alitretinoin,Drug,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,-1
PA164744894,alizapride,Drug,COC1=CC2=NNN=C2C=C1C(=O)NCC3CCCN3CC=C,-1
PA164712328,"Alkaloids, excl. rauwolfia",Drug Class,,-1
PA164712329,"Alkaloids, excl. rauwolfia, in combination with diuretics",Drug Class,,-1
PA164712331,Alkylating Agents,Drug Class,,-1
PA164712330,Alkyl sulfonates,Drug Class,,-1
PA166178623,allantoin,Biological Intermediate,,-1
PA164712336,Allergen extracts,Drug Class,,-1
PA164712337,Allergens,Drug Class,,-1
PA142320763,allopregnanolone,Drug,,-1
PA448320,allopurinol,Drug,C1=C2C(=NC=NC2=O)NN1,1
PA166211041,allopurinol riboside,Metabolite,,-1
PA166211062,allopurinol ribotide,Metabolite,,-1
PA164712332,All Other Non-therapeutic Products,Drug Class,,-1
PA164712334,All Other Therapeutic Products,Drug Class,,-1
PA164745307,allylestrenol,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34,-1
PA164750492,almitrine,Drug,C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C,-1
PA133888888,almokalant,Drug,,-1
PA10246,almotriptan,Drug,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,-1
PA448322,aloe,Drug,,-1
PA164745502,alosetron,Drug,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,-1
PA452626,alox5-pathway modifiers,Drug Class,,-1
PA166184523,alpelisib,Drug,,-1
PA10308,alpha-1-proteinase inhibitor,Drug,,-1
PA164712344,Alpha-adrenoreceptor antagonists,Drug Class,,-1
PA164712346,Alpha-adrenoreceptor antagonists and diuretics,Drug Class,,-1
PA164712343,Alpha- and beta-adrenoreceptor agonists,Drug Class,,-1
PA164712339,Alpha and beta blocking agents,Drug Class,,-1
PA164712340,Alpha and beta blocking agents and other diuretics,Drug Class,,-1
PA164712341,Alpha and beta blocking agents and thiazides,Drug Class,,-1
PA166250364,alpha-dihydrodeutetrabenazine,Metabolite,,-1
PA166250361,alpha-dihydrotetrabenazine,Metabolite,,-1
PA164712342,Alpha glucosidase inhibitors,Drug Class,,-1
PA166177865,alpha-hydroxymetoprolol,Metabolite,,-1
PA166180493,alpha-hydroxy sertraline ketone,Metabolite,C1CC(=O)C2=CC=CC=C2[C@@H]1C3=CC(=C(C=C3)Cl)Cl,-1
PA166180537,alpha-hydroxy sertraline ketone glucuronide,Metabolite,,-1
PA166131312,alpha-hydroxytamoxifen,Metabolite,CC(/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3)O,-1
PA166131256,alpha-hydroxytamoxifen o-glucuronide,Metabolite,,-1
PA166178654,alpha-ketoglutarate,Biological Intermediate,,-1
PA449384,alpha-linolenic acid,Drug,CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O,-1
PA147358765,alpha-methyl-para-tyrosine,Drug,,-1
PA166170627,alpha-MSH,Biological Intermediate,,-1
PA448333,alprazolam,Drug,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,-1
PA164750541,alprenolol,Drug,CC(C)NCC(COC1=CC=CC=C1CC=C)O,-1
PA448334,alprostadil,Drug,CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O,-1
PA164746411,alseroxylon,Drug,,-1
PA164776730,alteplase,Drug,,-1
PA164743136,altretamine,Drug,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,-1
PA164760864,aluminium,Drug,[Al],-1
PA164712347,Aluminium agents,Drug Class,,-1
PA164712348,Aluminium compounds,Drug Class,,-1
PA448348,aluminum chloride,Drug,,-1
PA165958393,aluminum hydroxide,Drug,,-1
PA166234821,"aluminum hydroxide, magnesium hydroxide, drug combination",Drug,,-1
PA164764505,alverine,Drug,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2,-1
PA165291491,alvespimycin,Drug,,-1
PA164754864,alvimopan,Drug,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,-1
PA448360,amantadine,Drug,C1C2CC3CC1CC(C2)(C3)N,-1
PA164764601,ambenonium,Drug,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl,-1
PA165860521,ambrisentan,Drug,,-1
PA164746074,amcinonide,Drug,CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)OC6(O2)CCCC6,-1
PA164754807,amdinocillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)O)C,-1
PA166049186,amfenac,Drug,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)O)N,-1
PA164712349,Amides,Drug Class,,-1
PA166185150,amifampridine,Drug,,-1
PA166182002,amifampridine phosphate,Drug,,-1
PA448365,amifostine,Drug,C(CN)CNCCSP(=O)(O)O,-1
PA164744372,amikacin,Drug,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,1
PA448368,amiloride,Drug,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,-1
PA448372,amino acids,"Drug,""Biological Intermediate""",,-1
PA164712351,Amino acids and derivatives,Drug Class,,-1
PA164712353,"Amino acids/carbohydrates/minerals/vitamins, combinations",Drug Class,,-1
PA164712352,"Amino acids, incl. combinations with polypeptides",Drug Class,,-1
PA164712354,Aminoalkyl ethers,Drug Class,,-1
PA10247,aminobenzoic acid,Drug,,-1
PA164774947,aminocaproic acid,Drug,C(CCC(=O)O)CCN,-1
PA448375,aminoglutethimide,Drug,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,-1
PA452167,aminoglycoside antibacterials,Drug Class,,-1
PA134711723,aminohippurate,Drug,C1=CC(=CC=C1C(=O)NCC(=O)O)N,-1
PA10015,aminolevulinic acid,Drug,C(CC(=O)O)C(=O)CN,-1
PA164748135,aminophenazone,Drug,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C,-1
PA164781029,aminophylline,Drug,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,-1
PA165109541,aminopterin,Drug,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N,-1
PA164712355,Aminoquinolines,Drug Class,,-1
PA448382,aminosalicylic acid,Drug,C1=CC(=C(C=C1N)O)C(=O)O,-1
PA164712356,Aminosalicylic acid and derivatives,Drug Class,,-1
PA164712357,Aminosalicylic acid and similar agents,Drug Class,,-1
PA448383,amiodarone,Drug,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,-1
PA162565877,amisulpride,Drug,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,-1
PA448385,amitriptyline,Drug,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,1
PA166163622,amitriptyline n-glucuronide,Metabolite,C[N+](C)(CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O)O)O,-1
PA166163680,amitriptylinoxide,Metabolite,C[N+](C)(CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31)[O-],-1
PA164745310,amlexanox,Drug,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,-1
PA448388,amlodipine,Drug,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,-1
PA166183785,amlodipine / atorvastatin / perindopril arginine,Drug,,-1
PA166131585,ammonia,"Drug,""Metabolite""",N,-1
PA166131461,ammonium,Metabolite,,-1
PA448392,ammonium chloride,Drug,,-1
PA165958400,ammonium lactate,Drug,,-1
PA448401,amobarbital,Drug,CCC1(C(=O)NC(=O)NC1=O)CCC(C)C,-1
PA448404,amodiaquine,Drug,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,-1
PA166131469,amodiaquine M2,Metabolite,,-1
PA448405,amoxapine,Drug,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,-1
PA448406,amoxicillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C,-1
PA164712358,Amphenicols,Drug Class,,-1
PA448408,amphetamine,Drug,C[C@@H](CC1=CC=CC=C1)N,-1
PA448415,amphotericin b,Drug,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,-1
PA448419,ampicillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C,-1
PA448422,amprenavir,Drug,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,-1
PA164746803,amrinone,Drug,C1=CN=CC=C1C2=CNC(=O)C(=C2)N,-1
PA10309,amsacrine,Drug,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,-1
PA166220604,amuvatinib,Drug,,-1
PA164750570,amyl nitrite,Drug,CC(C)CCON=O,-1
PA164712360,Anabolic Agents For Systemic Use,Drug Class,,-1
PA164712361,Anabolic Steroids,Drug Class,,-1
PA165960688,anacetrapib,Drug,,-1
PA164742986,anagrelide,Drug,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31,-1
PA10799,anakinra,Drug,,-1
PA164712362,Analgesics,Drug Class,,-1
PA164712363,Analgesics and anesthetics,Drug Class,,-1
PA166178985,anandamide,Biological Intermediate,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,-1
PA448432,anastrozole,Drug,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,-1
PA164712364,"Androgen, progestogen and estrogen in combination",Drug Class,,-1
PA10381,androgens and estrogens,Drug Class,,-1
PA164712365,Androgens And Female Sex Hormones In Combination,Drug Class,,-1
PA164712366,Androgens and female sex hormones in combination with other drugs,Drug Class,,-1
PA10733,androgens for topical use,Drug Class,,-1
PA164712367,Androstan derivatives,Drug Class,,-1
PA166178641,androstenedione,Biological Intermediate,,-1
PA166178989,angiotensin 1-5,Biological Intermediate,CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,-1
PA166178653,angiotensin 1-7,Biological Intermediate,,-1
PA166179133,angiotensin 1-9,Biological Intermediate,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)O)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,-1
PA166109575,angiotensin I,Biological Intermediate,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,-1
PA166109554,angiotensin II,Biological Intermediate,CC[C@H](C)C(C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,-1
PA164712372,Angiotensin II Antagonists,Drug Class,,-1
PA164712368,Angiotensin II antagonists and calcium channel blockers,Drug Class,,-1
PA164712369,Angiotensin II antagonists and diuretics,Drug Class,,-1
PA164712371,"Angiotensin II Antagonists, Combinations",Drug Class,,-1
PA166160603,anhydroerythromycin,Metabolite,CC[C@@H]1C2([C@@H]([C@H](C3(O2)[C@@H](CC(O3)([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC4CC(C(C(O4)C)O)(C)OC)C)OC5C(C(CC(O5)C)N(C)C)O)C)C)C)O)C,-1
PA164742938,anidulafungin,Drug,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O,-1
PA166277641,anifrolumab,Drug,,-1
PA164768817,anileridine,Drug,CCOC(=O)C1(CCN(CC1)CCC2=CC=C(C=C2)N)C3=CC=CC=C3,-1
PA164712373,Anilides,Drug Class,,-1
PA164746467,anisindione,Drug,COC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,-1
PA164754880,anisotropine methylbromide,Drug,CCCC(CCC)C(=O)OC1C[C@H]2CC[C@H](C1)[N+]2(C)C.[Br-],-1
PA164769075,anistreplase,Drug,,-1
PA452298,antacids,Drug Class,,-1
PA164712377,"Antacids, other combinations",Drug Class,,-1
PA164712374,Antacids with antiflatulents,Drug Class,,-1
PA164712375,Antacids with antispasmodics,Drug Class,,-1
PA164712376,Antacids with sodium bicarbonate,Drug Class,,-1
PA165958418,antazoline,Drug,,-1
PA164712378,Anterior Pituitary Lobe Hormones And Analogues,Drug Class,,-1
PA164712379,Anthelmintics,Drug Class,,-1
PA130620651,anthracyclines and related substances,Drug Class,,-1
PA164712380,Anthrax vaccines,Drug Class,,-1
PA164712381,Anti-acne Preparations,Drug Class,,-1
PA164712382,Anti-acne Preparations For Systemic Use,Drug Class,,-1
PA164712383,Anti-acne Preparations For Topical Use,Drug Class,,-1
PA164712390,Antiadrenal Preparations,Drug Class,,-1
PA164712391,"Antiadrenergic Agents, Centrally Acting",Drug Class,,-1
PA164712392,"Antiadrenergic Agents, Ganglion-blocking",Drug Class,,-1
PA164712393,"Antiadrenergic Agents, Peripherally Acting",Drug Class,,-1
PA164712394,"Antiallergic agents, excl. corticosteroids",Drug Class,,-1
PA164712397,Antiandrogens,Drug Class,,-1
PA164712384,Anti-androgens,Drug Class,,-1
PA164712398,Antiandrogens and estrogens,Drug Class,,-1
PA164712399,"Antiandrogens, plain",Drug Class,,-1
PA164712400,Antianemic Preparations,Drug Class,,-1
PA164712402,"Antiarrhythmics, class Ia",Drug Class,,-1
PA452249,"antiarrhythmics, class i and iii",Drug Class,,-1
PA164712403,"Antiarrhythmics, class Ib",Drug Class,,-1
PA164712404,"Antiarrhythmics, class Ic",Drug Class,,-1
PA164712401,"Antiarrhythmics, class III",Drug Class,,-1
PA164712405,Antibacterials For Systemic Use,Drug Class,,-1
PA164712406,Antibiotics,Drug Class,,-1
PA164712415,"Antibiotics And Chemotherapeutics, Combinations",Drug Class,,-1
PA164712414,Antibiotics And Chemotherapeutics For Dermatological Use,Drug Class,,-1
PA164712417,Antibiotics and corticosteroids,Drug Class,,-1
PA164712416,Antibiotics For Topical Use,Drug Class,,-1
PA164712418,Anticestodals,Drug Class,,-1
PA164712419,Anticholinergic Agents,Drug Class,,-1
PA164712420,Anticholinergics,Drug Class,,-1
PA164712423,Anticholinesterases,Drug Class,,-1
PA164712424,Anticorticosteroids,Drug Class,,-1
PA164712385,Anti-dementia Drugs,Drug Class,,-1
PA452229,antidepressants,Drug Class,,-1
PA164712425,Antidepressants in combination with psycholeptics,Drug Class,,-1
PA164712426,Antidiarrheal Microorganisms,Drug Class,,-1
PA164712428,"Antidiarrheals, Intestinal Antiinflammatory/antiinfective",Drug Class,,-1
PA164712429,Antidotes,Drug Class,,-1
PA164712431,Antiemetics And Antinauseants,Drug Class,,-1
PA143485705,antiepileptics,Drug Class,,-1
PA164712386,Anti-estrogens,Drug Class,,-1
PA164712433,Antifibrinolytics,Drug Class,,-1
PA164712434,Antifungals For Dermatological Use,Drug Class,,-1
PA164712435,Antifungals For Systemic Use,Drug Class,,-1
PA164712436,Antifungals For Topical Use,Drug Class,,-1
PA10393,antiglaucoma preparations and miotics,Drug Class,,-1
PA164712387,Anti-gonadotropin-releasing hormones,Drug Class,,-1
PA164712438,Antigonadotropins and similar agents,Drug Class,,-1
PA164712440,Antigout Preparations,Drug Class,,-1
PA164712441,Antigrowth hormones,Drug Class,,-1
PA164750168,antihemophilic factor,Drug,,-1
PA164712442,Antihemorrhagics,Drug Class,,-1
PA164712443,Antihidrotics,Drug Class,,-1
PA164712444,Antihistamines For Systemic Use,Drug Class,,-1
PA164712445,Antihypertensives,Drug Class,,-1
PA164712446,Antihypertensives And Diuretics In Combination,Drug Class,,-1
PA164712447,Antiinfectives,Drug Class,,-1
PA164712453,"Antiinfectives And Antiseptics, Excl. Combinations",Drug Class,,-1
PA164712455,Antiinfectives and antiseptics for local oral treatment,Drug Class,,-1
PA164712457,Antiinfectives/antiseptics In Combination With Corticosteroids,Drug Class,,-1
PA164712454,Antiinfectives For Systemic Use,Drug Class,,-1
PA164712456,Antiinfectives for treatment of acne,Drug Class,,-1
PA164712458,Antiinflammatory Agents,Drug Class,,-1
PA164712460,Antiinflammatory Agents And Antiinfectives In Combination,Drug Class,,-1
PA164712462,"Antiinflammatory agents, non-steroids",Drug Class,,-1
PA164712463,"Antiinflammatory agents, non-steroids and antiinfectives in combination",Drug Class,,-1
PA164712461,Antiinflammatory And Antirheumatic Products,Drug Class,,-1
PA10384,"antiinflammatory and antirheumatic products, non-steroids",Drug Class,,-1
PA164712466,Antiinflammatory/antirheumatic Agents In Combination,Drug Class,,-1
PA164712467,Antiinflammatory/antirheumatic agents in combination with corticosteroids,Drug Class,,-1
PA164712464,"Antiinflammatory preparations, non-steroids for topical use",Drug Class,,-1
PA164712465,Antiinflammatory products for vaginal administration,Drug Class,,-1
PA164712468,Antimalarials,Drug Class,,-1
PA452622,antimetabolites,Drug Class,,-1
PA164712469,Antimigraine Preparations,Drug Class,,-1
PA164712470,Antimony compounds,Drug Class,,-1
PA448452,antimony potassium tartrate,Drug,,-1
PA164712471,Antimycobacterials,Drug Class,,-1
PA164712473,Antimycotics For Systemic Use,Drug Class,,-1
PA164712474,Antinematodal Agents,Drug Class,,-1
PA452621,antineoplastic agents,Drug Class,,-1
PA164712475,Antineoplastic And Immunomodulating Agents,Drug Class,,-1
PA164712476,Antineovascularisation agents,Drug Class,,-1
PA164712478,"Antiobesity Preparations, Excl. Diet Products",Drug Class,,-1
PA164712479,"Antiparasitic Products, Insecticides And Repellents",Drug Class,,-1
PA164712388,Anti-parathyroid Agents,Drug Class,,-1
PA164712389,Anti-parkinson Drugs,Drug Class,,-1
PA164712480,Antiprogestogens,Drug Class,,-1
PA164712482,Antipropulsives,Drug Class,,-1
PA164712483,Antiprotozoals,Drug Class,,-1
PA164712484,"Antipruritics, Incl. Antihistamines, Anesthetics, Etc.",Drug Class,,-1
PA164712486,Antipsoriatics,Drug Class,,-1
PA164712487,Antipsoriatics For Systemic Use,Drug Class,,-1
PA164712488,Antipsoriatics For Topical Use,Drug Class,,-1
PA452233,antipsychotics,Drug Class,,-1
PA448453,antipyrine,Drug,CC1=CC(=O)N(N1C)C2=CC=CC=C2,-1
PA164712489,Antiseptics,Drug Class,,-1
PA164712492,Antiseptics and corticosteroids,Drug Class,,-1
PA164712491,Antiseptics And Disinfectants,Drug Class,,-1
PA164712493,Antispasmodics And Anticholinergics In Combination With Other Drugs,Drug Class,,-1
PA164712494,Antispasmodics In Combination With Analgesics,Drug Class,,-1
PA164712496,Antispasmodics in combination with other drugs,Drug Class,,-1
PA164712495,Antispasmodics In Combination With Psycholeptics,Drug Class,,-1
PA164712497,"Antispasmodics, psycholeptics and analgesics in combination",Drug Class,,-1
PA452200,antithrombotic agents,Drug Class,,-1
PA164743704,antithymocyte globulin,Drug,,-1
PA164712499,Antithyroid Preparations,Drug Class,,-1
PA164712500,Antitrematodals,Drug Class,,-1
PA164712501,Antivaricose Therapy,Drug Class,,-1
PA164712502,Antivertigo Preparations,Drug Class,,-1
PA452174,antivirals,Drug Class,,-1
PA164712504,Antivirals For Systemic Use,Drug Class,,-1
PA164712505,"Antivirals for treatment of HIV infections, combinations",Drug Class,,-1
PA164712506,Antracen derivatives,Drug Class,,-1
PA164784000,antrafenine,Drug,C1CN(CCN1CCOC(=O)C2=CC=CC=C2NC3=C4C=CC(=CC4=NC=C3)C(F)(F)F)C5=CC=CC(=C5)C(F)(F)F,-1
PA164712507,Anxiolytics,Drug Class,,-1
PA166131559,APC,Metabolite,,-1
PA166163740,apixaban,Drug,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,-1
PA166209601,APL-9,Drug,,-1
PA164781163,apomorphine,Drug,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(=C(C=C4)O)O,-1
PA164712508,Appetite Stimulants,Drug Class,,-1
PA166183406,apple juice,Drug,,-1
PA164748866,apraclonidine,Drug,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl,-1
PA166220442,apremilast,Drug,,-1
PA164747039,aprepitant,Drug,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@H]2[C@H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,-1
PA164764496,aprindine,Drug,CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3,-1
PA164754809,aprobarbital,Drug,CC(C)C1(C(=O)NC(=O)NC1=O)CC=C,-1
PA448472,aprotinin,Drug,,-1
PA166178659,arachidonic acid,Biological Intermediate,,-1
PA166180985,ara-CTP,Metabolite,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,-1
PA165958370,arbekacin,Drug,,-1
PA164747979,arbutamine,Drug,C1=CC(=CC=C1CCCCNC[C@@H](C2=CC(=C(C=C2)O)O)O)O,-1
PA166162383,AR-C124910XX,Metabolite,,-1
PA166267801,AR-C133913XX,Metabolite,CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N,-1
PA164746540,arcitumomab,Drug,,-1
PA164754878,ardeparin,Drug,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,-1
PA164743977,arformoterol,Drug,C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O,-1
PA164745516,argatroban,Drug,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@@H](C3)C,-1
PA10026,aripiprazole,Drug,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,-1
PA166161216,aripiprazole lauroxil,Prodrug,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=C1C=C(C=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,-1
PA166246361,aripiprazole metabolite DM-1451,Metabolite,,-1
PA164712509,Arsenic compounds,Drug Class,,-1
PA448486,arsenic trioxide,Drug,O1[As]2O[As]1O2,-1
PA452638,arsenite,Drug,,-1
PA165260403,arteether,Drug,CCO[C@@H]1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)OC(CC3)(OO4)C)C)C,-1
PA165111698,artemether,Drug,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)OC)C,-1
PA165111696,artemisinin,Drug,C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,-1
PA143485261,artemisinin and derivatives,Drug Class,,-1
PA166131467,artemisinin crystal-7,Metabolite,,-1
PA164712512,"Arteriolar Smooth Muscle, Agents Acting On",Drug Class,,-1
PA165111697,artesunate,Drug,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,-1
PA166182731,articaine,Drug,,-1
PA166182783,articaine / epinephrine,Drug,,-1
PA166165070,arverapamil,Metabolite,CC(C)[C@@](CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,-1
PA451998,arylhydrazines,Drug Class,,-1
PA164712513,Aryloxyacetic acid derivatives,Drug Class,,-1
PA166268841,asciminib,Drug,C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,-1
PA164712515,"Ascorbic acid (vitamin C), combinations",Drug Class,,-1
PA164712514,"Ascorbic Acid (vitamin C), Incl. Combinations",Drug Class,,-1
PA164712516,"Ascorbic acid (vitamin C), plain",Drug Class,,-1
PA448492,asparaginase,Drug,,-1
PA448493,aspartame,Drug,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,-1
PA448497,aspirin,Drug,CC(=O)OC1=CC=CC=C1C(=O)O,1
PA166205381,astegolimab,Drug,,-1
PA448498,astemizole,Drug,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,-1
PA166128168,asunaprevir,Drug,CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,-1
PA166200301,AT-001,Drug,,-1
PA166208581,AT-527,Drug,,-1
PA166151864,ataluren,Drug,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,-1
PA10251,atazanavir,Drug,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,1
PA166182674,atazanavir / cobicistat,Drug,,-1
PA166159187,atazanavir M1,Metabolite,CC(C)(C)[C@@H](C(=O)NN(CC1=CC=C(C=C1)C2=CC=CC=N2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)(C)CO)NC(=O)OC)O)NC(=O)OC,-1
PA166159186,atazanavir M2,Metabolite,,-1
PA166159189,atazanavir M3,Metabolite,,-1
PA166159190,atazanavir M4,Metabolite,,-1
PA166159192,atazanavir M5,Metabolite,,-1
PA166159188,atazanavir M7,Metabolite,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)CO)NC(=O)OC)O)NC(=O)OC,-1
PA166182624,atazanavir / ritonavir,Drug,,-1
PA448499,atenolol,Drug,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,-1
PA166129523,atezolizumab,Drug,,-1
PA134688071,atomoxetine,Drug,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,1
PA448500,atorvastatin,Drug,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1
PA166247803,atorvastatin acyl glucuronide,Metabolite,,-1
PA166247561,atorvastatin lactone,Metabolite,,-1
PA448502,atovaquone,Drug,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,-1
PA164776840,atracurium,Drug,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C,-1
PA143414738,atrasentan,Drug,,-1
PA448505,atropine,Drug,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,-1
PA164781017,attapulgite,Drug,,-1
PA448510,auranofin,Drug,CC[PH+](CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],-1
PA166182681,avanafil,Drug,,-1
PA166223903,avapritinib,Drug,,-1
PA166179849,avatrombopag,Drug,C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl.C(=C\C(=O)O)\C(=O)O,-1
PA166169875,avelumab,Drug,,-1
PA164712517,Avermectines,Drug Class,,-1
PA166211861,axatilimab,Drug,,-1
PA164924493,axitinib,Drug,,-1
PA451996,azacitidine,Drug,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,-1
PA166049192,azapropazone,Drug,CCCC1C(=O)N2C3=C(C=CC(=C3)C)N=C(N2C1=O)N(C)C,-1
PA164712518,Azaspirodecanedione derivatives,Drug Class,,-1
PA164747157,azatadine,Drug,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1,-1
PA448515,azathioprine,Drug,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],1
PA164738432,AZD1152,Drug,,-1
PA164754850,azelaic acid,Drug,C(CCCC(=O)O)CCCC(=O)O,-1
PA448517,azelastine,Drug,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,-1
PA165958414,azidocillin,Drug,,-1
PA166131371,aziridine,Metabolite,C1CN1,-1
PA448519,azithromycin,Drug,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H](C([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,-1
PA164749135,azlocillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,-1
PA448523,aztreonam,Drug,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)[O-])NC(=O)/C(=N/OC(C)(C)C(=O)O)/C2=CSC(=N2)[NH3+],-1
PA164745461,bacampicillin,Drug,CCOC(=O)OC(C)OC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2NC(=O)[C@@H](C3=CC=CC=C3)N)(C)C,-1
PA448531,bacitracin,Drug,CCC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H](C(C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)C2CN=C(S2)[C@H](C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,-1
PA448533,baclofen,Drug,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,-1
PA164712519,"Bacterial And Viral Vaccines, Combined",Drug Class,,-1
PA164712520,Bacterial Vaccines,Drug Class,,-1
PA448536,balsalazide,Drug,C1=CC(=CC=C1C(=O)NCCC(=O)O)N/N=C\2/C=CC(=O)C(=C2)C(=O)O,-1
PA164743113,bambuterol,Drug,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,-1
PA166226401,bamlanivimab,Drug,,-1
PA166185162,bamocaftor,Drug,,-1
PA448538,barbital,Drug,CCC1(C(=O)NC(=O)NC1=O)CC,-1
PA164712523,"Barbiturates, combinations",Drug Class,,-1
PA164712522,Barbiturates in combination with other drugs,Drug Class,,-1
PA10827,"barbiturates, plain",Drug Class,,-1
PA166197621,baricitinib,Drug,,-1
PA448540,barium sulfate,Drug,,-1
PA164712524,Barium sulfate containing X-ray contrast media,Drug Class,,-1
PA164747126,basiliximab,Drug,,-1
PA166220606,bazedoxifene,Drug,,-1
PA164749511,becaplermin,Drug,,-1
PA448547,beclomethasone,Drug,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)Cl)C,-1
PA166182604,bedaquiline,Drug,,-1
PA166114904,belimumab,Drug,,-1
PA165971474,belinostat,Drug,,-1
PA164712526,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds",Drug Class,,-1
PA164712527,"Belladonna alkaloids, tertiary amines",Drug Class,,-1
PA164712528,Belladonna and derivatives in combination with analgesics,Drug Class,,-1
PA164712529,Belladonna and derivatives in combination with psycholeptics,Drug Class,,-1
PA164712525,"Belladonna And Derivatives, Plain",Drug Class,,-1
PA166268761,belzutifan,Drug,CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,-1
PA448561,benazepril,Drug,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,-1
PA448563,bendroflumethiazide,Drug,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,-1
PA166049178,benoxaprofen,Drug,,-1
PA165360203,Benserazide,Drug,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O,-1
PA164750572,bentiromide,Drug,C1=CC=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC3=CC=C(C=C3)C(=O)O,-1
PA164748098,bentoquatam,Drug,O.O=[Al]O[Al]=O.O=[Si]=O,-1
PA448571,benzaldehyde,Drug,,-1
PA164712530,Benzamides,Drug Class,,-1
PA134852920,benzbromarone,Drug,,-1
PA451991,benzene,Drug,COC1=CC=C(C=C1)S(=O)[O-],-1
PA164712531,Benzimidazole derivatives,Drug Class,,-1
PA166228321,benznidazole,Drug,,-1
PA448576,benzocaine,Drug,CCOC(=O)C1=CC=C(C=C1)N,-1
PA10402,benzodiazepine derivatives,Drug Class,,-1
PA166131454,benzodiazepine glucoronidated metabolites,Metabolite,,-1
PA164712532,Benzodiazepine related drugs,Drug Class,,-1
PA448578,benzoic acid,Drug,C1=CC=C(C=C1)C(=O)O,-1
PA164712533,Benzomorphan derivatives,Drug Class,,-1
PA164745459,benzonatate,Drug,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,-1
PA164712534,Benzothiazepine derivatives,Drug Class,,-1
PA166182627,benzoyl peroxide,Drug,,-1
PA448586,benzphetamine,Drug,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,-1
PA164749018,benzquinamide,Drug,CCN(CC)C(=O)C1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C)OC)OC,-1
PA164776841,benzthiazide,Drug,C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N,-1
PA448591,benztropine,Drug,CN1[C@@H]2CC[C@@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,-1
PA134687812,benzydamine,Drug,,-1
PA448594,benzyl alcohol,Drug,,-1
PA164748881,benzyl benzoate,Drug,C1=CC=C(C=C1)COC(=O)C2=CC=CC=C2,-1
PA164754810,benzylpenicilloyl polylysine,Drug,CC1(C(NC(S1)C(C(=O)NCCCCCC(=O)O)NC(=O)CC2=CC=CC=C2)C(=O)O)C,-1
PA164781356,bepotastine,Drug,C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O,-1
PA164754755,bepridil,Drug,CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3,-1
PA165860812,berberine,Drug,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC,-1
PA166123556,beryllium,Drug,[Be],-1
PA164712535,Beta Blocking Agents,Drug Class,,-1
PA164712536,Beta Blocking Agents And Other Antihypertensives,Drug Class,,-1
PA164712537,Beta Blocking Agents And Other Diuretics,Drug Class,,-1
PA164712538,Beta Blocking Agents And Thiazides,Drug Class,,-1
PA164712539,Beta Blocking Agents And Vasodilators,Drug Class,,-1
PA164712541,"Beta blocking agents, non-selective",Drug Class,,-1
PA164712542,"Beta blocking agents, non-selective, and other antihypertensives",Drug Class,,-1
PA164712543,"Beta blocking agents, non-selective, and other diuretics",Drug Class,,-1
PA164712544,"Beta blocking agents, non-selective, and thiazides",Drug Class,,-1
PA164712545,"Beta blocking agents, non-selective, and vasodilators",Drug Class,,-1
PA164712546,"Beta blocking agents, non-selective, thiazides and other diuretics",Drug Class,,-1
PA164712547,"Beta blocking agents, selective",Drug Class,,-1
PA164712548,"Beta blocking agents, selective, and other antihypertensives",Drug Class,,-1
PA164712549,"Beta blocking agents, selective, and other diuretics",Drug Class,,-1
PA164712550,"Beta blocking agents, selective, and thiazides",Drug Class,,-1
PA164712551,"Beta blocking agents, selective, and vasodilators",Drug Class,,-1
PA164712552,"Beta blocking agents, selective, thiazides and other diuretics",Drug Class,,-1
PA164712540,"Beta Blocking Agents, Thiazides And Other Diuretics",Drug Class,,-1
PA448601,beta carotene,Drug,,-1
PA166250362,beta-dihydrodeutetrabenazine,Metabolite,,-1
PA166250363,beta-dihydrotetrabenazine,Metabolite,,-1
PA165958372,betahistine,Drug,CNCCC1=CC=CC=N1,-1
PA448603,betaine,Drug,,-1
PA452154,"beta-lactam antibacterials, penicillins",Drug Class,,-1
PA164712554,Beta-lactamase inhibitors,Drug Class,,-1
PA164712555,Beta-lactamase resistant penicillins,Drug Class,,-1
PA164712556,Beta-lactamase sensitive penicillins,Drug Class,,-1
PA164754818,betamethasone,Drug,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,-1
PA448611,betaxolol,Drug,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,-1
PA164784036,betazole,Drug,C1=C(NN=C1)CCN,-1
PA448613,bethanechol,Drug,CC(C[N+](C)(C)C)OC(=O)N,-1
PA164743235,bethanidine,Drug,C\1[C@H](NC(=C/C1=C/C=[N+]2[C@@H](CC3=CC(=C(C=C32)O)O)C(=O)[O-])C(=O)O)C(=O)O,-1
PA130232992,bevacizumab,Drug,,-1
PA164743236,bevantolol,Drug,CC1=CC(=CC=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O,-1
PA164752250,bexarotene,Drug,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,-1
PA162364313,bezafibrate,Drug,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,-1
PA164746255,bicalutamide,Drug,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,-1
PA164746464,bifonazole,Drug,C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=CC=C3)N4C=CN=C4,-1
PA164712557,Biguanides,Drug Class,,-1
PA164712559,Biguanides and amidines,Drug Class,,-1
PA448617,bile acid preparations,Drug Class,,-1
PA164712560,Bile And Liver Therapy,Drug Class,,-1
PA166123346,bilirubin,Biological Intermediate,CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C\4/C(=C(C(=O)N4)C=C)C,-1
PA164748867,bimatoprost,Drug,CCNC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](CCC2=CC=CC=C2)O)O)O,-1
PA166179867,binimetinib,Drug,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,-1
PA164712561,Bioflavonoids,Drug Class,,-1
PA448625,biotin,Drug,C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)O)NC(=O)N2,-1
PA448626,biperiden,Drug,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,-1
PA164924560,Biricodar,Drug,COC1=CC(=CC(=C1OC)OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCC3=CN=CC=C3)CCCC4=CN=CC=C4,-1
PA146096021,bisantrene,Drug,,-1
PA164712562,Bismuth preparations,Drug Class,,-1
PA164774805,bismuth subsalicylate,Drug,C1=CC=C2C(=C1)C(=O)O[Bi]O2.O,-1
PA448641,bisoprolol,Drug,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,-1
PA166184057,bisoprolol fumarate / perindopril arginine,Drug,,-1
PA164712563,Bisphosphonates,Drug Class,,-1
PA164712564,"Bisphosphonates, combinations",Drug Class,,-1
PA164712565,Bisquaternary ammonium compounds,Drug Class,,-1
PA166248703,BITP,Metabolite,,-1
PA166248702,BITP sulfone,Metabolite,,-1
PA166248701,BITP sulfoxide,Metabolite,,-1
PA10032,bivalirudin,Drug,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](CC6=CC=CC=C6)N,-1
PA448645,bleomycin,Drug,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,-1
PA166129524,blinatumomab,Drug,,-1
PA164712566,Blood And Blood Forming Organs,Drug Class,,-1
PA164712567,Blood And Related Products,Drug Class,,-1
PA164712570,Blood coagulation factors,Drug Class,,-1
PA164712568,"Blood Glucose Lowering Drugs, Excl. Insulins",Drug Class,,-1
PA164712569,Blood Substitutes And Perfusion Solutions,Drug Class,,-1
PA164712571,Blood substitutes and plasma protein fractions,Drug Class,,-1
PA164712572,"Blood tests, auxiliary products",Drug Class,,-1
PA164712573,"Blood transfusion, auxiliary products",Drug Class,,-1
PA166122526,bnp-32,Drug,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)N,-1
PA165948902,boceprevir,Drug,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,-1
PA164712574,Bone morphogenetic proteins,Drug Class,,-1
PA165958425,bopindolol,Drug,,-1
PA164712575,Boric acid products,Drug Class,,-1
PA10252,bortezomib,Drug,B([C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,-1
PA10034,bosentan,Drug,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,-1
PA166114906,bosutinib,Drug,,-1
PA164754825,botulinum toxin type a,Drug,,-1
PA164747061,botulinum toxin type b,Drug,,-1
PA166109574,bradykinin,Biological Intermediate,C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,-1
PA165948903,brentuximab vedotin,Drug,,-1
PA448662,bretylium,Drug,CC[N+](C)(C)CC1=CC=CC=C1Br,-1
PA166160053,brexpiprazole,Drug,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,-1
PA166260821,brexpiprazole S-oxide,Metabolite,,-1
PA166163482,brigatinib,Drug,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,-1
PA448665,brimonidine,Drug,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,-1
PA164744929,brinzolamide,Drug,CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,-1
PA164924492,brivanib,Drug,,-1
PA166153491,brivaracetam,Drug,CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,-1
PA166184058,brivudine,Drug,,-1
PA10035,bromazepam,Drug,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3,-1
PA448670,bromfenac,Drug,C1=CC(=C(C(=C1)CC(=O)O)N)C(=O)C2=CC=C(C=C2)Br,-1
PA166233484,bromide,"Metabolite,""Ion""",,-1
PA448671,bromocriptine,Drug,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,-1
PA164760854,bromodiphenhydramine,Drug,CN(C)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)Br,-1
PA165282097,bromperidol,Drug,,-1
PA448675,brompheniramine,Drug,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,-1
PA166119001,brostallicin,Drug,CN1C=C(C=C1C(=O)NCCN=C(N)N)NC(=O)C2=CC(=CN2C)NC(=O)C3=CC(=CN3C)NC(=O)C4=CC(=CN4C)NC(=O)C(=C)Br,-1
PA166175777,brotizolam,Drug,,-1
PA164712576,Brucellosis vaccines,Drug Class,,-1
PA165291474,BSI-201,Drug,,-1
PA166123566,bucillamine,Drug,CC(C)(C(=O)N[C@@H](CS)C(=O)O)S,-1
PA165945764,bucindolol,Drug,CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O,-1
PA164748223,buclizine,Drug,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,-1
PA448681,budesonide,Drug,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,-1
PA166110256,bufuralol,Drug,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O,-1
PA164712577,Bulk producers,Drug Class,,-1
PA448682,bumetanide,Drug,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,-1
PA135057240,bupivacaine,Drug,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,-1
PA165958426,bupranolol,Drug,,-1
PA448685,buprenorphine,Drug,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,1
PA166182641,buprenorphine / naloxone,Drug,,-1
PA448687,bupropion,Drug,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,-1
PA10253,buserelin,Drug,,-1
PA448689,buspirone,Drug,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,-1
PA448691,busulfan,Drug,CS(=O)(=O)OCCCCOS(=O)(=O)C,-1
PA166131462,busulfan glutathione conjugate,Metabolite,,-1
PA166131463,busulfan n-acetylated cysteine conjugate,Metabolite,,-1
PA164743463,butabarbital,Drug,CCC(C)C1(C(=O)NC(=O)NC1=O)CC,-1
PA448695,butalbital,Drug,CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C,-1
PA164745478,butenafine,Drug,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,-1
PA164748035,butethal,Drug,CCCCC1(C(=O)NC(=O)NC1=O)CC,-1
PA164781353,butoconazole,Drug,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl,-1
PA164745398,butorphanol,Drug,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,-1
PA448704,butylated hydroxytoluene,Drug,,-1
PA164712578,Butylpyrazolidines,Drug Class,,-1
PA164712579,Butyrophenone derivatives,Drug Class,,-1
PA166131518,c3-coenzyme A,Metabolite,,-1
PA166131519,c5-coenzyme A,Metabolite,,-1
PA165958401,cabazitaxel,Drug,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,-1
PA448708,cabergoline,Drug,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C,-1
PA166251361,cabotegravir,Drug,,-1
PA166251381,cabotegravir / rilpivirine,Drug,,-1
PA165906891,cabozantinib,Drug,,-1
PA448710,caffeine,Drug,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,-1
PA132595336,calcein,Drug,,-1
PA164745614,calcidiol,Drug,C[C@H](CCCC(C)(C)O)[C@H]1CCC\2[C@@]1(CCC/C2=C\C=C/3\C[C@@H](CCC3=C)O)C,-1
PA164712580,Calcineurin inhibitors,Drug Class,,-1
PA448714,calcipotriol,Drug,C[C@H](/C=C/C(C1CC1)O)[C@H]2CC[C@@H]\3[C@@]2(CCC/C3=C\C=C/4\C[C@H](C[C@@H](C4=C)O)O)C,-1
PA164712581,Calcitonin preparations,Drug Class,,-1
PA448717,calcitriol,Drug,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,-1
PA164712582,calcium,"Drug,""Ion""",[Ca+2],-1
PA164746897,calcium acetate,Drug,CC(=O)[O-].CC(=O)[O-].[Ca+2],-1
PA448726,calcium carbonate,Drug,,-1
PA10407,calcium channel blockers,Drug Class,,-1
PA164712584,Calcium Channel Blockers And Diuretics,Drug Class,,-1
PA448729,calcium chloride,Drug,[Cl-].[Cl-].[Ca+2],-1
PA164712588,"Calcium, combinations with other drugs",Drug Class,,-1
PA164712587,Calcium compounds,Drug Class,,-1
PA164746233,calcium gluceptate,Drug,C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(C(=O)[O-])O)O)O)O)O)O.[Ca+2],-1
PA448735,calcium gluconate,Drug,,-1
PA164712585,Calcium Homeostasis,Drug Class,,-1
PA448744,calcium pantothenate,Drug,,-1
PA10373,calcium phosphate,Drug,,-1
PA166131546,calicheamicin gamma1,Metabolite,,-1
PA166197181,camostat mesilate,Drug,,-1
PA153590860,camptothecin,Drug,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,-1
PA165958358,canakinumab,Drug,,-1
PA448765,candesartan,Drug,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,-1
PA166182234,candesartan cilexetil,Prodrug,,-1
PA164754911,candicidin,Drug,C[C@@H]1[C@H]([C@@H]([C@@H](C(O1)OC2CC3C(C(CC(O3)(CC(CC(CC(CC(=O)CCCC(=O)CC(=O)OC(C(C=CC=CC=CC=CC=CC=CC=C2)C)C(C)CC(C)C(CC(=O)C4=CC=C(C=C4)N)O)O)O)O)O)O)C(=O)O)O)N)O,-1
PA164764517,candoxatril,Drug,COCCOC[C@H](CC1(CCCC1)C(=O)NC2CCC(CC2)C(=O)O)C(=O)OC3=CC4=C(CCC4)C=C3,-1
PA134687925,canertinib,Drug,,-1
PA165945763,cangrelor,Drug,CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F,-1
PA166175791,cannabidiol,Drug,,-1
PA166226461,cannabidiol-O-glucuronide,Metabolite,,-1
PA131890620,cannabinoids,Drug Class,,-1
PA448771,capecitabine,Prodrug,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,1
PA164712589,Capillary Stabilizing Agents,Drug Class,,-1
PA166224201,capmatinib,Drug,,-1
PA164746226,capreomycin,Drug,C[C@H]1C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CNC(=O)C[C@H](CCCN)N.C1CN=C(N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N,-1
PA164745489,capromab,Drug,,-1
PA448776,capsaicin,Drug,,-1
PA164712590,Capsaicin and similar agents,Drug Class,,-1
PA448780,captopril,Drug,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,-1
PA448784,carbachol,Drug,C[N+](C)(C)CCOC(=O)N,-1
PA164712591,Carbamates,Drug Class,,-1
PA448785,carbamazepine,Drug,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,1
PA165817196,"carbamazepine 10,11-epoxide",Metabolite,C1=CC=C2C(=C1)C3C(O3)C4=CC=CC=C4N2C(=O)N,-1
PA166131486,"carbamazepine 2,3-epoxide",Metabolite,,-1
PA166131483,carbamazepine catechol,Metabolite,,-1
PA166131487,carbamazepine epoxide glucuronide,Metabolite,,-1
PA165817199,carbamazepine glucuronide,Metabolite,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)NC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,-1
PA166131484,carbamazepine iminoquinone,Metabolite,,-1
PA166131482,carbamazepine o-quinone,Metabolite,,-1
PA164712592,Carbamic acid esters,Drug Class,,-1
PA164712593,Carbamide products,Drug Class,,-1
PA164712594,Carbapenems,Drug Class,,-1
PA166184059,carbasalate calcium,Drug,,-1
PA448788,carbenicillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)O)C(=O)O)C,-1
PA164743086,carbetocin,Drug,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSCCCC(=O)N([C@H](C(=O)N1)CC2=CC=C(C=C2)O)C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,-1
PA448794,carbidopa,Drug,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,-1
PA164742970,carbimazole,Prodrug,CCOC(=O)N1C=CN(C1=S)C,-1
PA164746898,carbinoxamine,Drug,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,-1
PA166184060,carbocisteine,Drug,,-1
PA448797,carbohydrates,Drug Class,,-1
PA164712595,"Carbohydrates/proteins/minerals/vitamins, combinations",Drug Class,,-1
PA448801,carbon dioxide,Drug,,-1
PA10410,carbonic anhydrase inhibitors,Drug Class,,-1
PA448803,carboplatin,Drug,C1CC(C1)(C(=O)O)C(=O)O.N.N.[Pt],-1
PA164754883,carboprost tromethamine,Drug,CCCCC[C@@](C)(/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C/CCCC(=O)O)O)O)O,-1
PA166131343,carbovir 5'-diphosphate,Metabolite,C1[C@@H](C=C[C@@H]1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)OP(=O)(O)O,-1
PA166131332,carbovir 5'-monophosphate,Metabolite,C1[C@@H](C=C[C@@H]1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)O,-1
PA166131328,carbovir 5'-triphosphate,Metabolite,C1[C@@H](C=C[C@@H]1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O,-1
PA164712596,Carboxamide derivatives,Drug Class,,-1
PA166131471,carboxycelecoxib,Metabolite,,-1
PA166278861,carboxy dabrafenib,Metabolite,CC(C)(C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F)C(=O)O,-1
PA166131268,carboxyibuprofen,Metabolite,CC(CC1=CC=C(C=C1)C(C)C(=O)O)C(=O)O,-1
PA166131544,carboxyibuprofen glucuronide,Metabolite,,-1
PA166131285,carboxyifosfamide,Metabolite,C(COP(=O)(NCCCl)NCCCl)C(=O)O,-1
PA166265644,carboxymethoxymethylguanine,Metabolite,,-1
PA166238241,carboxyomeprazole,Metabolite,,-1
PA166131318,carboxyphosphamide,Metabolite,C(COP(=O)(N)N(CCCl)CCCl)C(=O)O,-1
PA164712597,Cardiac Glycosides,Drug Class,,-1
PA164712598,Cardiac Stimulants Excl. Cardiac Glycosides,Drug Class,,-1
PA164712599,Cardiac Therapy,Drug Class,,-1
PA164712600,Cardiovascular System,Drug Class,,-1
PA166165203,carfilzomib,Drug,CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,-1
PA165958402,carglumic acid,Drug,C(CC(=O)O)[C@@H](C(=O)O)NC(=O)N,-1
PA164712602,Caries prophylactic agents,Drug Class,,-1
PA166177476,cariprazine,Drug,,-1
PA448809,carisoprodol,Drug,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,-1
PA448810,carmustine,Drug,C(CCl)NC(=O)N(CCCl)N=O,-1
PA164750571,carphenazine,Drug,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO,-1
PA164781361,carprofen,Drug,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,-1
PA448814,carrageenan,Drug,,-1
PA164768736,carteolol,Drug,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O,-1
PA448817,carvedilol,Drug,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,-1
PA166177962,carvedilol glucuronide,Metabolite,,-1
PA166251541,casimersen,Drug,,-1
PA166255843,casirivimab,Drug,,-1
PA166255844,casirivimab / imdevimab,Drug,,-1
PA166129533,casopitant,Drug,CC1=C(C=CC(=C1)F)[C@H]2C[C@H](CCN2C(=O)N(C)[C@H](C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C(=O)C,-1
PA164743013,caspofungin,Drug,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O,-1
PA448827,castor oil,Drug,,-1
PA133822447,catecholamines,Drug Class,,-1
PA452605,cationic xenobiotics,Drug Class,,-1
PA166163226,cavosonstat,Drug,C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O,-1
PA162370429,CBLB502,Drug,,-1
PA166269022,CD1530,Small Molecule,C1C2CC3CC1CC(C2)(C3)C4=C(C=C5C=CC(=CC5=C4)C6=CC=C(C=C6)C(=O)O)O,-1
PA164776752,cefacetrile,Drug,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC#N)SC1)C(=O)O,-1
PA164749137,cefaclor,Drug,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,-1
PA448835,cefadroxil,Drug,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,-1
PA448886,cefalotin,Drug,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O,-1
PA448837,cefamandole,Drug,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O,-1
PA448839,cefazolin,Drug,CC1=NN=C(S1)SCC2=C(N3C([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O,-1
PA164768739,cefdinir,Drug,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O,-1
PA164747187,cefditoren,Drug,CC1=C(SC=N1)/C=C\C2=C(N3[C@@H](C(C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,-1
PA164754876,cefepime,Drug,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-],-1
PA164768821,cefixime,Drug,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O,-1
PA164750569,cefmenoxime,Drug,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)O,-1
PA164746819,cefmetazole,Drug,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O,-1
PA164743021,cefonicid,Drug,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O,-1
PA448849,cefoperazone,Drug,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,-1
PA164746057,ceforanide,Drug,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O,-1
PA448852,cefotaxime,Drug,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O,-1
PA164784033,cefotetan,Drug,CN1C(=NN=N1)SCC2=C(N3C([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,-1
PA164749298,cefotiam,Drug,CN(C)CCN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O,-1
PA448856,cefoxitin,Drug,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3,-1
PA164748136,cefpiramide,Drug,CC1=CC(=O)C(=CN1)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)NC3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,-1
PA164746385,cefpodoxime,Drug,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,-1
PA164746342,cefprozil,Drug,C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O,-1
PA448890,cefradine,Drug,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O,-1
PA448861,ceftazidime,Drug,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],-1
PA164744555,ceftibuten,Drug,C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)/C3=CSC(=N3)N)C(=O)O,-1
PA164748758,ceftizoxime,Drug,CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O,-1
PA448866,ceftriaxone,Drug,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,-1
PA448868,cefuroxime,Drug,CO/N=C(\C1=CC=CO1)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,-1
PA448871,celecoxib,Drug,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,1
PA166131266,celecoxib glucuronide,Metabolite,C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)C(=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,-1
PA164924561,celiprolol,Drug,,-1
PA448873,cellulose,Drug,,-1
PA166251401,cemiplimab-rwlc,Drug,,-1
PA166220421,cenicriviroc,Drug,,-1
PA164712604,Centrally acting antiobesity products,Drug Class,,-1
PA164712605,Centrally acting sympathomimetics,Drug Class,,-1
PA164712603,Central Nervous System,Drug Class,,-1
PA448883,cephalexin,Drug,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,-1
PA164781027,cephaloglycin,Drug,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,-1
PA164749340,cephapirin,Drug,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O,-1
PA166220607,cepharanthine,Drug,,-1
PA166124616,ceritinib,Drug,,-1
PA448897,cerivastatin,Drug,CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC,-1
PA166169879,cerliponase alfa,Drug,,-1
PA165107055,certolizumab pegol,Drug,,-1
PA164764551,cerulenin,Drug,C/C=C/C/C=C/CCC(=O)[C@@H]1[C@@H](O1)C(=O)N,-1
PA164774919,ceruletide,Drug,CCCC[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)N,-1
PA448905,cetirizine,Drug,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,-1
PA164764506,cetrorelix,Drug,C[C@H](C(=O)N)NC(=O)C1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@@H](CC2=CC=C(C=C2)O)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C,-1
PA10040,cetuximab,Drug,,-1
PA164754754,cevimeline,Drug,C[C@@H]1O[C@]2(CN3CCC2CC3)CS1,-1
PA448918,charcoal preparations,Drug Class,,-1
PA164712606,Chemicals and reagents for analysis,Drug Class,,-1
PA164712607,Chemotherapeutics For Topical Use,Drug Class,,-1
PA165958403,chenodeoxycholic acid,Drug,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,-1
PA164748134,chlophedianol,Drug,CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2Cl)O,-1
PA448925,chloral hydrate,Drug,C(C(Cl)(Cl)Cl)(O)O,-1
PA448926,chlorambucil,Drug,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,-1
PA448927,chloramphenicol,Drug,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],-1
PA448932,chlordiazepoxide,Drug,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,-1
PA164776863,chlorhexidine,Drug,C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\N)N)N)/N)Cl,-1
PA166131575,chloride,Ion,[Cl-],-1
PA164712608,Chlorine containing products,Drug Class,,-1
PA164748977,chlormerodrin,Drug,COC(CNC(=O)N)C[Hg]Cl,-1
PA448939,chlormezanone,Drug,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,-1
PA166131319,chloroacetaldehyde,Metabolite,C(C=O)Cl,-1
PA166131307,chloroacetic acid,Metabolite,C(C(=O)O)Cl,-1
PA166122627,chlorocresol,Drug,CC1=C(C=CC(=C1)O)Cl,-1
PA166131565,chloroethyl aziridine,Metabolite,C1CN1CCCl,-1
PA166163821,chlorophenyl piperidinol,Metabolite,C1CNCCC1(C2=CC=C(C=C2)Cl)O,-1
PA448942,chlorophyll,Drug,,-1
PA448946,chloroprocaine,Drug,CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl,-1
PA165958419,chloropyramine,Drug,,-1
PA448948,chloroquine,Drug,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,-1
PA448953,chlorothiazide,Drug,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,-1
PA164768822,chlorotrianisene,Drug,COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC,-1
PA164754879,chloroxine,Drug,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,-1
PA164784022,chlorphenesin,Drug,C1=CC(=CC=C1OCC(CO)O)Cl,-1
PA448960,chlorpheniramine,Drug,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,-1
PA165857067,chlorproguanil,Drug,CC(C)N=C(N)/N=C(\N)/NC1=CC(=C(C=C1)Cl)Cl,-1
PA166228322,Chlorproguanil / Dapsone,Drug,,-1
PA448964,chlorpromazine,Drug,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,-1
PA448966,chlorpropamide,Drug,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,-1
PA164781400,chlorprothixene,Drug,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,-1
PA448970,chlorthalidone,Drug,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,-1
PA448971,chlorzoxazone,Drug,C1=CC2=C(C=C1Cl)NC(=O)O2,-1
PA164748138,cholecalciferol,,,0
PA164712609,Cholera vaccines,Drug Class,,-1
PA166178639,cholesterol,Biological Intermediate,,-1
PA166179663,cholesterol ester,Biological Intermediate,,-1
PA448974,cholestyramine,Drug,,-1
PA166160055,cholic acid,Drug,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,-1
PA448976,choline,Drug,C[N+](C)(C)CCO,-1
PA166265645,choline acyclovir,Metabolite,,-1
PA164712610,Choline derivatives,Drug Class,,-1
PA164712611,Choline esters,Drug Class,,-1
PA166182865,CHOP,Drug,,-1
PA164783947,choriogonadotropin alfa,Drug,,-1
PA448989,chromium,Drug,,-1
PA448994,chymotrypsin,Drug,,-1
PA164712612,Cicatrizants,Drug Class,,-1
PA164781399,ciclesonide,Drug,CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)OC(O2)C6CCCCC6,-1
PA164747060,ciclopirox,Drug,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,-1
PA448997,cidofovir,Drug,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O,-1
PA448998,cilastatin,Drug,CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C,-1
PA164748302,cilazapril,Drug,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(=O)O.O,-1
PA164924491,cilengitide,Drug,,-1
PA165948031,cilomilast,Drug,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,-1
PA164746334,cilostazol,Drug,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,-1
PA449001,cimetidine,Drug,CC1=C(N=CN1)CSCCNC(=NC)NC#N,-1
PA164776671,cinacalcet,Drug,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,-1
PA164743057,cinalukast,Drug,CCC(CC)(CC(=O)NC1=CC=CC(=C1)/C=C/C2=NC(=CS2)C3CCC3)C(=O)O,-1
PA165958427,cinitapride,Drug,,-1
PA164749342,cinnarizine,Drug,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4,-1
PA164748034,cinolazepam,Drug,C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCC#N)O)F,-1
PA449007,cinoxacin,Drug,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,-1
PA449009,ciprofloxacin,Drug,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,-1
PA449011,cisapride,Drug,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,-1
PA164744925,cisatracurium besylate,Drug,C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],-1
PA449014,cisplatin,Drug,N.N.Cl[Pt+2]Cl,-1
PA449015,citalopram,Drug,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,1
PA166131261,citalopram-n-oxide,Metabolite,C[N+](C)(CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F)[O-],-1
PA166131265,citalopram propionic acid,Metabolite,C1C2=C(C=CC(=C2)C#N)C(O1)(CCC(=O)O)C3=CC=C(C=C3)F,-1
PA449021,citric acid,Drug,C(C(=O)O)C(CC(=O)O)(C(=O)O)O,-1
PA449027,cladribine,Drug,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,-1
PA449028,clarithromycin,Drug,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,-1
PA164742987,clavulanate,Drug,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O,-1
PA166199781,clazakizumab,Drug,,-1
PA164776997,clemastine,Drug,C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C,-1
PA164745640,clenbuterol,Drug,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,-1
PA166198261,clevudine,Drug,,-1
PA164781044,clidinium,Drug,C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O,-1
PA449035,clindamycin,Drug,CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl,-1
PA10888,clobazam,Drug,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,-1
PA164744375,clobetasol,Drug,CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl,-1
PA164744013,clocortolone,Drug,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,-1
PA10239,clodronate,Drug,C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl,-1
PA164754863,clofarabine,Drug,C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)N=C(N=C2N)Cl,-1
PA164748759,clofazimine,Drug,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,-1
PA449045,clofibrate,Drug,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,-1
PA449046,clomifene,Drug,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\Cl)/C3=CC=CC=C3,-1
PA449048,clomipramine,Drug,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,1
PA164771235,clomocycline,Drug,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)/C(=C(\NCO)/O)/C(=O)[C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)N(C)C)O,-1
PA449050,clonazepam,Drug,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,-1
PA166131455,clonazepam acetylated metabolites,Metabolite,,-1
PA449051,clonidine,Drug,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,-1
PA449053,clopidogrel,Prodrug,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,1
PA166182061,clopidogrel acyl glucuronide,Metabolite,,-1
PA166182027,clopidogrel carboxylic acid,Metabolite,,-1
PA166182316,clopidogrel endo-thiol,Metabolite,,-1
PA166182117,clopidogrel thiol metabolite H1,Metabolite,,-1
PA166182093,clopidogrel thiol metabolite H2,Metabolite,,-1
PA166182094,clopidogrel thiol metabolite H3,Metabolite,,-1
PA166131260,clopidogrel thiol metabolite H4,Metabolite,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC(/C(=C\C(=O)O)/C2)S,-1
PA164749297,clorazepate,Drug,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O,-1
PA164752437,clotiazepam,Drug,CCC1=CC2=C(S1)N(C(=O)CN=C2C3=CC=CC=C3Cl)C,-1
PA449057,clotrimazole,Drug,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,-1
PA449059,cloxacillin,Drug,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,-1
PA449061,clozapine,Drug,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,-1
PA166213001,clozapine 5-N-glucuronide,Metabolite,,-1
PA166261781,clozapine N+ glucuronide,Metabolite,,-1
PA166163658,clozapine n-oxide,Metabolite,C[N+]1(CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl)[O-],-1
PA166182867,CMF,Drug,,-1
PA164744952,coagulation factor ix,Drug,,-1
PA164748389,coagulation factor viia,Drug,,-1
PA166165092,cobicistat,Drug,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,-1
PA166160044,cobimetinib,Drug,C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,-1
PA449072,cocaine,Drug,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,-1
PA449088,codeine,Prodrug,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,1
PA166131341,codeine-6-glucuronide,Metabolite,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,-1
PA164712613,Cod-liver oil ointments,Drug Class,,-1
PA449092,colchicine,Drug,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,-1
PA164712614,Colchicine derivatives,Drug Class,,-1
PA449095,colesevelam,Drug,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],-1
PA449096,colestipol,Drug,C1C(O1)CCl.C(CNCCNCCNCCN)N,-1
PA164749509,colistimethate,Drug,CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+],-1
PA164760862,colistin,Drug,CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O,-1
PA449107,collagenase,Drug,,-1
PA10420,colony stimulating factors,Drug Class,,-1
PA164712615,Colouring agents,Drug Class,,-1
PA166230961,combination nicotine replacement therapy,Drug,,-1
PA164712618,"Combinations and complexes of aluminium, calcium and magnesium compounds",Drug Class,,-1
PA164712619,Combinations for eradication of Helicobacter pylori,Drug Class,,-1
PA164712620,Combinations of adrenergics,Drug Class,,-1
PA164712616,Combinations Of Antibacterials,Drug Class,,-1
PA164712622,Combinations of antihistamines,Drug Class,,-1
PA164712617,Combinations Of Antihypertensives In Atc-gr. C02,Drug Class,,-1
PA164712623,Combinations of antineoplastic agents,Drug Class,,-1
PA164712624,Combinations of drugs for treatment of tuberculosis,Drug Class,,-1
PA164712625,Combinations of oral blood glucose lowering drugs,Drug Class,,-1
PA164712626,"Combinations of penicillins, incl. beta-lactamase inhibitors",Drug Class,,-1
PA10492,"combinations of sulfonamides and trimethoprim, incl. derivatives",Drug Class,,-1
PA164712627,Combinations of vitamins,Drug Class,,-1
PA164742939,conivaptan,Drug,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,-1
PA164754789,conjugated estrogens,"Drug,""Biological Intermediate""",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+],-1
PA164712628,Contact laxatives,Drug Class,,-1
PA164712629,Contraceptives For Topical Use,Drug Class,,-1
PA164712630,Contrast Media,Drug Class,,-1
PA449114,copper,Drug,,-1
PA449119,copper sulfate,Drug,,-1
PA166153416,coptisine,Drug,C1C[N+]2=C(C=C3C=CC4=C(C3=C2)OCO4)C5=CC6=C(C=C51)OCO6,-1
PA449122,corn oil,Drug,,-1
PA166158935,corr-4a,Small Molecule,CC1=C(SC(=N1)NC(=O)C2=CC=CC=C2)C3=CSC(=N3)NC4=C(C=CC(=C4)Cl)OC,-1
PA164712631,Corticosteroid derivatives,Drug Class,,-1
PA10832,corticosteroids,Drug Class,,-1
PA164712634,Corticosteroids And Antiinfectives In Combination,Drug Class,,-1
PA164712641,Corticosteroids and mydriatics in combination,Drug Class,,-1
PA164712664,Corticosteroids/antiinfectives/mydriatics in combination,Drug Class,,-1
PA164712647,"Corticosteroids, combinations for treatment of acne",Drug Class,,-1
PA164712643,"Corticosteroids, Combinations With Antibiotics",Drug Class,,-1
PA164712644,"Corticosteroids, Combinations With Antiseptics",Drug Class,,-1
PA164712645,"Corticosteroids, Dermatological Preparations",Drug Class,,-1
PA164712636,Corticosteroids For Systemic Use,Drug Class,,-1
PA164712637,"Corticosteroids For Systemic Use, Combinations",Drug Class,,-1
PA164712649,"Corticosteroids, moderately potent, combinations with antibiotics",Drug Class,,-1
PA164712650,"Corticosteroids, moderately potent, combinations with antiseptics",Drug Class,,-1
PA164712648,"Corticosteroids, moderately potent (group II)",Drug Class,,-1
PA164712651,"Corticosteroids, moderately potent, other combinations",Drug Class,,-1
PA164712646,"Corticosteroids, Other Combinations",Drug Class,,-1
PA164712653,"Corticosteroids, potent, combinations with antibiotics",Drug Class,,-1
PA164712654,"Corticosteroids, potent, combinations with antiseptics",Drug Class,,-1
PA164712652,"Corticosteroids, potent (group III)",Drug Class,,-1
PA164712655,"Corticosteroids, potent, other combinations",Drug Class,,-1
PA164712657,"Corticosteroids, very potent, combinations with antibiotics",Drug Class,,-1
PA164712658,"Corticosteroids, very potent, combinations with antiseptics",Drug Class,,-1
PA164712656,"Corticosteroids, very potent (group IV)",Drug Class,,-1
PA164712659,"Corticosteroids, very potent, other combinations",Drug Class,,-1
PA164712661,"Corticosteroids, weak, combinations with antibiotics",Drug Class,,-1
PA164712662,"Corticosteroids, weak, combinations with antiseptics",Drug Class,,-1
PA164712660,"Corticosteroids, weak (group I)",Drug Class,,-1
PA164712663,"Corticosteroids, weak, other combinations",Drug Class,,-1
PA449129,corticotropin,Drug,,-1
PA449130,cortisone acetate,Drug,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,-1
PA164712665,Cosmetics,Drug Class,,-1
PA164749052,cosyntropin,Drug,CC(C)[C@@H](C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC8=CNC=N8)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C(CO)N,-1
PA166114414,cotinine,Metabolite,CN1[C@@H](CCC1=O)C2=CN=CC=C2,-1
PA166131561,cotinine glucuronide,Metabolite,,-1
PA166131378,cotinine n-oxide,Metabolite,CN1[C@@H](CCC1=O)C2=C[N+](=CC=C2)[O-],-1
PA164712666,Cough And Cold Preparations,Drug Class,,-1
PA164712667,"Cough Suppressants And Expectorants, Combinations",Drug Class,,-1
PA164712668,"Cough Suppressants, Excl. Combinations With Expectorants",Drug Class,,-1
PA134521193,coumarin,Drug,,-1
PA164712669,Coxibs,Drug Class,,-1
PA165107062,"CP-800,569",Drug,,-1
PA164778930,creatine,Drug,CN(CC(=O)O)C(=N)N,-1
PA165111677,Cremophor EL,Drug,,-1
PA166189801,crizanlizumab-tmca,Drug,,-1
PA165946122,crizotinib,Drug,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,-1
PA166163406,crizotinib M10,Metabolite,,-1
PA449138,cromoglicate,Drug,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O,-1
PA164745460,crotamiton,Drug,CCN(C1=CC=CC=C1C)C(=O)/C=C/C,-1
PA164749510,cryptenamine,Drug,,-1
PA164712670,Curare alkaloids,Drug Class,,-1
PA151958596,curcumin,Drug,,-1
PA451892,cyanocobalamin,"Drug,""Biological Intermediate""",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)(O)O[C@H](C)CNC(=O)CC[C@@]\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=N7)/C=C\8/C([C@@H](C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2],-1
PA164743456,cyclacillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C,-1
PA164748026,cyclandelate,Drug,CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O,-1
PA166178640,cyclic adenosine monophosphate,Biological Intermediate,,-1
PA164712671,Cyclic amines,Drug Class,,-1
PA164742937,cyclizine,Drug,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,-1
PA449160,cyclobenzaprine,Drug,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,-1
PA165107357,cycloguanil,"Drug,""Metabolite""",,-1
PA164743019,cyclopentolate,Drug,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,-1
PA449165,cyclophosphamide,Prodrug,C1CNP(=O)(OC1)N(CCCl)CCCl,-1
PA164764600,cycloserine,Drug,C1C(C(=O)NO1)N,-1
PA449167,cyclosporine,Drug,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,-1
PA166131534,cyclosporine am1,Metabolite,,-1
PA166131535,cyclosporine am4n,Metabolite,,-1
PA166131536,cyclosporine am9,Metabolite,,-1
PA449168,cyclothiazide,Drug,C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl,-1
PA164749387,cycrimine,Drug,C1CCN(CC1)CCC(C2CCCC2)(C3=CC=CC=C3)O,-1
PA164749366,cyproheptadine,Drug,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,-1
PA10049,cyproterone,Drug,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)O,-1
PA166178631,cystathionine,Biological Intermediate,,-1
PA449171,cysteamine,Drug,C(CS)N,-1
PA449177,cytarabine,Drug,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,-1
PA164712672,Cytotoxic Antibiotics And Related Substances,Drug Class,,-1
PA165110351,dabigatran,Drug,,-1
PA165958369,dabigatran etexilate,Prodrug,CCCCCCOC(=O)/N=C(/C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)\N,-1
PA166114911,dabrafenib,Drug,,-1
PA449197,dacarbazine,Drug,CN(C)N/N=C\1/C(=NC=N1)C(=O)N,-1
PA166128167,daclatasvir,Drug,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,-1
PA164764446,daclizumab,Drug,,-1
PA166182279,dacomitinib,Drug,,-1
PA151917012,dactinomycin,Drug,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,-1
PA166210781,dactolisib,Drug,,-1
PA166209982,dalbavancin,Drug,,-1
PA166131581,dalcetrapib,Drug,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,-1
PA164746234,dalfopristin,Drug,CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C1C(=O)O[C@@H]([C@@H](/C=C\C(=O)NC/C=C\C(=C/[C@H](CC(=O)CC3=NC(=CO3)C2=O)O)\C)C)C(C)C,-1
PA165958404,dalteparin,Drug,,-1
PA166248921,danaparoid,Drug,,-1
PA164749056,danazol,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5,-1
PA166119201,daniquidone,Drug,C1C2=C(C=CC(=C2)N)N=C3N1C(=O)C4=CC=CC=C43,-1
PA449208,dantrolene,Drug,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],-1
PA164712673,Dantrolene and derivatives,Drug Class,,-1
PA166104278,dapagliflozin,Drug,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl,-1
PA164749109,dapiprazole,Drug,CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4,-1
PA166151992,dapoxetine,Drug,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3,-1
PA166280581,daprodustat,Drug,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,-1
PA449211,dapsone,Drug,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,-1
PA164768820,daptomycin,Drug,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,-1
PA165884699,darapladib,Drug,CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F,-1
PA164743138,darbepoetin alfa,Drug,,-1
PA164774901,darifenacin,Drug,C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,-1
PA163522472,darunavir,Drug,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,-1
PA166182623,darunavir / ritonavir,Drug,,-1
PA166197161,DAS181,Drug,,-1
PA166163411,dasabuvir,Drug,CC(C)(C)C1=C(C(=CC(=C1)N2C=CC(=O)NC2=O)C3=CC4=C(C=C3)C=C(C=C4)NS(=O)(=O)C)OC,-1
PA166160002,dasabuvir / ombitasvir / paritaprevir / ritonavir,Drug,CC1=NC=C(N=C1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8.CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)CC([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O.CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)C1=C(C(=CC(=C1)N2C=CC(=O)NC2=O)C3=CC4=C(C=C3)C=C(C=C4)NS(=O)(=O)C)OC,-1
PA162372878,dasatinib,Drug,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,-1
PA166164869,dasatinib beta-d-glucuronide,Metabolite,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO[C@H]5C(C([C@H](C(O5)C(=O)O)O)O)O)C,-1
PA166163868,dasatinib carboxylic acid,Metabolite,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CC(=O)O)C,-1
PA166163688,dasatinib M20,Metabolite,CC1=CC(=CC(=C1NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C)Cl)O,-1
PA166163687,dasatinib M4,Metabolite,[2H]C1(C(N(C(C(N1)([2H])[2H])([2H])[2H])C2=CC(=NC(=N2)C)NC3=NC=C(S3)C(=O)NC4=C(C=CC=C4Cl)C)([2H])[2H])[2H],-1
PA166163867,dasatinib n-oxide,Metabolite,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CC[N+](CC4)(CCO)[O-])C,-1
PA449212,daunorubicin,Drug,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,-1
PA166248083,daunorubicinol,Metabolite,,-1
PA166122486,db-289,Drug,CO/N=C(/N)\C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)/C(=N\OC)/N.C(=C\C(=O)O)\C(=O)O,-1
PA452616,debrisoquine,Drug,C1CN(CC2=CC=CC=C21)C(=N)N,-1
PA164747980,decamethonium,Drug,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,-1
PA166269381,dechlororivaroxaban,Metabolite,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=CS4,-1
PA164749631,decitabine,Drug,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,-1
PA164712674,Decongestants And Antiallergics,Drug Class,,-1
PA164712675,Decongestants And Other Nasal Preparations For Topical Use,Drug Class,,-1
PA166254761,deethyltamsulosin,Metabolite,,-1
PA166254762,deethyltamsulosin glucuronide,Metabolite,,-1
PA166254763,deethyltamsulosin sulfate,Metabolite,,-1
PA164760843,deferasirox,Drug,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,-1
PA166163512,deferasirox m1,Metabolite,C1=C/C(=C\2/N/C(=C/3\C=C(C=CC3=O)O)/NN2C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,-1
PA166163510,deferasirox m3,Metabolite,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O)/C(=O)C=C1,-1
PA166163511,deferasirox m4,Metabolite,C1=C/C(=C/2\N/C(=C\3/C=C(C=CC3=O)O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,-1
PA166163509,deferasirox m6,Metabolite,C1=CC=C(C(=C1)C2=N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,-1
PA166118041,deferiprone,Drug,CC1=C(C(=O)C=CN1C)O,-1
PA164746490,deferoxamine,Drug,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,-1
PA164749105,defibrotide,Drug,,-1
PA165958373,degarelix,Drug,C[C@H](C(=O)N)NC(=O)C1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)NC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)NC(=O)[C@H]4CC(=O)NC(=O)N4)NC(=O)[C@H](CO)NC(=O)[C@@H](CC5=CN=CC=C5)NC(=O)[C@@H](CC6=CC=C(C=C6)Cl)NC(=O)[C@@H](CC7=CC8=CC=CC=C8C=C7)NC(=O)C,-1
PA166170895,dehydroaripiprazole,Metabolite,,-1
PA166131398,dehydrowarfarin,Metabolite,,-1
PA449223,delavirdine,Drug,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,-1
PA166128130,deleobuvir,Drug,CN1C2=C(C=CC(=C2)C(=O)NC3(CCC3)C4=NC5=C(N4C)C=C(C=C5)/C=C/C(=O)O)C(=C1C6=NC=C(C=N6)Br)C7CCCC7,-1
PA164745610,demecarium bromide,Drug,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-],-1
PA164745513,demeclocycline,Drug,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(\N)/O)/C1=O)O)O)O)Cl)O,-1
PA166165038,demethylated sirolimus metabolites,Metabolite,,-1
PA166131450,demethylcitalopram,Metabolite,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,-1
PA166254781,demethyl tamsulosin glucuronide,Metabolite,,-1
PA164750594,denileukin diftitox,Drug,,-1
PA166048634,denosumab,Drug,,-1
PA166131464,deoxyartemisinin,Metabolite,,-1
PA166131465,deoxydihydroartemisinin,Metabolite,,-1
PA166160637,deoxy-thioguanosine diphosphate,Metabolite,,-1
PA166160638,deoxy-thioguanosine monophosphate,Metabolite,,-1
PA166160634,deoxy-thioguanosine triphosphate,Metabolite,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=S)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,-1
PA166178644,deoxythymidine monophosphate,Biological Intermediate,,-1
PA166178645,deoxyuridine monophosphate,Biological Intermediate,,-1
PA164712676,Dermatologicals,Drug Class,,-1
PA166131457,desalkylflurazepam,Metabolite,,-1
PA166131456,desalkyl hydroxyflurazepam,Metabolite,,-1
PA164742966,deserpidine,Drug,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,-1
PA166200321,desethylchloroquine,Metabolite,,-1
PA166279944,desethylene ciprofloxacin,Metabolite,CN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,-1
PA166197521,desethyl hydroxychloroquine,Metabolite,,-1
PA164749136,desflurane,Drug,C(C(F)(F)F)(OC(F)F)F,1
PA449233,desipramine,"Drug,""Metabolite""",CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,1
PA166262181,desisopropyl-dihydro-fluvastatin,Metabolite,,-1
PA164747478,deslanoside,Drug,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@H]3C[C@H]([C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)O)C)O)O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O,-1
PA164776964,desloratadine,Drug,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,-1
PA165817936,desmethylastemizole,Drug,C1CN(CCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)CCC5=CC=C(C=C5)O,-1
PA166177862,desmethylbosutinib,Metabolite,,-1
PA134687941,desmethylcitalopram,Drug,,-1
PA166131507,desmethyl clomipramine,Metabolite,CNCCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl,-1
PA166264701,desmethylclozapine glucuronide,Metabolite,,-1
PA166278881,desmethyl dabrafenib,Metabolite,CC(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,-1
PA166131337,desmethyldoxepin,Metabolite,CNCC/C=C\1/C2=CC=CC=C2COC3=CC=CC=C31,-1
PA166160601,desmethylerythromycin,Metabolite,CC[C@@H]1C([C@@H]([C@H](C(=O)[C@@H](CC([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)NC)O)(C)O)C)C)O)(C)O,-1
PA166131383,desmethylimatinib,Metabolite,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCNCC3)NC4=NC=CC(=N4)C5=CN=CC=C5,-1
PA166163690,desmethylnaproxen,Metabolite,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,-1
PA166163738,desmethylnaproxen acyl glucuronide,Metabolite,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O[C@H]3[C@@H]([C@H]([C@@H](O[C@@H]3C(=O)O)O)O)O,-1
PA166163739,desmethylnaproxen glucuronide,Metabolite,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C(=O)O,-1
PA165946746,desmethylnortriptyline,Metabolite,C1CC2=CC=CC=C2C(=CCCN)C3=CC=CC=C31,-1
PA166164916,desmethyl olanzapine,Metabolite,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCNCC4,-1
PA166246221,desmethyl piroxicam,Metabolite,,-1
PA166227262,desmethyl rabeprazole,Metabolite,,-1
PA166227263,desmethyl rabeprazole thioether,Metabolite,,-1
PA166278741,desmethyl regorafenib,Metabolite,C1=CC(=C(C=C1NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)N)F)C(F)(F)F)Cl,-1
PA166180536,desmethylsertraline,Metabolite,C1C[C@@H](C2=CC=CC=C2[C@@H]1C3=CC(=C(C=C3)Cl)Cl)N.Cl,-1
PA166244741,desmethyltrimipramine,Metabolite,,-1
PA449237,desmopressin,Drug,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,-1
PA449238,desogestrel,Drug,CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,-1
PA164776996,desonide,Drug,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@]35C)O,-1
PA164746011,desoximetasone,Drug,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C,-1
PA449245,desoxycorticosterone pivalate,Drug,CC12CCC3C(C1CCC2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CCC34C,-1
PA165958374,desvenlafaxine,"Drug,""Metabolite""",CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,-1
PA164712677,Detoxifying agents for antineoplastic treatment,Drug Class,,-1
PA166169881,deutetrabenazine,Drug,,-1
PA449247,dexamethasone,Drug,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,-1
PA164746251,dexbrompheniramine,Drug,CN(C)CC[C@@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2,-1
PA164747936,dexfenfluramine,Drug,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,-1
PA166049174,dexibuprofen,Drug,C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)O,-1
PA166049175,dexketoprofen,Drug,C[C@@H](C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,-1
PA166110257,dexlansoprazole,Drug,CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,1
PA449256,dexmedetomidine,Drug,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,-1
PA10054,dexmethylphenidate,Drug,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,-1
PA449259,dexrazoxane,Drug,C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,-1
PA449261,dextran,Drug,,-1
PA449269,dextroamphetamine,Drug,C[C@@H](CC1=CC=CC=C1)N,-1
PA449273,dextromethorphan,Drug,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,-1
PA166278341,dextromethorphan hydrobromide / bupropion hydrochloride,Drug,,-1
PA166175998,dextromethorphan / quinidine,Drug,,-1
PA166183939,dextropropoxyphene,Drug,,-1
PA166265441,dextrorphan,Metabolite,,-1
PA166265461,dextrorphan O-glucuronide,Metabolite,,-1
PA164752444,dextrothyroxine,Drug,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,-1
PA164746059,dezocine,Drug,C[C@]12CCCCC[C@H](C1N)CC3=C2C=C(C=C3)O,-1
PA166227961,DHPBI,Metabolite,,-1
PA166131587,diacetylhydrazine,Metabolite,CC(=O)NNC(=O)C,-1
PA166178987,diacylglycerol,Biological Intermediate,CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC/C=C/CCCCCCCC,-1
PA164712678,Diagnostic Agents,Drug Class,,-1
PA164712680,Diagnostic Radiopharmaceuticals,Drug Class,,-1
PA164712681,Diaminopyrimidines,Drug Class,,-1
PA449281,diatrizoate,Drug,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,-1
PA449283,diazepam,Drug,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,-1
PA164712682,"Diazepines, oxazepines and thiazepines",Drug Class,,-1
PA449285,diazoxide,Drug,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,-1
PA164712683,Dibenzo-bicyclo-octadiene derivatives,Drug Class,,-1
PA449286,dibucaine,Drug,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,-1
PA164712684,Dichloroacetamide derivatives,Drug Class,,-1
PA165947835,dichloroacetic acid,"Drug,""Metabolite""",,-1
PA164745512,dichlorphenamide,Drug,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,-1
PA449293,diclofenac,Drug,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,1
PA166163692,diclofenac acyl glucuronide,Metabolite,C1=CC=C(C(=C1)CC(=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)NC3=C(C=CC=C3Cl)Cl,-1
PA164749649,dicloxacillin,Drug,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,-1
PA449298,dicumarol,Drug,C1=CC=C2C(=C1)C(=O)C(=C(O2)O)CC3=C(OC4=CC=CC=C4C3=O)O,-1
PA164744928,dicyclomine,Drug,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,-1
PA449301,didanosine,Drug,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O,-1
PA166265081,didesethyl chloroquine,Metabolite,,-1
PA166178346,didesethyl sunitinib,Metabolite,,-1
PA166131293,didesmethylcitalopram,Metabolite,C1C2=C(C=CC(=C2)C#N)C(O1)(CCCN)C3=CC=C(C=C3)F,-1
PA166131316,didesmethyl clomipramine,Metabolite,C1CC2=CC=CC=C2N(C3=C1C=CC(=C3)Cl)CCCN,-1
PA166131527,didesmethyldoxepin,Metabolite,,-1
PA164745534,dienestrol,Drug,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,-1
PA164712685,Diet Formulations For Treatment Of Obesity,Drug Class,,-1
PA164748883,diethylcarbamazine,Drug,CCN(CC)C(=O)N1CCN(CC1)C,-1
PA164778098,diethylpropion,Drug,CCN(CC)C(C)C(=O)C1=CC=CC=C1,-1
PA449307,diethylstilbestrol,Drug,CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O,-1
PA134653756,diflomotecan,Drug,,-1
PA164749408,diflorasone,Drug,C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F,-1
PA449313,diflunisal,Drug,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,-1
PA166131569,difluorodeoxyuridine,Metabolite,,-1
PA166179662,difluorodeoxyuridine monophosphate,Metabolite,C1[C@@H]([C@H](O[C@H]1N2C(=C(C(=O)NC2=O)F)F)COP(=O)(O)O)O,-1
PA166232101,difluoromethoxydifluoroacetic acid,Metabolite,,-1
PA165958405,difluprednate,Drug,CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C(=O)COC(=O)C,-1
PA164712687,"Digestives, Incl. Enzymes",Drug Class,,-1
PA452244,digitalis glycosides,Drug Class,,-1
PA449316,digitoxin,Drug,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O,-1
PA449319,digoxin,Drug,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,-1
PA164769030,digoxin immune fab,Drug,,-1
PA166131280,dihydroartemisinin,Metabolite,C[C@@H]1CC[C@H]2[C@H](C(O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)O)C,-1
PA166131466,dihydroartemisinin glucuronide,Metabolite,,-1
PA166176885,dihydrocodeine,"Drug,""Metabolite""",,-1
PA166220703,dihydrocodeine-6-glucuronide,Metabolite,,-1
PA164743028,dihydroergotamine,Drug,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C,-1
PA164752819,dihydroergotoxine,Drug,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5CC6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O,-1
PA166131284,dihydrofluorouracil,Metabolite,C1C(C(=O)NC(=O)N1)F,-1
PA166178651,dihydrofolic acid,Biological Intermediate,,-1
PA166220641,dihydroisocodeine,Metabolite,,-1
PA166220642,dihydroisomorphine,Metabolite,,-1
PA166220741,dihydroisomorphine-3-glucuronide,Metabolite,,-1
PA166210741,dihydromorphine,Metabolite,,-1
PA166220722,dihydromorphine-3-glucuronide,Metabolite,,-1
PA166220721,dihydromorphine-6-glucuronide,Metabolite,,-1
PA164712688,Dihydropyridine derivatives,Drug Class,,-1
PA166165010,dihydro-sirolimus,Metabolite,,-1
PA166242461,dihydrostreptomycin,Drug,,-1
PA164744345,dihydrotachysterol,Drug,CC\1CCC(C/C1=C/C=C/2\CCCC3(C2CCC3C(C)/C=C/C(C)C(C)C)C)O,-1
PA164746763,dihydroxyaluminium,Drug,C(C(=O)O[Al])N.O.O,-1
PA165817198,dihydroxycarbazepine,Metabolite,C1=CC=C2C(=C1)C(C(C3=CC=CC=C3N2C(=O)N)O)O,-1
PA166252521,dihydroxypaclitaxel,Metabolite,,-1
PA166159256,dihydroxyvoriconazole,Metabolite,,-1
PA166159257,dihydroxyvoriconazole o-glucuronide,Metabolite,,-1
PA152530737,dilazep,Drug,,-1
PA165958413,diloxanide,Drug,,-1
PA449334,diltiazem,Drug,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,-1
PA449338,dimenhydrinate,Drug,CN1C(=C2C(=NC(=N2)Cl)N(C1=O)C)[O-].C[NH+](C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,-1
PA165958406,dimercaprol,Drug,C(C(CS)S)O,-1
PA165958420,dimethindene,Drug,,-1
PA166152838,dimethyl fumarate,Drug,COC(=O)/C=C/C(=O)OC,-1
PA449342,dimethyl sulfoxide,Drug,CS(=O)C,-1
PA164781385,dinoprost tromethamine,Drug,CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O)O.C(C(CO)(CO)N)O,-1
PA166160060,dinutuximab,Drug,,-1
PA164712689,Dipeptidyl peptidase 4 (DPP-4) inhibitors,Drug Class,,-1
PA164748388,diphemanil methylsulfate,Drug,C[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C.COS(=O)(=O)[O-],-1
PA449349,diphenhydramine,Drug,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,-1
PA164746037,diphenidol,Drug,C1CCN(CC1)CCCC(C2=CC=CC=C2)(C3=CC=CC=C3)O,-1
PA164746539,diphenoxylate,Drug,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,-1
PA164712690,Diphenylbutylpiperidine derivatives,Drug Class,,-1
PA164712691,Diphenylmethane derivatives,Drug Class,,-1
PA164712692,Diphenylpropylamine derivatives,Drug Class,,-1
PA164746377,diphenylpyraline,Drug,CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3,-1
PA164712693,Diphtheria vaccines,Drug Class,,-1
PA449364,dipivefrin,Drug,CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C,-1
PA449367,dipyridamole,Drug,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,-1
PA166128206,dipyrone,Drug,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],1
PA166179660,direct acting antivirals,Drug Class,,-1
PA164712694,Direct thrombin inhibitors,Drug Class,,-1
PA449368,dirithromycin,Drug,CC[C@@H]1[C@@](C2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O,-1
PA449373,disopyramide,Drug,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,-1
PA449376,disulfiram,Drug,CCN(CC)C(=S)SSC(=S)N(CC)CC,-1
PA151249535,diuretics,Drug Class,,-1
PA164712695,Diuretics And Potassium-sparing Agents In Combination,Drug Class,,-1
PA164783479,divalproex sodium,Drug,CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+],-1
PA166110254,divicine,Drug,C1(C(=O)C(=O)NC(=N1)N)N,-1
PA449381,dobutamine,Drug,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,-1
PA449383,docetaxel,Drug,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,-1
PA166266361,docetaxel metabolite m1/m3,Metabolite,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)N6[C@@H](C(OC6=O)(C)C)O)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)O,-1
PA166266362,docetaxel metabolite m4,Metabolite,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)N6C(=O)C(OC6=O)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)O,-1
PA164749211,docosanol,Drug,CCCCCCCCCCCCCCCCCCCCCCO,-1
PA451988,dodecane-trimethylamine,Drug,CCCCCCCCCCCC[N+](C)(C)C,-1
PA449389,dofetilide,Drug,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,-1
PA449390,dolasetron,Drug,C1[C@@H]2CC(CC3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54,-1
PA166114961,dolutegravir,Drug,C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,-1
PA166184505,dolutegravir / abacavir / lamivudine,Drug,,-1
PA166270381,dolutegravir glucuronide,Metabolite,C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O[C@@H]5C[C@@H]([C@H]([C@@H]([C@H]5O)O)O)C(=O)O,-1
PA166270401,dolutegravir M1,Metabolite,C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)N)O,-1
PA134711056,domperidone,Drug,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,-1
PA449394,donepezil,Drug,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,-1
PA164712696,Dopa and dopa derivatives,Drug Class,,-1
PA449396,dopamine,"Drug,""Biological Intermediate""",C1=CC(=C(C=C1CCN)O)O,-1
PA164712697,Dopamine agonists,Drug Class,,-1
PA164712698,Dopaminergic Agents,Drug Class,,-1
PA10318,dornase alfa,Drug,,-1
PA164748765,dorzolamide,Drug,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,-1
PA166251481,dostarlimab-gxly,Drug,,-1
PA166131608,dovitinib,Drug,CN1CCN(CC1)C2=CC3=C(C=C2)N/C(=C/4\C(=C5C(=NC4=O)C=CC=C5F)N)/N3,-1
PA164744927,doxacurium,Drug,C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C,-1
PA164784026,doxapram,Drug,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,-1
PA449407,doxazosin,Drug,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,-1
PA449409,doxepin,Drug,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,1
PA166131345,doxepin n-oxide,Metabolite,C[N+](C)(CCC=CC1C2CCCCC2COC3C1CCCC3)[O-],-1
PA166131528,doxepin n-oxide glucuronide,Metabolite,,-1
PA449412,doxorubicin,Drug,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,-1
PA166131459,doxorubicin deoxyaglycone,Metabolite,,-1
PA165291926,doxorubicin hydroxyaglycone,Metabolite,,-1
PA165291922,doxorubicinol,Metabolite,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)([C@H](CO)O)O)N)O,-1
PA165291925,doxorubicinol aglycone,Metabolite,COC1=CC=CC2=C1C(=O)C3=C(C2=O)C(=C4C[C@](CCC4=C3O)([C@H](CO)O)O)O,-1
PA166131460,doxorubicinol hydroxyaglycone,Metabolite,,-1
PA166131458,doxorubicin semiquinone,Metabolite,,-1
PA165291923,doxorubicin semiquinone radical,Metabolite,,-1
PA449415,doxycycline,Drug,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)/C(=C(\N)/O)/C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,-1
PA449419,doxylamine,Drug,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,-1
PA165291460,DPCPX,Drug,,-1
PA164760855,dromostanolone,Drug,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@H](C(=O)C4)C)C)C,-1
PA449421,dronabinol,Drug,CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O,-1
PA153619853,dronedarone,Drug,,-1
PA449422,droperidol,Drug,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,-1
PA164749409,drospirenone,Drug,C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,-1
PA165290928,drospirenone / ethinyl estradiol,Drug,,-1
PA165958398,drotaverine,Drug,CCOC1=C(C=C(C=C1)/C=C\2/C3=CC(=C(C=C3CCN2)OCC)OCC)OCC,-1
PA131548935,drotrecogin alfa,Drug,,-1
PA166049182,droxicam,Drug,CN1C2=C(C3=CC=CC=C3S1(=O)=O)OC(=O)N(C2=O)C4=CC=CC=N4,-1
PA164748386,droxidopa,Drug,C1=CC(=C(C=C1[C@@H]([C@H](C(=O)O)N)O)O)O,-1
PA164712712,Drugs acting on serotonin receptors,Drug Class,,-1
PA164712699,Drugs Affecting Bone Structure And Mineralization,Drug Class,,-1
PA164712700,Drugs For Acid Related Disorders,Drug Class,,-1
PA164712701,Drugs For Bile Therapy And Lipotropics In Combination,Drug Class,,-1
PA164712713,Drugs for embolisation,Drug Class,,-1
PA164712702,Drugs For Functional Bowel Disorders,Drug Class,,-1
PA164712703,Drugs For Functional Gastrointestinal Disorders,Drug Class,,-1
PA164712704,Drugs For Obstructive Airway Diseases,Drug Class,,-1
PA164712705,Drugs For Peptic Ulcer And Gastro-oesophageal Reflux Disease (gord),Drug Class,,-1
PA164712706,Drugs For Treatment Of Bone Diseases,Drug Class,,-1
PA164712714,Drugs for treatment of hypercalcemia,Drug Class,,-1
PA164712715,Drugs for treatment of hyperkalemia and hyperphosphatemia,Drug Class,,-1
PA164712716,Drugs for treatment of hypoglycemia,Drug Class,,-1
PA164712707,Drugs For Treatment Of Lepra,Drug Class,,-1
PA164712708,Drugs For Treatment Of Tuberculosis,Drug Class,,-1
PA164712709,Drugs Used In Addictive Disorders,Drug Class,,-1
PA164712718,Drugs used in alcohol dependence,Drug Class,,-1
PA164712710,Drugs Used In Benign Prostatic Hypertrophy,Drug Class,,-1
PA164712711,Drugs Used In Diabetes,Drug Class,,-1
PA164712719,Drugs used in erectile dysfunction,Drug Class,,-1
PA164712720,Drugs used in nicotine dependence,Drug Class,,-1
PA164712721,Drugs used in opioid dependence,Drug Class,,-1
PA451455,d-sorbitol,Drug,C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O,-1
PA166285081,dulaglutide,Drug,,-1
PA10066,duloxetine,Drug,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,-1
PA166169883,durvalumab,Drug,,-1
PA164749300,dutasteride,Drug,C[C@]12CCC3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,-1
PA166182761,duvelisib,Drug,,-1
PA451938,d-xylitol,Drug,C([C@H](C([C@H](CO)O)O)O)O,-1
PA164748037,dyclonine,Drug,CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2,-1
PA164745443,dydrogesterone,Drug,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C,-1
PA164748027,dyphylline,Drug,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,-1
PA166094735,e 7010,Drug,,-1
PA161660841,ebselen,Drug,,-1
PA165958350,ecabet,Drug,CC(C)C1=C(C=C2C(=C1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)C(=O)O)C)S(=O)(=O)O,-1
PA166222861,ecallantide,"Drug,""Biological Intermediate""",,-1
PA131550706,echinacea,Drug,,-1
PA164743139,echothiophate iodide,Drug,CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-],-1
PA164746010,econazole,Drug,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,-1
PA164712722,"Ectoparasiticides, Incl. Scabicides",Drug Class,,-1
PA164712723,"Ectoparasiticides, Incl. Scabicides, Insecticides And Repellents",Drug Class,,-1
PA164776637,eculizumab,Drug,,-1
PA449439,edetic acid,Drug,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,-1
PA166128806,edoxaban,Drug,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,-1
PA449437,edrophonium,Drug,CC[N+](C)(C)C1=CC(=CC=C1)O,-1
PA164748817,efalizumab,Drug,,-1
PA449441,efavirenz,Drug,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,1
PA166176033,efavirenz / emtricitabine / tenofovir disoproxil,Drug,,-1
PA166131557,efavirenz-n-glucuronide,Metabolite,,-1
PA166268781,efgartigimod alfa,Drug,,-1
PA153561371,egfr inhibitors,Drug Class,,-1
PA166206962,eidd-2801,Prodrug,,-1
PA134687926,EKB-569,Drug,,-1
PA164924562,elacridar,Drug,,-1
PA166182348,elagolix,Drug,,-1
PA166163436,elbasvir,Drug,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC4=C(C=C3)N5[C@@H](OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,-1
PA166163438,elbasvir / grazoprevir,Drug,CC(C)[C@@H](C(=O)N1CCC[C@@H]1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5[C@@H](O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)[C@@H]9CCCN9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,-1
PA10068,electrolytes,Drug,,-1
PA164712724,Electrolyte solutions,Drug Class,,-1
PA164712725,Electrolytes With Carbohydrates,Drug Class,,-1
PA134687947,eletriptan,Drug,CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,-1
PA166185161,elexacaftor,Drug,,-1
PA166190041,elexacaftor / tezacaftor / ivacaftor,Drug,,-1
PA166123486,eliglustat,Drug,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O,-1
PA166159062,elosulfase alfa,Drug,,-1
PA165981594,eltrombopag,Drug,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N/N=C/3\C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,-1
PA165291498,elvitegravir,Drug,,-1
PA166182675,elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil fumarate,Drug,,-1
PA166182763,emapalumab,Drug,,-1
PA166247421,EMDP,Metabolite,,-1
PA164751802,emedastine,Drug,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C,-1
PA164712727,Emollients And Protectives,Drug Class,,-1
PA166163327,empagliflozin,Drug,C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl,-1
PA10069,emtricitabine,Drug,C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F,-1
PA449456,enalapril,Drug,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,-1
PA166177484,enasidenib,Drug,,-1
PA449459,encainide,Drug,CC(CN1CCCCC1)C2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC,-1
PA164712728,Encephalitis vaccines,Drug Class,,-1
PA166179872,encorafenib,Drug,C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=CC(=CC(=C3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC,-1
PA164712729,Endocrine Therapy,Drug Class,,-1
PA166124478,endoxifen,"Drug,""Metabolite""",CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3,-1
PA166131410,endoxifen o-glucuronide,Metabolite,,-1
PA166131411,endoxifen sulfate,Metabolite,,-1
PA164712730,Enemas,Drug Class,,-1
PA449461,enflurane,Drug,C(C(OC(F)F)(F)F)(F)Cl,1
PA166190121,enfortumab vedotin,Drug,,-1
PA164744517,enfuvirtide,Drug,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C,-1
PA449462,enoxacin,Drug,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,-1
PA449463,enoxaparin,Drug,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,-1
PA164768794,enoximone,Drug,CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC,-1
PA164749350,enprofylline,Drug,CCCN1C2=C(C(=O)NC1=O)NC=N2,-1
PA164748726,entacapone,Drug,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N,-1
PA164784025,entecavir,Drug,C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N,-1
PA166190161,entrectinib,Drug,,-1
PA166123406,enzalutamide,Drug,,-1
PA164712731,"Enzyme and acid preparations, combinations",Drug Class,,-1
PA164712732,Enzyme inhibitors,Drug Class,,-1
PA164712733,Enzyme preparations,Drug Class,,-1
PA164712734,Enzymes,Drug Class,,-1
PA164777031,ephedra,Drug,,-1
PA449466,ephedrine,Drug,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC,-1
PA164764489,epinastine,Drug,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N,-1
PA449470,epinephrine,Drug,CNC[C@@H](C1=CC(=C(C=C1)O)O)O,-1
PA452611,epipodophyllotoxin,Drug,,-1
PA449476,epirubicin,Drug,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,-1
PA164749044,eplerenone,Drug,C[C@]12CCC(=O)C=C1C[C@H](C3[C@]24C(O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,-1
PA10072,epoetin alfa,Drug,,-1
PA164712740,Epoxides,Drug Class,,-1
PA449481,eprosartan,Drug,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O,-1
PA449483,eptifibatide,Drug,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,-1
PA166238941,equilenin sulfate,Drug,,-1
PA166238861,equilin sulfate,Drug,,-1
PA166182720,erdafitinib,Drug,,-1
PA449484,ergocalciferol,Drug,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,-1
PA164752439,ergoloid mesylate,Drug,CCC(C)(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O,-1
PA449487,ergonovine,Drug,C[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,-1
PA164712741,Ergot alkaloids,Drug Class,,-1
PA164712744,"Ergot alkaloids and oxytocin incl. analogues, in combination",Drug Class,,-1
PA164747651,ergotamine,Drug,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C,-1
PA166182723,eribulin,Drug,,-1
PA134687924,erlotinib,Drug,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,-1
PA164777032,ertapenem,Drug,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O,-1
PA166269521,ertugliflozin,Drug,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl,-1
PA165291442,ertumaxomab,Drug,,-1
PA164746528,erythrityl tetranitrate,Drug,C(C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],-1
PA166170177,erythrohydrobupropion,Metabolite,,-1
PA166170193,erythrohydrobupropion glucuronide,Metabolite,,-1
PA449493,erythromycin,Drug,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,-1
PA166176008,erythromycin ethylsuccinate / sulfisoxazole acetyl,Drug,,-1
PA10074,escitalopram,Drug,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,1
PA165947475,eslicarbazepine acetate,Prodrug,,-1
PA449500,esmolol,Drug,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,-1
PA10075,esomeprazole,Drug,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,1
PA166184493,esomeprazole / naproxen,Drug,,-1
PA449502,estazolam,Drug,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,-1
PA164712745,Esters of aminobenzoic acid,Drug Class,,-1
PA164712746,Esters of benzoic acid,Drug Class,,-1
PA449503,estradiol,"Drug,""Biological Intermediate""",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,-1
PA166178647,estradiol 3-sulfate,Biological Intermediate,,-1
PA166190221,estradiol / progesterone,Drug,,-1
PA166278261,estradiol valerate,Drug,CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)O)C,-1
PA449507,estramustine,Drug,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl,-1
PA164712747,Estren derivatives,Drug Class,,-1
PA164769104,estriol,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O,-1
PA449509,estrogens,Drug Class,,-1
PA164712749,"Estrogens, combinations with other drugs",Drug Class,,-1
PA449512,estrone,"Drug,""Biological Intermediate""",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O,-1
PA166185957,estrone sulfate,"Metabolite,""Biological Intermediate""",,-1
PA165958342,estropipate,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1,-1
PA162630444,eszopiclone,Drug,CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,-1
PA449515,etanercept,Drug,,-1
PA166163432,eteplirsen,Drug,,-1
PA166255861,etesevimab,Drug,,-1
PA449518,ethacrynic acid,Drug,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,-1
PA164784021,ethambutol,Drug,CCC(CO)NCCNC(CC)CO,-1
PA448073,ethanol,Drug,CCO,-1
PA164746758,ethanolamine oleate,Drug,CCCCCCCC/C=C\CCCCCCCC(=O)O.C(CO)N,-1
PA164746383,ethchlorvynol,Drug,CCC(C=CCl)(C#C)O,-1
PA449525,ether,Drug,,-1
PA164712750,Ethers,Drug Class,,-1
PA164712751,Ethers chemically close to antihistamines,Drug Class,,-1
PA164712753,"Ethers, chemically close to antihistamines",Drug Class,,-1
PA164712752,Ethers of tropine or tropine derivatives,Drug Class,,-1
PA164745394,ethinamate,Drug,C#CC1(CCCCC1)OC(=O)N,-1
PA449527,ethinyl estradiol,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,-1
PA165290929,ethinyl estradiol / norelgestromin,Drug,,-1
PA164768833,ethiodized oil,Drug,,-1
PA164768738,ethionamide,Drug,CCC1=NC=CC(=C1)C(=S)N,-1
PA449531,ethopropazine,Drug,CCN(CC)C(C)CN1C2=CC=CC=C2SC3=CC=CC=C31,-1
PA449533,ethosuximide,Drug,CCC1(CC(=O)NC1=O)C,-1
PA164768735,ethotoin,Drug,CCN1C(=O)C(NC1=O)C2=CC=CC=C2,-1
PA164754743,ethoxzolamide,Drug,CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N,-1
PA164712754,Ethylene imines,Drug Class,,-1
PA166210801,ethylmorphine,Drug,,-1
PA164749157,ethynodiol diacetate,Drug,CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C,-1
PA449548,etidronic acid,Drug,CC(O)(P(=O)(O)O)P(=O)(O)O,-1
PA449550,etodolac,Drug,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,-1
PA164743987,etomidate,Drug,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,-1
PA164771231,etonogestrel,Drug,CCC12CC(=C)C3C(C1CC[C@]2(C#C)O)CCC4=CC(=O)CCC34,-1
PA449552,etoposide,Drug,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,-1
PA166131303,etoposide catechol,Metabolite,C1=CC=C(C(=C1)O)O,-1
PA166131329,etoposide glucuronide,Metabolite,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)C(=O)O)O)O)O)OC)O)O,-1
PA166131331,etoposide quinone,Metabolite,C1=CC(=O)C=CC1=O,-1
PA164776853,etoricoxib,Drug,CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl,-1
PA166014703,etravirine,Drug,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,-1
PA449554,etretinate,Drug,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C,-1
PA166177894,evacetrapib,Drug,,-1
PA164746311,everolimus,Drug,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,-1
PA166222281,evinacumab,Drug,,-1
PA165860788,evodiamine,Drug,,-1
PA166160027,evolocumab,Drug,,-1
PA449563,exemestane,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,-1
PA164749238,exenatide,Drug,,-1
PA164712755,Expectorants,Drug Class,,-1
PA164712756,"Expectorants, Excl. Combinations With Cough Suppressants",Drug Class,,-1
PA10816,ezetimibe,Drug,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,-1
PA166184498,ezetimibe / rosuvastatin,Drug,,-1
PA166184495,ezetimibe / simvastatin,Drug,,-1
PA166128132,faldaprevir,Drug,CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)O[C@@H]4C[C@H](N(C4)C(=O)[C@H](C(C)(C)C)NC(=O)OC5CCCC5)C(=O)N[C@@]6(C[C@H]6C=C)C(=O)O,-1
PA449585,famciclovir,Drug,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,-1
PA449586,famotidine,Drug,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,-1
PA166123389,fampridine,Drug,C1=CN=CC=C1N,-1
PA165815771,Farglitazar,Drug,,-1
PA166178662,farnesyl diphosphate,Biological Intermediate,,-1
PA152207466,farnesyltransferase inhibitors,Drug Class,,-1
PA165946121,fasudil,Drug,,-1
PA164712757,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",Drug Class,,-1
PA164712758,Fatty acid derivatives,Drug Class,,-1
PA166196742,favipiravir,Drug,,-1
PA165958521,febuxostat,Drug,,-1
PA166227641,febuxostat 67M-1,Metabolite,,-1
PA166227661,febuxostat 67M-2,Metabolite,,-1
PA166227662,febuxostat 67M-4,Drug,,-1
PA166185677,FEC100,Drug,,-1
PA166280361,fedratinib,Drug,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,-1
PA449590,felbamate,Drug,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,-1
PA166049177,felbinac,Drug,C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)O,-1
PA449591,felodipine,Drug,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,-1
PA164744374,felypressin,Drug,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=CC=C4)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N,-1
PA164712759,Fenamates,Drug Class,,-1
PA166049176,fenbufen,Drug,C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)O,-1
PA164747055,fencamfamine,Drug,CCNC1C2CCC(C2)C1C3=CC=CC=C3,-1
PA449592,fenfluramine,Drug,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,-1
PA166280442,fenfluramine diol,Metabolite,CC(C(C1=CC(=CC=C1)C(F)(F)F)O)O,-1
PA449594,fenofibrate,Drug,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,-1
PA166248881,fenofibrate / simvastatin,Drug,,-1
PA164784034,fenoldopam,Drug,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,-1
PA449597,fenoprofen,Drug,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,-1
PA10079,fenoterol,Drug,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,-1
PA449599,fentanyl,Drug,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,1
PA449617,ferrous sulfate,Drug,,-1
PA165958376,fesoterodine,Drug,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,-1
PA166182922,fevipiprant,Drug,,-1
PA449621,fexofenadine,Drug,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,-1
PA164712760,Fibrates,Drug Class,,-1
PA164712761,Fibrinogen,Drug Class,,-1
PA449626,filgrastim,Drug,,-1
PA449627,finasteride,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,-1
PA166264521,fingolimod,Drug,,-1
PA166049194,firocoxib,Drug,CC1(C(=C(C(=O)O1)OCC2CC2)C3=CC=C(C=C3)S(=O)(=O)C)C,-1
PA164712762,First-generation cephalosporins,Drug Class,,-1
PA166178667,flavin adenine dinucleotide,Biological Intermediate,,-1
PA166178668,flavin mononucleotide,Biological Intermediate,,-1
PA452627,flavopiridol,Drug,CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,-1
PA164781386,flavoxate,Drug,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,-1
PA449646,flecainide,Drug,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,-1
PA164774762,fleroxacin,Drug,,-1
PA166153431,flibanserin,Drug,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F,-1
PA449652,floxuridine,Metabolite,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O,-1
PA164781042,flucloxacillin,Drug,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,-1
PA449653,fluconazole,Drug,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,-1
PA449654,flucytosine,Drug,C1=NC(=O)NC(=C1F)N,-1
PA449655,fludarabine,Drug,C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,-1
PA164745609,fludiazepam,Drug,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,-1
PA164743961,fludrocortisone,Drug,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)F,-1
PA166049190,flufenamic acid,Drug,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,-1
PA165980614,fluindione,Drug,,-1
PA449659,flumazenil,Drug,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,-1
PA164749388,flumethasone pivalate,Drug,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C(C)(C)C)O)C)O)F)C)F,-1
PA164776636,flunarizine,Drug,C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,-1
PA449661,flunisolide,Drug,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O,-1
PA164781320,flunitrazepam,Drug,CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3F,-1
PA166049179,flunoxaprofen,Drug,C[C@@H](C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)C(=O)O,-1
PA164754912,fluocinolone acetonide,Drug,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O,-1
PA449664,fluocinonide,Drug,CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C,-1
PA164746009,fluorescein,Drug,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,-1
PA449667,fluoride,"Metabolite,""Ion""",,-1
PA166163822,fluorobenzoylpropionic acid,Metabolite,C1=CC(=CC=C1C(=O)CCC(=O)O)F,-1
PA166131415,fluoro-beta-alanine,Metabolite,,-1
PA166131421,fluoro-beta-ureidopropionate,Metabolite,,-1
PA166131416,fluorodeoxyuridine diphosphate,Metabolite,,-1
PA166131356,fluorodeoxyuridine monophosphate,Metabolite,C1C(C(OC1N2C=C(C(=O)NC2=O)F)COP(=O)(O)[O-])O.[Na+],-1
PA166131417,fluorodeoxyuridine triphosphate,Metabolite,,-1
PA164781355,fluorometholone,Drug,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,-1
PA452613,fluoroquinolones,Drug Class,,-1
PA128406956,fluorouracil,Drug,C1=C(C(=O)NC(=O)N1)F,1
PA166183787,fluorouracil / salicylic acid,Drug,,-1
PA166131326,fluorouridine,Metabolite,C1=C(C(=O)NC(=O)N1C2[C@@H]([C@@H]([C@H](O2)CO)O)O)F,-1
PA166131418,fluorouridine diphosphate,Metabolite,,-1
PA166131419,fluorouridine monophosphate,Metabolite,,-1
PA166131263,fluorouridine triphosphate,Metabolite,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)F,-1
PA449673,fluoxetine,Drug,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,-1
PA166131439,fluoxetine glucuronide,Metabolite,,-1
PA166131441,fluoxetine inactive metabolites,Metabolite,,-1
PA166176027,fluoxetine / olanzapine,Drug,,-1
PA164744518,fluoxymesterone,Drug,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F,-1
PA10268,flupenthixol,Drug,C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,-1
PA449676,fluphenazine,Drug,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,-1
PA166152829,flupirtine,Drug,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,-1
PA164750513,flurandrenolide,Drug,C[C@]12CCC(=O)C=C1[C@H](C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CO)C)O)F,-1
PA449681,flurazepam,Drug,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,-1
PA449683,flurbiprofen,Drug,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,1
PA166245284,flurbiprofen glucuronide,Metabolite,,-1
PA166245285,flurbiprofen sulfate,Metabolite,,-1
PA162565878,fluspirilene,Drug,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,-1
PA449685,flutamide,Drug,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,-1
PA166182582,fluticasone,Drug,,-1
PA449686,fluticasone propionate,Drug,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,-1
PA165290926,fluticasone/salmeterol,Drug,,-1
PA449688,fluvastatin,Drug,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,1
PA166131391,fluvastatin active metabolites; fluvastatin inactive metabolites,Metabolite,,-1
PA449690,fluvoxamine,Drug,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,1
PA166163834,fluvoxamine acid,Metabolite,C1=CC(=CC=C1/C(=N/OCCN)/CCCC(=O)O)C(F)(F)F,-1
PA166163833,fluvoxamine m3,Metabolite,COCCCCC(=NO)C1=CC=C(C=C1)C(F)(F)F,-1
PA166163865,fluvoxaminoalcohol,Metabolite,CC1=CC=C(C=C1)/C(=N\OCCN)/CCCCO,-1
PA166182863,FOLFIRI,Drug,,-1
PA166240141,FOLFIRINOX,Drug,,-1
PA166182862,FOLFOX,Drug,,-1
PA449692,folic acid,Drug,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,-1
PA150481187,folic acid analogues,Drug Class,,-1
PA164712763,Folic acid and derivatives,Drug Class,,-1
PA449693,follitropin beta,Drug,,-1
PA449697,fomepizole,Drug,CC1=CNN=C1,-1
PA164746297,fondaparinux sodium,Drug,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],-1
PA164776845,forasartan,Drug,CCCCC1=NN(C(=N1)CCCC)CC2=CN=C(C=C2)C3=CC=CC=C3C4=NNN=N4,-1
PA166185382,foretinib,Drug,,-1
PA449703,formaldehyde,"Drug,""Biological Intermediate""",C=O,-1
PA449705,formic acid,Drug,C(=O)O,-1
PA134687907,formoterol,Drug,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,-1
PA166279943,formyl ciprofloxacin,Metabolite,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCN(CC4)C=O)F)C(=O)O,-1
PA146096022,forskolin,Drug,CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,-1
PA10084,fosamprenavir,Drug,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,-1
PA166182625,fosamprenavir / ritonavir,Drug,,-1
PA165958390,fosaprepitant,Drug,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F,-1
PA449706,foscarnet,Drug,C(=O)(O)P(=O)(O)O,-1
PA166252761,fosdenopterin,Drug,,-1
PA164748039,fosfomycin,Drug,C[C@H]1[C@H](O1)P(=O)(O)O,-1
PA449710,fosinopril,Drug,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(=O)O)C3CCCCC3,-1
PA164746820,fosphenytoin,Prodrug,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,1
PA165958389,fospropofol,Drug,CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)([O-])[O-].[Na+].[Na+],-1
PA164712764,Fourth-generation cephalosporins,Drug Class,,-1
PA164743181,framycetin,Drug,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,-1
PA166179687,free fatty acids,Biological Intermediate,,-1
PA164754891,frovatriptan,Drug,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,-1
PA449716,fructose,"Drug,""Biological Intermediate""",C([C@H]([C@H]([C@@H](C(=O)CO)O)O)O)O,-1
PA165107975,"fructose 1,6 bisphosphate",Drug,,-1
PA166178625,fructose-1-phosphate,Biological Intermediate,,-1
PA166178278,fructose-6-phosphate,Biological Intermediate,,-1
PA164747170,fulvestrant,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,-1
PA452614,furafylline,Drug,,-1
PA164746760,furazolidone,Drug,C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],-1
PA449719,furosemide,Drug,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,-1
PA164749648,fusidic acid,Drug,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)O)C,-1
PA449720,gabapentin,Drug,C1CCC(CC1)(CC(=O)O)CN,-1
PA164745426,gadobenate dimeglumine,Drug,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)O.[Gd+3],-1
PA165958377,gadobutrol,Drug,C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3],-1
PA164784027,gadodiamide,Drug,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3],-1
PA165958378,gadofosveset trisodium,Drug,,-1
PA164748760,gadopentetate dimeglumine,Drug,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3],-1
PA164746463,gadoteridol,Drug,CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3],-1
PA164743703,gadoversetamide,Drug,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],-1
PA165985534,Gadoxetic acid,Drug,[H+].[H+].CCOC1=CC=C(C=C1)C[C@@H](CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Gd+3],-1
PA449725,galactose,Drug,,-1
PA449726,galantamine,Drug,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O,-1
PA166197481,galidesivir,Drug,,-1
PA164745088,gallamine triethiodide,Drug,CCN(CC)CCOC1=C(C(=CC=C1)OCCN(CC)CC)OCCN(CC)CC,-1
PA164781198,gallium nitrate,Drug,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Ga+3],-1
PA164746235,galsulfase,Drug,,-1
PA166178621,gamma-aminobutyric acid,Biological Intermediate,,-1
PA164743249,gamma-homolinolenic acid,Drug,CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O,-1
PA10819,gamma hydroxybutyric acid,Drug,C(CC(=O)[O-])CO,-1
PA166278301,ganaxolone,Drug,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@](C4)(C)O)C)C,-1
PA449733,ganciclovir,Drug,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N,-1
PA166265647,ganciclovir diphosphate,Metabolite,,-1
PA166265648,Ganciclovir Monophosphate,Metabolite,,-1
PA166265646,ganciclovir triphosphate,Metabolite,,-1
PA164712765,Gangliosides and ganglioside derivatives,Drug Class,,-1
PA449737,garlic oil,Drug,,-1
PA449738,gatifloxacin,Drug,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,-1
PA131301952,gefitinib,Drug,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,-1
PA166131425,gefitinib M387783,Metabolite,,-1
PA166131279,gefitinib M523595,Metabolite,C1COCCN1CCCOC2=CC3=C(N=CNC3=CC2=O)NC4=CC(=C(C=C4)F)Cl,-1
PA166131426,gefitinib M537194,Metabolite,,-1
PA449741,gelatin agents,Drug,,-1
PA152031327,geldanamycin,Drug,C[C@@H]1C[C@H]([C@@H]([C@@H](/C=C(\[C@H]([C@@H](/C=C\C=C(/C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)/C)C)O)OC,-1
PA449748,gemcitabine,Prodrug,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,-1
PA166131349,gemcitabine diphosphate,Metabolite,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O)O)(F)F,-1
PA166131570,gemcitabine monophosphate,Metabolite,,-1
PA166131567,gemcitabine triphosphate,"Drug,""Metabolite""",,-1
PA166122506,gemcitabine triphosphate ditriethylamine,Drug,,-1
PA449750,gemfibrozil,Drug,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,-1
PA10088,gemifloxacin,Drug,CO/N=C\1/CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,-1
PA164749431,gemtuzumab ozogamicin,Drug,,-1
PA164712766,General Nutrients,Drug Class,,-1
PA165109660,genistein,Drug,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,-1
PA164712767,Genito Urinary System And Sex Hormones,Drug Class,,-1
PA449753,gentamicin,Drug,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,1
PA449755,gentian violet,Drug,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C,-1
PA166123367,gepirone hydrochloride,Drug,CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=NC=CC=N3)C.Cl,-1
PA166178663,geranyl diphosphate,Biological Intermediate,,-1
PA166178664,geranylgeranyl diphosphate,Biological Intermediate,,-1
PA165958397,gestodene,Drug,CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,-1
PA166182767,gilteritinib,Drug,,-1
PA166190061,gimeracil,Drug,,-1
PA449758,ginkgo biloba,Drug,,-1
PA166118565,ginkgo biloba extract,Drug,,-1
PA164781150,ginseng,Drug,,-1
PA166190681,givosiran,Drug,,-1
PA449760,glatiramer acetate,Drug,C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,-1
PA10892,gliclazide,Drug,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,-1
PA449761,glimepiride,Drug,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,-1
PA449762,glipizide,Drug,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,-1
PA164744895,gliquidone,Drug,CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C,-1
PA164743233,glisoxepide,Drug,CC1=CC(=NO1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NN3CCCCCC3,-1
PA164779052,glucagon recombinant,Drug,,-1
PA165949771,Glucarpidase,Drug,,-1
PA452347,glucocorticoids,Drug Class,,-1
PA449770,gluconic acid,"Drug,""Biological Intermediate""",C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,-1
PA164747613,glucosamine,Drug,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)N)O)O)O,-1
PA449773,glucose,"Drug,""Biological Intermediate""",,-1
PA166178274,glucose-6-phosphate,Biological Intermediate,,-1
PA449777,glutaraldehyde,Drug,,-1
PA449780,glutathione,Biological Intermediate,C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,-1
PA166131563,glutathione conjugate,Metabolite,,-1
PA166180475,glutathione-etoposide quinone adduct,Metabolite,,-1
PA164749505,glutethimide,Drug,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,-1
PA449782,glyburide,Drug,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,-1
PA449783,glycerin,Drug,,-1
PA166268801,glycerol phenylbutyrate,Drug,C1=CC=C(C=C1)CCCC(=O)OCC(COC(=O)CCCC2=CC=CC=C2)OC(=O)CCCC3=CC=CC=C3,-1
PA449789,glycine,"Drug,""Biological Intermediate""",C(C(=O)O)N,-1
PA166160617,glycineamide ribonucleotide,Biological Intermediate,C([C@@H]1[C@H]([C@H]([C@@H](O1)NC(=O)CN)O)O)OP(=O)(O)O,-1
PA166182228,glycinexylidide,Metabolite,,-1
PA164748839,glycodiazine,Drug,COCCOC1=CN=C(N=C1)NS(=O)(=O)C2=CC=CC=C2,-1
PA164712768,Glycogenolytic Hormones,Drug Class,,-1
PA164712770,Glycopeptide antibacterials,Drug Class,,-1
PA164754882,glycopyrrolate,Drug,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,-1
PA140222783,glycyl-sarcosine,Drug,,-1
PA449798,gold preparations,Drug Class,,-1
PA166190721,golodirsen,Drug,,-1
PA449801,gonadorelin,Drug,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,-1
PA449804,"gonadotropin,chorionic",Drug,,-1
PA164712771,Gonadotropin releasing hormone analogues,Drug Class,,-1
PA164712772,Gonadotropin-releasing hormones,Drug Class,,-1
PA164712773,Gonadotropins,Drug Class,,-1
PA164712774,Gonadotropins And Other Ovulation Stimulants,Drug Class,,-1
PA164747674,goserelin,Drug,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,-1
PA449808,gramicidin d,Drug,C[C@@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)CNC(=O)[C@H](C(C)C)NC=O,-1
PA449809,granisetron,Drug,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,-1
PA130620649,granulocyte colony-stimulating factor,Drug,,-1
PA151958355,grapefruit juice,Drug,,-1
PA166163437,grazoprevir,Drug,CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,-1
PA449812,grepafloxacin,Drug,CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F,-1
PA449814,griseofulvin,Drug,C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,-1
PA166264441,GS-331007,Metabolite,,-1
PA166255401,GS-441524,Metabolite,,-1
PA166255882,GS-441524 monophosphate,Metabolite,,-1
PA166255901,GS-443902,Metabolite,,-1
PA166256401,GS-461203,Metabolite,,-1
PA166264461,GS-566500,Metabolite,,-1
PA166264481,GS-606965,Metabolite,,-1
PA166255881,GS-704277,Metabolite,,-1
PA165291499,GS-9350,Drug,,-1
PA449818,guaifenesin,Drug,COC1=CC=CC=C1OCC(CO)O,-1
PA164774903,guanabenz,Drug,C1=CC(=C(C(=C1)Cl)/C=N/N=C(N)N)Cl,-1
PA164745308,guanadrel sulfate,Drug,C1CCC2(CC1)OCC(O2)CN=C(N)N,-1
PA449823,guanethidine,Drug,C1CCCN(CCC1)CCN=C(N)N,-1
PA449825,guanfacine,Drug,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,-1
PA164781028,guanidine,Drug,C(=N)(N)N,-1
PA164712775,Guanidine derivatives,Drug Class,,-1
PA164712777,Guanidine derivatives and diuretics,Drug Class,,-1
PA166178643,guanosine diphosphate,Biological Intermediate,,-1
PA166178642,guanosine triphosphate,Biological Intermediate,,-1
PA134687923,GW2016,Drug,,-1
PA164712778,Gynecological Antiinfectives And Antiseptics,Drug Class,,-1
PA164712779,H2-receptor antagonists,Drug Class,,-1
PA10240,haemophilus b conjugate vaccine (prp-d-diphtheria toxoid conjugate),Drug,,-1
PA164746526,halazepam,Drug,C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)CC(F)(F)F,-1
PA164768832,halobetasol propionate,Drug,CCC(=O)O[C@@]1([C@H](CC2C1(CC([C@]3(C2C[C@@H](C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl,-1
PA449839,halofantrine,Drug,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,-1
PA164712782,Halogenated hydrocarbons,Drug Class,,-1
PA449841,haloperidol,Drug,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,-1
PA166163823,haloperidol glucuronide,Metabolite,C1CN(CCC1(C2=CC=C(C=C2)Cl)OC3C(C(C(C(O3)C(=O)O)O)O)O)CCCC(=O)C4=CC=C(C=C4)F,-1
PA166163824,haloperidol n-oxide,Metabolite,C1C[N+](CCC1(C2=CC=C(C=C2)Cl)O)(CCCC(=O)C3=CC=C(C=C3)F)[O-],-1
PA166163825,haloperidol pyridinium,Metabolite,C1=CC(=CC=C1C2=CC=[N+](C=C2)CCCC(=O)C3=CC=C(C=C3)F)Cl,-1
PA164768737,haloprogin,Drug,C1=C(C(=CC(=C1Cl)Cl)Cl)OCC#CI,-1
PA449845,halothane,Drug,C(C(F)(F)F)(Cl)Br,1
PA166129559,hdl cholesterol,Biological Intermediate,,-1
PA449848,helium,Drug,,-1
PA449849,hemin,Drug,,-1
PA164712783,Hemodialytics And Hemofiltrates,Drug Class,,-1
PA164712784,"Hemodialytics, concentrates",Drug Class,,-1
PA164712785,Hemofiltrates,Drug Class,,-1
PA10339,hemophilus influenzae b vaccines,Drug Class,,-1
PA449855,heparin,Drug,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,-1
PA164712786,Heparin group,Drug Class,,-1
PA164712787,Heparins or heparinoids for topical use,Drug Class,,-1
PA164712788,Hepatic And Reticulo Endothelial System,Drug Class,,-1
PA164712789,Hepatitis vaccines,Drug Class,,-1
PA164783812,heptabarbital,Drug,CCC1(C(=O)NC(=O)NC1=O)C2=CCCCCC2,-1
PA452619,heroin,Drug,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,-1
PA164742902,hesperetin,Drug,COC1=C(C=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O)O,-1
PA449867,hesperidin,Drug,,-1
PA164746559,hetacillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N3C(=O)[C@H](NC3(C)C)C4=CC=CC=C4)C(=O)O)C,-1
PA449871,hexachlorophene,Drug,C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl,-1
PA166232681,hexafluoroisopropanol,Metabolite,,-1
PA166233501,hexafluoroisopropanol glucuronide,Metabolite,,-1
PA164743020,hexafluronium bromide,Drug,C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.[Br-].[Br-],-1
PA449875,hexobarbital,Drug,CC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2,-1
PA449877,hexocyclium,Drug,,-1
PA142899133,hexoprenaline,Drug,,-1
PA164746489,hexylcaine,Drug,CC(CNC1CCCCC1)OC(=O)C2=CC=CC=C2,-1
PA164712790,High-ceiling Diuretics,Drug Class,,-1
PA164712791,High-ceiling diuretics and potassium-sparing agents,Drug Class,,-1
PA166177229,highly active antiretroviral therapy (haart),Drug,,-1
PA449880,histamine phosphate,Drug,,-1
PA133950441,hmg coa reductase inhibitors,Drug Class,,-1
PA164712780,HMG CoA reductase inhibitors in combination with other lipid modifying agents,Drug Class,,-1
PA164712781,"HMG CoA reductase inhibitors, other combinations",Drug Class,,-1
PA164749405,homatropine methylbromide,Drug,C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-],-1
PA166178626,homocysteine,Biological Intermediate,,-1
PA166114929,homoharringtonine,Drug,,-1
PA166181084,homovanillic acid,"Metabolite,""Biological Intermediate""",COC1=C(C=CC(=C1)CC(=O)O)O,-1
PA166181086,homovanillin,"Metabolite,""Biological Intermediate""",COC1=C(C=CC(=C1)CC=O)O,-1
PA452637,hormonal contraceptives for systemic use,Drug Class,,-1
PA164712792,Hormone Antagonists And Related Agents,Drug Class,,-1
PA164712793,Hormones And Related Agents,Drug Class,,-1
PA166222881,human C1 esterase inhibitor,Drug,,-1
PA165958431,hyaluronan,Drug,,-1
PA164745713,hyaluronidase,Drug,,-1
PA10387,hydantoin derivatives,Drug Class,,-1
PA449894,hydralazine,Drug,C1=CC=C2C(=C1)C=NN=C2NN,-1
PA166271223,hydralazine acetone hydrazone,Metabolite,CC(=NNC1=NN=CC2=CC=CC=C21)C,-1
PA166176017,hydralazine / isosorbide dinitrate,Drug,,-1
PA166271221,hydralazine pyruvic acid hydrazone,Metabolite,C/C(=N\NC1=NN=CC2=CC=CC=C21)/C(=O)O,-1
PA164712794,Hydrazides,Drug Class,,-1
PA166131584,hydrazine,Metabolite,NN,-1
PA164712795,Hydrazinophthalazine derivatives,Drug Class,,-1
PA164712796,Hydrazinophthalazine derivatives and diuretics,Drug Class,,-1
PA449899,hydrochlorothiazide,Drug,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,-1
PA449900,hydrocodone,Drug,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,1
PA164745515,hydrocortamate,Drug,CCN(CC)CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O,-1
PA449905,hydrocortisone,Drug,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,-1
PA164752557,hydroflumethiazide,Drug,C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1,-1
PA449917,hydrogen peroxide,Drug,,-1
PA166220665,hydromorphol n-oxide,"Drug,""Metabolite""",,-1
PA166220667,hydromorphol-N-oxide-glucuronide,Metabolite,,-1
PA449918,hydromorphone,"Drug,""Metabolite""",CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4,1
PA166220661,Hydromorphone-3-glucuronide,Metabolite,,-1
PA166220666,hydromorphone-3-sulfate,Metabolite,,-1
PA166220664,hydromorphone n-oxide,Metabolite,,-1
PA166220682,hydromorphone-N-oxide-glucuronide,Metabolite,,-1
PA166131577,hydron,Ion,[H+],-1
PA133888889,hydroquinidine,Drug,,-1
PA449924,hydroquinone,Drug,,-1
PA166178632,hydroxide,"Ion,""Biological Intermediate""",,-1
PA164768689,hydroxocobalamin,Drug,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@@H](C)CNC(=O)CC[C@@]\4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=N7)/C=C\8/C([C@@H](C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co],-1
PA166270701,hydroxyabemaciclib,Metabolite,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)CO)F,-1
PA166131452,hydroxyalprazolam,Metabolite,C1C2=NN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4)CO,-1
PA165946747,hydroxyamitriptyline,Metabolite,CN(C)CC/C=C\1/C2=CC=CC=C2CC(C3=CC=CC=C31)O,-1
PA166131295,hydroxybromazepam,Metabolite,C1=CC=NC(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Br)O,-1
PA166226561,hydroxybupropion,Metabolite,,-1
PA166131385,hydroxycelecoxib,Metabolite,C1=CC(=CC=C1CO)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,-1
PA164777036,hydroxychloroquine,Drug,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,-1
PA166131505,hydroxy clomipramine,Metabolite,CN(C)CCCN1C2=CC=CC=C2CC(C3=C1C=C(C=C3)Cl)O,-1
PA166131506,hydroxy clomipramine glucuronide,Metabolite,,-1
PA166228341,hydroxycobalamin,Drug,,-1
PA166278841,hydroxy dabrafenib,Metabolite,CC(C)(CO)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,-1
PA166131508,hydroxy desmethyl clomipramine,Metabolite,CNCCCN1C2=C(CCC3=C1C=C(C=C3)Cl)C=C(C=C2)O,-1
PA166131509,hydroxy desmethyl clomipramine glucuronide,Metabolite,,-1
PA166131529,hydroxy-desmethyldoxepin,Metabolite,,-1
PA166131526,hydroxy-desmethyldoxepin glucuronide,Metabolite,,-1
PA166252541,hydroxydocetaxel,Metabolite,,-1
PA166131530,hydroxydoxepin,Metabolite,,-1
PA166131531,hydroxydoxepin glucuronide,Metabolite,,-1
PA166131286,hydroxyflunitrazepam,Metabolite,CN1C2=C(C=C(C=C2)[N+](=O)[O-])C(=NC(C1=O)O)C3=CC=CC=C3F,-1
PA166131442,hydroxyimatinib metabolites,Metabolite,,-1
PA166165036,hydroxylated sirolimus metabolites,Metabolite,,-1
PA166280661,hydroxy-m-chlorophenylpiperazine,Metabolite,C1CN(CCN1)C2=CC(=C(C=C2)O)Cl,-1
PA166163689,hydroxymethyl dasatinib,Metabolite,CC1=NC(=CC(=N1)NC2=NC=C(S2)C(=O)NC3=C(C=CC=C3Cl)CO)N4CCN(CC4)CCO,-1
PA166160398,hydroxymethyl ivacaftor,Metabolite,,-1
PA166131451,hydroxymidazolam,Metabolite,C1C2=CN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4F)CO,-1
PA166270703,hydroxy-N-desethylabemaciclib,Metabolite,CC(C)N1C2=C(C(=CC(=C2)C3=NC(=NC=C3F)NC4=NC=C(C=C4)CN5CCNCC5)F)N=C1CO,-1
PA165946719,hydroxynortriptyline,Metabolite,CNCC/C=C\1/C2=CC=CC=C2CC(C3=CC=CC=C31)O,-1
PA166238281,hydroxyomeprazole sulfone,Metabolite,,-1
PA165823907,hydroxyphenytoin,Metabolite,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=C(C=C3)O,-1
PA165823908,hydroxyphenytoin glucuronide,Metabolite,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=C(C=C3)OC4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,-1
PA449932,hydroxyprogesterone,Drug,,-1
PA164746492,hydroxypropyl cellulose,Drug,,-1
PA164712797,Hydroxyquinoline derivatives,Drug Class,,-1
PA164745514,hydroxystilbamidine isethionate,Drug,C1=CC(=C(N)N)C=CC1=C/C=C\2/C=CC(=CC2=O)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,-1
PA166271321,hydroxysulfapyridine,Metabolite,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=C(C=C2)O,-1
PA166131453,hydroxytriazolam,Metabolite,C1C2=NN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4Cl)CO,-1
PA140222718,hydroxytryptamine,Drug,,-1
PA449942,hydroxyurea,Drug,C(=O)(N)NO,-1
PA166178673,hydroxy-vitamin K,Biological Intermediate,,-1
PA166159254,hydroxyvoriconazole,Metabolite,,-1
PA166159255,hydroxyvoriconazole o-glucuronide,Metabolite,,-1
PA449943,hydroxyzine,Drug,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,-1
PA166242401,hygromycin b,Drug,,-1
PA166222902,hymecromone,Drug,,-1
PA164776844,hyoscyamine,Drug,CN1C2CCC1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3,-1
PA165985514,hyperforin,Drug,,-1
PA164712798,Hypertonic solutions,Drug Class,,-1
PA164712799,Hypnotics And Sedatives,Drug Class,,-1
PA164712800,"Hypnotics and sedatives in combination, excl. barbiturates",Drug Class,,-1
PA164712801,Hypothalamic Hormones,Drug Class,,-1
PA166178630,hypoxanthine,Biological Intermediate,,-1
PA10270,ibandronate,Drug,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,-1
PA164781375,ibritumomab,Drug,,-1
PA166121346,ibrutinib,Drug,C=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,-1
PA165958351,ibudilast,Drug,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,-1
PA166049187,ibufenac,Drug,CC(C)CC1=CC=C(C=C1)CC(=O)O,-1
PA449957,ibuprofen,Drug,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,1
PA166131540,ibuprofen glucuronide,Metabolite,,-1
PA449958,ibutilide,Drug,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,-1
PA164749185,icatibant,Drug,C1CC[C@H]2[C@@H](C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=CS5)NC(=O)CNC(=O)C6C[C@H](CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,-1
PA164743096,icodextrin,Drug,,-1
PA164746077,icosapent,Drug,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,-1
PA166114460,icotinib,Drug,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,-1
PA449961,idarubicin,Drug,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,-1
PA164781019,idoxuridine,Drug,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O,-1
PA153627678,idraparinux,Drug,,-1
PA164749134,idursulfase,Drug,,-1
PA449964,ifosfamide,Drug,C1CN(P(=O)(OC1)NCCCl)CCCl,-1
PA166178387,iguratimod,Drug,,-1
PA165947499,ilaprazole,Drug,CC1=C(C=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)N4C=CC=C4)OC,-1
PA161199368,iloperidone,Drug,,-1
PA164746843,iloprost,Drug,CC#CCC(C)C(/C=C/C1C(CC2C1C/C(=C\CCCC(=O)OCC(=O)C3=CC=CC=C3)/C2)O)O,-1
PA10804,imatinib,Drug,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,-1
PA166181986,imatinib (piperidine)-n-oxide,Metabolite,,-1
PA166181985,imatinib (pyridine)-n-oxide,Metabolite,,-1
PA166255842,imdevimab,Drug,,-1
PA452640,imidapril,Drug,,-1
PA164712804,Imidazole and triazole derivatives,Drug Class,,-1
PA164712807,Imidazole derivatives,Drug Class,,-1
PA164712809,Imidazole derivatives and corticosteroids,Drug Class,,-1
PA164712810,Imidazoline derivatives,Drug Class,,-1
PA164712811,Imidazoline receptor agonists,Drug Class,,-1
PA164712812,Imidazoline receptor agonists in combination with diuretics,Drug Class,,-1
PA164712813,Imidazothiazole derivatives,Drug Class,,-1
PA164742934,imiglucerase,Drug,,-1
PA449968,imipenem,Drug,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,-1
PA449969,imipramine,Drug,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,1
PA449972,imiquimod,Drug,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,-1
PA164754884,immune globulin,Drug,,-1
PA164712814,Immune Sera,Drug Class,,-1
PA164712815,Immune Sera And Immunoglobulins,Drug Class,,-1
PA164712817,Immunoglobulins,Drug Class,,-1
PA164712818,"Immunoglobulins, normal human",Drug Class,,-1
PA164712819,Immunostimulants,Drug Class,,-1
PA164712821,Immunosuppressants,Drug Class,,-1
PA166268802,inclisiran,Drug,,-1
PA164712823,Incontinence equipment,Drug Class,,-1
PA165958348,indacaterol,Drug,CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,-1
PA449975,indapamide,Drug,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,-1
PA164754881,indecainide,Drug,CC(C)NCCCC1(C2=CC=CC=C2C3=CC=CC=C31)C(=O)N,-1
PA164712824,Indifferent preparations,Drug Class,,-1
PA449977,indinavir,Drug,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,-1
PA164712825,Indium (111In) compounds,Drug Class,,-1
PA449981,indocyanine green,Drug,,-1
PA164712827,Indole derivatives,Drug Class,,-1
PA449982,indomethacin,Drug,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,1
PA166224921,inebilizumab-cdon,Drug,,-1
PA164712828,Infant Formulas,Drug Class,,-1
PA166252061,infigratinib,Drug,,-1
PA164712829,Inflammation And Infection Detection,Drug Class,,-1
PA452639,infliximab,Drug,,-1
PA164712830,Influenza vaccines,Drug Class,,-1
PA166160616,inosine,Biological Intermediate,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,-1
PA166160619,inosine monophosphate,Biological Intermediate,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,-1
PA166163464,"inositol 1,4,5-trisphosphate",Biological Intermediate,[C@H]1([C@@H]([C@H]([C@@H]([C@H]([C@@H]1OP(=O)(O)O)O)OP(=O)(O)O)OP(=O)(O)O)O)O,-1
PA166182756,inotersen,Drug,,-1
PA166177510,inotuzumab ozogamicin,Drug,,-1
PA164712831,Insecticides And Repellents,Drug Class,,-1
PA164784029,insulin-aspart,Drug,,-1
PA164746470,insulin-detemir,Drug,,-1
PA449992,insulin glargine,Drug,,-1
PA164760859,insulin-glulisine,Drug,,-1
PA164747059,insulin-lispro,Drug,,-1
PA164745627,insulin lyspro recombinant,Drug,,-1
PA166175761,insulin peglispro,Drug,,-1
PA164781053,"insulin, porcine",Drug,,-1
PA164744571,insulin recombinant,Drug,,-1
PA164712832,Insulins And Analogues,Drug Class,,-1
PA164712833,Insulins and analogues for inhalation,Drug Class,,-1
PA164712834,"Insulins and analogues for injection, fast-acting",Drug Class,,-1
PA164712835,"Insulins and analogues for injection, intermediate-acting",Drug Class,,-1
PA164712836,"Insulins and analogues for injection, intermediate-acting combined with fast-acting",Drug Class,,-1
PA164712837,"Insulins and analogues for injection, long-acting",Drug Class,,-1
PA164779048,"interferon alfa-2a, recombinant",Drug,,-1
PA164783990,"interferon alfa-2b, recombinant",Drug,,-1
PA164749376,interferon alfacon-1,Drug,,-1
PA164746538,interferon alfa-n1,Drug,,-1
PA164746228,interferon alfa-n3,Drug,,-1
PA450037,interferon beta-1a,Drug,,-1
PA450039,interferon beta-1b,Drug,,-1
PA164746386,interferon gamma-1b,Drug,,-1
PA451999,interferons,Drug Class,,-1
PA164712838,Interleukin inhibitors,Drug Class,,-1
PA164712839,Interleukins,Drug Class,,-1
PA164712840,Intermediate-acting sulfonamides,Drug Class,,-1
PA164712841,Intestinal Adsorbents,Drug Class,,-1
PA164712842,Intestinal Antiinfectives,Drug Class,,-1
PA164712843,Intestinal Antiinflammatory Agents,Drug Class,,-1
PA164712844,Intrauterine contraceptives,Drug Class,,-1
PA164712845,Intravaginal contraceptives,Drug Class,,-1
PA450043,inulin,Drug,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO[C@]3([C@H]([C@@H]([C@H](O3)CO)O)O)CO[C@]4([C@H]([C@@H]([C@H](O4)CO)O)O)CO[C@]5([C@H]([C@@H]([C@H](O5)CO)O)O)CO[C@]6([C@H]([C@@H]([C@H](O6)CO)O)O)CO[C@]7([C@H]([C@@H]([C@H](O7)CO)O)O)CO[C@]8([C@H]([C@@H]([C@H](O8)CO)O)O)CO[C@]9([C@H]([C@@H]([C@H](O9)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO[C@]1([C@H]([C@@H]([C@H](O1)CO)O)O)CO)O)O)O)O,-1
PA10116,iobenguane (131i),Drug,,-1
PA450049,iodine,Drug,,-1
PA164712846,Iodine (123I) compounds,Drug Class,,-1
PA164712847,Iodine (125I) compounds,Drug Class,,-1
PA164712848,Iodine (131I) compounds,Drug Class,,-1
PA164712851,Iodine products,Drug Class,,-1
PA164712850,Iodine Therapy,Drug Class,,-1
PA164745532,iodipamide,Drug,C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I,-1
PA164783998,iodixanol,Drug,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,-1
PA450061,iohexol,Drug,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,-1
PA164743143,iophendylate,Drug,CCOC(=O)CCCCCCCCC(C)C1=CC=CC=C1I,-1
PA166182718,ipilimumab,Drug,,-1
PA450082,ipratropium,Drug,CC(C)[N+]1([C@@H]2CC[C@@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C,-1
PA165949694,iptakalim,Drug,,-1
PA450084,irbesartan,Drug,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,-1
PA450085,irinotecan,Prodrug,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,-1
PA166131560,irinotecan M4,Metabolite,,-1
PA450087,iron,Drug,[Fe],-1
PA166131578,iron(2+),Ion,[Fe+2],-1
PA164712854,"Iron bivalent, oral preparations",Drug Class,,-1
PA164712855,Iron chelating agents,Drug Class,,-1
PA164764618,iron dextran,Drug,,-1
PA164712856,Iron in combination with folic acid,Drug Class,,-1
PA164712857,Iron in other combinations,Drug Class,,-1
PA164712853,Iron Preparations,Drug Class,,-1
PA164712858,"Iron trivalent, oral preparations",Drug Class,,-1
PA164712859,"Iron trivalent, parenteral preparations",Drug Class,,-1
PA164712860,Irrigating Solutions,Drug Class,,-1
PA166224941,isatuximab,Drug,,-1
PA166241781,isepamicin,Drug,,-1
PA450101,isocarboxazid,Drug,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,-1
PA450103,isoetharine,Drug,CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C,-1
PA450106,isoflurane,Drug,C(C(F)(F)F)(OC(F)F)Cl,1
PA164748933,isoflurophate,Drug,CC(C)OP(=O)(OC(C)C)F,-1
PA165958379,isometheptene,Drug,CC(CCC=C(C)C)NC,-1
PA450112,isoniazid,Drug,C1=CN=CC=C1C(=O)NN,-1
PA166131591,isoniazid diazene metabolite,Metabolite,,-1
PA166131592,isoniazid diazohydroxide metabolite,Metabolite,,-1
PA166131593,isoniazid hydrazones,Metabolite,,-1
PA166131590,isoniazid metabolic intermediates,Metabolite,,-1
PA166176022,isoniazid / pyrazinamide / rifampin,Drug,,-1
PA166131583,isonicotinic acid,Metabolite,C1=CN=CC=C1C(=O)O,-1
PA166131589,isonicotinyl glucuronate,Metabolite,,-1
PA166131588,isonicotinyl glycine,Metabolite,,-1
PA166131259,isophosphoramide mustard,Metabolite,C(CCl)NP(=O)(NCCCl)O,-1
PA164781398,isopropamide,Drug,CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C,-1
PA450117,isopropyl alcohol,Drug,CC(C)O,-1
PA450121,isoproterenol,Drug,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,-1
PA450125,isosorbide dinitrate,Drug,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O[N+](=O)[O-])O[N+](=O)[O-],-1
PA450126,isosorbide mononitrate,Drug,C1[C@@H]([C@@H]2[C@H](O1)[C@@H](CO2)O[N+](=O)[O-])O,-1
PA165958421,isothipendyl,Drug,,-1
PA164712861,Isotonic solutions,Drug Class,,-1
PA450128,isotretinoin,Drug,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,-1
PA166049183,isoxicam,Drug,CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,-1
PA166185381,ispinesib mesylate,Drug,,-1
PA450131,isradipine,Drug,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,-1
PA152432599,itopride,Drug,,-1
PA450132,itraconazole,Drug,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5CO[C@](O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,-1
PA166123415,ivabradine,Drug,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)C[C@H]3CC4=CC(=C(C=C34)OC)OC,-1
PA165950341,ivacaftor,Drug,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1
PA166160397,ivacaftor carboxylate,Metabolite,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C(=O)O,-1
PA166152935,ivacaftor / lumacaftor,Drug,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,-1
PA166179845,ivacaftor / tezacaftor,Drug,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C.CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,-1
PA450133,ivermectin,Drug,CC[C@@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C,-1
PA166182707,ivosidenib,Drug,,-1
PA164712802,I.v. Solution Additives,Drug Class,,-1
PA164712803,I.v. Solutions,Drug Class,,-1
PA165110439,ixabepilone,Drug,C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@H](C(C(=O)[C@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C,-1
PA164749133,josamycin,Drug,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,-1
PA450137,kanamycin,Drug,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,1
PA10457,kaolin,Drug,,-1
PA450144,ketamine,Drug,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,-1
PA131053734,ketanserin,Drug,,-1
PA164749385,ketazolam,Drug,CC1=CC(=O)N2CC(=O)N(C3=C(C2(O1)C4=CC=CC=C4)C=C(C=C3)Cl)C,-1
PA166211241,ketobemidone,Drug,,-1
PA450146,ketoconazole,Drug,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,-1
PA450149,ketoprofen,Drug,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,-1
PA450150,ketorolac,Drug,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,-1
PA450152,ketotifen,Drug,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,-1
PA164749508,kunecatechins,Drug,,-1
PA140222784,kyotorphin,Drug,,-1
PA164743150,labetalol,Drug,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,-1
PA166187141,lacidipine,Drug,,-1
PA166160048,lacosamide,Drug,CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1,-1
PA450161,lactose,Drug,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O,-1
PA164748762,lactulose,Drug,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@]([C@H]2O)(CO)O)CO)O)O)O)O,-1
PA166110255,lafutidine,Drug,C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3,-1
PA448055,l-alanine,Drug,C[C@@H](C(=O)O)N,-1
PA450163,lamivudine,Prodrug,C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N,-1
PA166184501,lamivudine / abacavir,Drug,,-1
PA166131489,lamivudine diphosphate choline,Metabolite,,-1
PA166131490,lamivudine diphosphate ethanolamine,Metabolite,,-1
PA166131314,lamivudine sulfoxide,Metabolite,C1[C@H](O[C@H](S1=O)CO)N2C=CC(=NC2=O)N,-1
PA450164,lamotrigine,Drug,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,-1
PA166170363,lamotrigine 2-n-glucuronide,Metabolite,,-1
PA166170364,lamotrigine 5-n-glucuronide,Metabolite,,-1
PA166170365,lamotrigine-arene-oxide,Metabolite,,-1
PA166170381,lamotrigine glutathione adduct,Metabolite,,-1
PA166170379,lamotrigine n2-oxide,Metabolite,,-1
PA450180,lansoprazole,Drug,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,1
PA166227281,lansoprazole sulfide,Metabolite,,-1
PA166225542,lansoprazole sulfone,Metabolite,,-1
PA10305,lanthanum carbonate,Drug,,-1
PA152241907,lapatinib,Drug,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,-1
PA448478,l-arginine,Drug,C(C[C@@H](C(=O)O)N)CN=C(N)N,-1
PA164776670,laronidase,Drug,,-1
PA166129564,laropiprant,Drug,CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)[C@H](CC3)CC(=O)O,-1
PA166182733,larotrectinib sulfate,Drug,,-1
PA164776968,l-asparagine,Drug,C([C@@H](C(=O)O)N)C(=O)N,-1
PA448494,l-aspartic acid,Drug,C([C@@H](C(=O)O)N)C(=O)O,-1
PA164743144,latamoxef,Drug,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O,-1
PA164774763,latanoprost,Drug,CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O,-1
PA166153449,latonduine a,Drug,C1C2=NC(=NC=C2C3=C(C(=O)N1)NC(=C3Br)Br)N,-1
PA166246641,lauric acid,Biological Intermediate,,-1
PA164712862,Laxatives,Drug Class,,-1
PA450154,l-carnitine,Drug,C[N+](C)(C)C[C@@H](CC(=O)[O-])O,-1
PA164747225,l-citrulline,Drug,C(C[C@@H](C(=O)O)N)CNC(=O)N,-1
PA449173,l-cysteine,Drug,C([C@@H](C(=O)O)N)S,-1
PA449176,l-cystine,Drug,C([C@@H](C(=O)O)N)SSC[C@@H](C(=O)O)N,-1
PA450191,lecithin,Drug,,-1
PA166128166,ledipasvir,Drug,CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,-1
PA166163427,ledipasvir / sofosbuvir,Drug,C[C@@H](C(=O)OC(C)C)N[P@@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3.CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,-1
PA450192,leflunomide,Drug,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,-1
PA162363968,lenalidomide,Drug,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,-1
PA166153472,lenvatinib,Drug,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,-1
PA166211881,lenzilumab,Drug,,-1
PA450195,lepirudin,Drug,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC6=CC=C(C=C6)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC7=CC=C(C=C7)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)N,-1
PA164769058,lercanidipine,Drug,CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,-1
PA166211921,leronlimab,Drug,,-1
PA166160006,lesinurad,Drug,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,-1
PA166184379,letermovir,Drug,,-1
PA450196,letrozole,Drug,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,-1
PA450198,leucovorin,"Drug,""Biological Intermediate""",C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,-1
PA166131294,leukomethylene blue,Metabolite,CN(C)C1=CC2=C(C=C1)NC3=C(S2)C=C(C=C3)N(C)C,-1
PA166178669,leukotriene A4,Biological Intermediate,,-1
PA166178670,leukotriene B4,Biological Intermediate,,-1
PA166178671,leukotriene C4,Biological Intermediate,,-1
PA166178929,leukotriene D4,Biological Intermediate,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)NCC(=O)O)N,-1
PA166178930,leukotriene E4,Biological Intermediate,CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N,-1
PA164712863,Leukotriene receptor antagonists,Drug Class,,-1
PA450203,leuprolide,Drug,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,-1
PA164749284,levallorphan,Drug,C=CCN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,-1
PA450205,levamisole,Drug,C1CSC2=N[C@H](CN21)C3=CC=CC=C3,-1
PA450206,levetiracetam,Drug,CC[C@H](C(=O)N)N1CCCC1=O,-1
PA166247961,levetiracetam metabolite LO57,Metabolite,,-1
PA164747027,levobunolol,Drug,CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O,-1
PA164754741,levobupivacaine,Drug,CCCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C,-1
PA164742988,levocabastine,Drug,C[C@@H]1CN(CC[C@@]1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,-1
PA450213,levodopa,Drug,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,-1
PA450214,levofloxacin,Drug,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,-1
PA166129561,levomefolic acid,"Drug,""Biological Intermediate""",CN1[C@H](CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,-1
PA134687942,levomepromazine,Drug,,-1
PA166227621,levomethadone,Drug,,1
PA450215,levomethadyl acetate,Drug,CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,-1
PA166182150,levomilnacipran,Drug,,-1
PA165958380,levonordefrin,Drug,C[C@@H]([C@@H](C1=CC(=C(C=C1)O)O)O)N,-1
PA450218,levonorgestrel,Drug,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,-1
PA164744368,levorphanol,Drug,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,-1
PA164749138,levosimendan,Drug,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,-1
PA450221,levothyroxine,Drug,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N,-1
PA449776,l-glutamic acid,Drug,C(CC(=O)O)[C@@H](C(=O)O)N,-1
PA10090,l-glutamine,Drug,C(CC(=O)N)[C@@H](C(=O)O)N,-1
PA449882,l-histidine,Drug,C1=C(NC=N1)C[C@@H](C(=O)O)N,-1
PA450226,lidocaine,Drug,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,-1
PA166182735,lidocaine and tetracaine,Drug,,-1
PA166176018,lidocaine / prilocaine,Drug,,-1
PA165818137,lidoflazine,Drug,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,-1
PA164749212,lincomycin,Drug,CCC[C@@H]1CC(N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O,-1
PA164712864,Lincosamides,Drug Class,,-1
PA164754914,lindane,Drug,C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,-1
PA450233,linezolid,Drug,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,-1
PA164778866,liothyronine,Drug,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,-1
PA164748036,liotrix,Drug,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)[O-])N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)[O-])N.[Na+].[Na+],-1
PA450239,lipase,Drug,,-1
PA164712865,Lipid Modifying Agents,Drug Class,,-1
PA164712866,"Lipid Modifying Agents, Combinations",Drug Class,,-1
PA164712867,"Lipid Modifying Agents, Plain",Drug Class,,-1
PA164776929,lipoic acid,Drug,C1CSS[C@@H]1CCCCC(=O)O,-1
PA164712868,Liquid plasters,Drug Class,,-1
PA165958364,liraglutide,Drug,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N,-1
PA164748975,lisdexamfetamine,Drug,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O,-1
PA450242,lisinopril,Drug,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,-1
PA164750430,l-isoleucine,Drug,CC[C@H](C)[C@@H](C(=O)O)N,-1
PA164749019,lisuride,Drug,CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,-1
PA450243,lithium,Drug,[Li+],-1
PA450249,liver extract,Drug,,-1
PA164712871,Liver therapy,Drug Class,,-1
PA164712870,"Liver Therapy, Lipotropics",Drug Class,,-1
PA450197,l-leucine,Drug,CC(C)CC(C(=O)O)N,-1
PA450280,l-lysine,Drug,C(CCN)C[C@@H](C(=O)O)N,-1
PA450453,l-methyldopa,Drug,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N,-1
PA166182939,l-methylfolate,"Drug,""Metabolite"",""Biological Intermediate""",,-1
PA164712872,Local Anesthetics,Drug Class,,-1
PA164712873,Local hemostatics,Drug Class,,-1
PA164744510,lofexidine,Drug,CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl,-1
PA164749165,lomefloxacin,Drug,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,-1
PA166114922,lomitapide,Drug,,-1
PA164749407,lomustine,Drug,C1CCC(CC1)NC(=O)N(CCCl)N=O,-1
PA166129466,lonafarnib,Drug,C1CN(CCC1CC(=O)N2CCC(CC2)[C@@H]3C4=C(C=C(C=C4CCC5=CC(=CN=C35)Br)Cl)Br)C(=O)N,-1
PA164712874,Long-acting sulfonamides,Drug Class,,-1
PA450262,loperamide,Drug,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,-1
PA450264,lopinavir,Drug,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,-1
PA166182605,lopinavir / ritonavir,Drug,,-1
PA164754806,loracarbef,Drug,C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,-1
PA450266,loratadine,Drug,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,-1
PA450267,lorazepam,Drug,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,-1
PA136437519,Lorenzo's oil,Drug,,-1
PA166182743,lorlatinib,Drug,,-1
PA164783814,l-ornithine,Drug,C(C[C@@H](C(=O)O)N)CN,-1
PA165958395,lornoxicam,Drug,CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=C(S1(=O)=O)C=C(S3)Cl,1
PA450268,losartan,Drug,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,-1
PA166131273,losartan E-3174,Metabolite,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)Cl,-1
PA166131443,losartan E-3179,Metabolite,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C=O)Cl,-1
PA166131444,losartan M1,Metabolite,,-1
PA166131445,losartan M2,Metabolite,,-1
PA166131446,losartan M4,Metabolite,,-1
PA166131447,losartan M5,Metabolite,,-1
PA166131448,losartan M7,Metabolite,,-1
PA166131449,losartan P1,Metabolite,,-1
PA166169432,losigamone,Drug,,-1
PA164764569,loteprednol etabonate,Drug,CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl,-1
PA450272,lovastatin,Drug,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,1
PA166163161,lovastatin acid,Metabolite,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C,-1
PA164712877,Low-ceiling diuretics and potassium-sparing agents,Drug Class,,-1
PA164712875,"Low-ceiling Diuretics, Excl. Thiazides",Drug Class,,-1
PA164712876,"Low-ceiling Diuretics, Thiazides",Drug Class,,-1
PA166165399,low density lipoprotein,Biological Intermediate,,-1
PA164712878,Low-energy diets,Drug Class,,-1
PA450273,loxapine,Drug,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,-1
PA166049180,loxoprofen,Drug,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O,-1
PA450931,l-phenylalanine,Drug,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,-1
PA451125,l-proline,Drug,C1C[C@H](NC1)C(=O)O,-1
PA451330,l-serine,"Drug,""Biological Intermediate""",C([C@@H](C(=O)O)N)O,-1
PA451673,l-threonine,Drug,C[C@H]([C@@H](C(=O)O)N)O,-1
PA10323,l-tryptophan,"Drug,""Biological Intermediate""",C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N,-1
PA451822,l-tyrosine,"Drug,""Biological Intermediate""",C1=CC(=CC=C1C[C@@H](C(=O)O)N)O,-1
PA164777012,lubiprostone,Drug,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@H]2CCCCCCC(=O)O)O)(F)F,-1
PA164748783,lucanthone,Drug,CCN(CC)CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O,-1
PA166131607,lucitanib,Drug,CNC(=O)C1=CC=CC2=C1C=CC(=C2)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,-1
PA166114483,lumacaftor,Drug,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,-1
PA166235281,lumasiran,Drug,,-1
PA165111722,lumefantrine,Drug,CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O,-1
PA164769031,lumiracoxib,Drug,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,1
PA164712879,Lung surfactants,Drug Class,,-1
PA166129557,lurasidone,Drug,C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O,-1
PA166117453,lurbinectedin,Drug,,-1
PA166190001,luspatercept-aamt,Drug,,-1
PA166182748,lusutrombopag,Drug,,-1
PA166224981,lutetium (177Lu) oxodotreotide,Drug,,-1
PA166278141,lutetium (177lu) vipivotide tetraxetan,Drug,C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O.[177Lu+3],-1
PA164750539,lutropin alfa,Drug,,-1
PA451843,l-valine,Drug,CC(C)[C@@H](C(=O)O)N,-1
PA165816891,LY2140023,Drug,CSCC[C@@H](C(=O)N[C@]1(CS(=O)(=O)[C@@H]2[C@H]1[C@H]2C(=O)O)C(=O)O)N,-1
PA161660849,LY686017,Drug,,-1
PA164747190,lymecycline,Drug,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)NCNCCCC[C@@H](C(=O)O)N)N(C)C)O,-1
PA166261201,macitentan,Drug,,-1
PA164712882,Macrolides,Drug Class,,-1
PA164712883,"Macrolides, Lincosamides And Streptogramins",Drug Class,,-1
PA166114925,mafenide,Drug,,-1
PA164712884,Magnesium,Drug Class,[Mg+2],-1
PA450290,magnesium acetate,Drug,,-1
PA450294,magnesium chloride,Drug,,-1
PA164712885,Magnesium compounds,Drug Class,,-1
PA450296,magnesium gluconate,Drug,,-1
PA166234822,Magnesium Hydroxide,Drug,,-1
PA450298,magnesium oxide,Drug,O=[Mg],-1
PA450302,magnesium sulfate,Drug,[O-]S(=O)(=O)[O-].[Mg+2],-1
PA166182547,magnesium trisilicate,Drug,,-1
PA164712886,Magnetic Resonance Imaging Contrast Media,Drug Class,,-1
PA164748092,malathion,Drug,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,-1
PA450320,mannitol,Drug,C(C(C(C(C(CO)O)O)O)O)O,-1
PA164712880,MAO inhibitors,Drug Class,,-1
PA164712881,MAO inhibitors and diuretics,Drug Class,,-1
PA450322,maprotiline,Drug,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24,-1
PA166268803,maralixibat,Drug,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)[C@H]([C@H]1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC,-1
PA164768835,maraviroc,Drug,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,-1
PA166235241,margetuximab,Drug,,-1
PA164748329,marimastat,Drug,CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@H](C(=O)NC)C(C)(C)C,-1
PA166185383,masitinib,Drug,,-1
PA164746493,masoprocol,Drug,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O,-1
PA166272922,mavacamten,Drug,C[C@@H](C1=CC=CC=C1)NC2=CC(=O)N(C(=O)N2)C(C)C,-1
PA166209301,mavrilimumab,Drug,,-1
PA165291473,maytansine,Drug,,-1
PA450326,mazindol,Drug,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,-1
PA166280401,m-chlorophenylpiperazine (m-CPP),Metabolite,C1CN(CCN1)C2=CC(=CC=C2)Cl,-1
PA164712887,Measles vaccines,Drug Class,,-1
PA164776669,mebendazole,Drug,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,-1
PA450334,mecamylamine,Drug,CC1(C2CCC(C2)C1(C)NC)C,-1
PA164774876,mecasermin,Drug,,-1
PA450336,mechlorethamine,Drug,CN(CCCl)CCCl,-1
PA450338,meclizine,Drug,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,-1
PA450341,meclofenamic acid,Drug,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl,-1
PA164712888,Medical gases,Drug Class,,-1
PA164712890,Medicated Dressings,Drug Class,,-1
PA164712891,Medicated dressings with antiinfectives,Drug Class,,-1
PA164712892,Medicated shampoos,Drug Class,,-1
PA450344,medroxyprogesterone,Drug,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,-1
PA165290930,medroxyprogesterone/conjugated estrogens,Drug,,-1
PA450346,medrysone,Drug,C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C,-1
PA450347,mefenamic acid,Drug,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,-1
PA450348,mefloquine,Drug,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,-1
PA450351,megestrol,Drug,CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,-1
PA162360980,meglitinides,Drug Class,,-1
PA166127606,melacine(ribi immunochem),Drug,,-1
PA10136,melarsoprol,Drug,,-1
PA164752558,melatonin,Drug,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,-1
PA164712893,Melatonin receptor agonists,Drug Class,,-1
PA450353,meloxicam,Drug,CC1=CN=C(S1)N/C(=C\2/C(=O)C3=CC=CC=C3S(=O)(=O)N2C)/O,1
PA450354,melphalan,Drug,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,-1
PA10364,memantine,Drug,CC12CC3CC(C1)(CC(C3)(C2)N)C,-1
PA450358,menadione,Drug,CC1=CC(=O)C2=CC=CC=C2C1=O,-1
PA166123066,menadione sodium bisulfite,Drug,CC1(CC(=O)C2=CC=CC=C2C1=O)S(=O)(=O)[O-].[Na+],-1
PA164712894,Meningococcal vaccines,Drug Class,,-1
PA164749406,menotropins,Drug,,-1
PA164776605,menthol,Drug,C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C,-1
PA164746250,mepenzolate,Drug,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,-1
PA450369,meperidine,Drug,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,-1
PA166186321,meperidinic acid,Metabolite,,-1
PA166184711,mephedrone,Drug,,-1
PA164745533,mephentermine,Drug,CC(C)(CC1=CC=CC=C1)NC,-1
PA450373,mephenytoin,Drug,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,-1
PA164748741,mepivacaine,Drug,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,-1
PA450377,meprobamate,Drug,CCCC(C)(COC(=O)N)COC(=O)N,-1
PA165958366,mepyramine,Drug,,-1
PA164748010,mequitazine,Drug,C1CN2CCC1C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53,-1
PA450379,mercaptopurine,"Drug,""Metabolite""",C1=NC2=C(N1)C(=S)N=CN2,1
PA166160609,mercaptopurine riboside,Metabolite,C1=NC(=S)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,-1
PA164712895,Mercurial diuretics,Drug Class,,-1
PA164712896,Mercurial products,Drug Class,,-1
PA166210763,merimepodib,Drug,,-1
PA164764445,meropenem,Drug,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3CC[C@H](N3)C(=O)N(C)C)C(=O)O)[C@@H](C)O,-1
PA450384,mesalazine,Drug,C1=CC(=C(C=C1N)C(=O)O)O,-1
PA450385,mesna,Drug,,-1
PA450386,mesoridazine,Drug,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C,-1
PA450388,mestranol,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC,-1
PA166183788,metabutethamine,Drug,,-1
PA164748761,metaraminol,Drug,C[C@@H]([C@@H](C1=CC(=CC=C1)O)O)N,-1
PA164747189,metaxalone,Drug,CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C,-1
PA450395,metformin,Drug,CN(C)C(=N)N=C(N)N,-1
PA165958382,methacholine,Drug,CC(C[N+](C)(C)C)OC(=O)C,-1
PA450398,methacholine chloride,Drug,,-1
PA164750512,methacycline,Drug,CN(C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O,-1
PA450401,methadone,Drug,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,1
PA166247441,methadone M3,Metabolite,,-1
PA166247461,methadone M4,Metabolite,,-1
PA166247481,methadone M5,Metabolite,,-1
PA164746889,methadyl acetate,Drug,CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,-1
PA450403,methamphetamine,Drug,C[C@@H](CC1=CC=CC=C1)NC,-1
PA164712897,Methanolquinolines,Drug Class,,-1
PA164747037,methantheline,Drug,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13,-1
PA164746525,metharbital,Drug,CCC1(C(=O)NC(=O)N(C1=O)C)CC,-1
PA450413,methazolamide,Drug,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,-1
PA164743018,methdilazine,Drug,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,-1
PA450422,methimazole,Drug,CN1C=CNC1=S,-1
PA450423,methionine,"Drug,""Biological Intermediate""",CSCC[C@@H](C(=O)O)N,-1
PA164749506,methocarbamol,Drug,COC1=CC=CC=C1OCC(COC(=O)N)O,-1
PA164784030,methohexital,Drug,CCC#CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C,-1
PA450428,methotrexate,Drug,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,-1
PA166131573,methotrexate glutamate,Metabolite,,-1
PA166131322,methotrexate polyglutamate,Metabolite,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,-1
PA164743234,methotrimeprazine,Drug,C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,-1
PA450431,methoxamine,Drug,CC(C(C1=C(C=CC(=C1)OC)OC)O)N,-1
PA450433,methoxsalen,Drug,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,-1
PA166234681,methoxydifluoroacetic acid,Metabolite,,-1
PA450434,methoxyflurane,Drug,COC(C(Cl)Cl)(F)F,1
PA166182621,methoxyphenamine,Drug,,-1
PA164743145,methsuximide,Drug,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,-1
PA164748094,methyclothiazide,Drug,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl,-1
PA164784028,methyl aminolevulinate,Drug,COC(=O)CCC(=O)CN,-1
PA151958365,methyl-CCNU,Drug,,-1
PA165816878,methylcholanthrene,Drug,,-1
PA164712898,Methyldopa,Drug Class,,-1
PA164712899,Methyldopa and diuretics in combination,Drug Class,,-1
PA450457,methylene blue,Drug,,-1
PA166250241,methylene diacetate,Drug,,-1
PA450461,methylergonovine,Drug,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,-1
PA164712900,Methylhydrazines,Drug Class,,-1
PA166160612,methylmercaptopurine,Metabolite,CSC1=NC=NC2=C1NC=N2,-1
PA450464,methylphenidate,Drug,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,-1
PA450374,methylphenobarbital,Drug,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2,-1
PA450466,methylprednisolone,Drug,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,-1
PA164784032,methylscopolamine,Drug,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C,-1
PA165958383,methyltestosterone,Drug,,-1
PA166160636,methyl-thioguanosine monophosphate,Metabolite,CSC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N,-1
PA166160604,methyl-thioinosine monophosphate,Metabolite,CC1=NC(=S)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,-1
PA164746748,methyprylon,Drug,CCC1(C(=O)C(CNC1=O)C)CC,-1
PA164743265,methysergide,Drug,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,-1
PA164777034,meticillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C,-1
PA164748727,metipranolol,Drug,CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O,-1
PA164783811,metixene,Drug,CN1CCCC(C1)CC2C3=CC=CC=C3SC4=CC=CC=C24,-1
PA450475,metoclopramide,Drug,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,-1
PA164749507,metocurine,Drug,C[N+]1(CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C,-1
PA164781022,metolazone,Drug,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,-1
PA450480,metoprolol,Drug,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,-1
PA166177866,metoprolol acid,Metabolite,,-1
PA166235301,metreleptin,Drug,,-1
PA164742936,metrizamide,Drug,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)N[C@@H]2[C@H]([C@@H]([C@H](OC2O)CO)O)O)I)N(C)C(=O)C)I,-1
PA450484,metronidazole,Drug,CC1=NC=C(N1CCO)[N+](=O)[O-],-1
PA450486,metyrapone,Drug,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,-1
PA450487,metyrosine,Drug,C[C@](CC1=CC=C(C=C1)O)(C(=O)O)N,-1
PA166178624,mevalonic acid,Biological Intermediate,,-1
PA450488,mexiletine,Drug,CC1=C(C(=CC=C1)C)OCC(C)N,-1
PA164750540,mezlocillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C,-1
PA165290932,MI-63,Drug,CC(C)(C)C[C@@H]1[C@]2([C@H]([C@@H](N1)C(=O)NCCN3CCOCC3)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O,-1
PA134687937,mianserin,Drug,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,-1
PA450492,mibefradil,Drug,CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,-1
PA164781026,micafungin,Drug,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O,-1
PA450494,miconazole,Drug,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,-1
PA166241801,micronomicin,Drug,,-1
PA450496,midazolam,Drug,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,-1
PA164749381,midodrine,Drug,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,-1
PA166169917,midostaurin,Drug,,-1
PA450500,mifepristone,Drug,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,-1
PA166182881,migalastat,Drug,,-1
PA164776726,miglitol,Drug,C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O,-1
PA10140,miglustat,Drug,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O,-1
PA164712901,Milk substitutes,Drug Class,,-1
PA164752812,milnacipran,Drug,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2,-1
PA166255303,milnacipran carbamoyl glucuronide,Metabolite,,-1
PA164749171,milrinone,Drug,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,-1
PA164752445,mimosine,Drug,C1=CN(C=C(C1=O)O)C[C@@H](C(=O)O)N,-1
PA164748351,minaprine,Drug,CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3,-1
PA164712903,Mineralocorticoids,Drug Class,,-1
PA164712902,Mineral Supplements,Drug Class,,-1
PA450519,minocycline,Drug,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O)N(C)C,-1
PA450521,minoxidil,Drug,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,-1
PA166114927,mipomersen,Drug,,-1
PA166177513,mirabegron,Drug,,-1
PA166049181,miroprofen,Drug,CC(C1=CC=C(C=C1)C2=CN3C=CC=CC3=N2)C(=O)O,-1
PA450522,mirtazapine,Drug,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,-1
PA450523,misoprostol,Drug,CCCCC(C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)OC)O)O,-1
PA166278021,mitapivat,Drug,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,-1
PA164748124,mitiglinide,Drug,C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)O,-1
PA450524,mitomycin,Drug,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N,-1
PA164746157,mitotane,Drug,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,-1
PA450526,mitoxantrone,Drug,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,-1
PA450528,mivacurium,Drug,C[N+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,-1
PA450529,mivacurium chloride,Drug,,-1
PA166129535,mizolastine,Drug,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,-1
PA165109661,MK-571,Drug,,-1
PA165964366,MK-7246,Drug,CN(C1CCC2=C(C3=CC=CC=C3N2C1)CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F,-1
PA166268804,mobocertinib,Drug,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,-1
PA452615,moclobemide,Drug,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,-1
PA450530,modafinil,Drug,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,-1
PA164769059,moexipril,Drug,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(C=C3C[C@H]2C(=O)O)OC)OC,-1
PA164746756,molindone,Drug,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C,-1
PA450536,molybdenum,Drug,,-1
PA450541,mometasone,Drug,C[C@@H]1C[C@H]2C3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C,-1
PA164712904,Monoamine oxidase A inhibitors,Drug Class,,-1
PA164712905,Monoamine oxidase B inhibitors,Drug Class,,-1
PA164712906,"Monoamine oxidase inhibitors, non-selective",Drug Class,,-1
PA164712907,Monobactams,Drug Class,,-1
PA164764582,monobenzone,Drug,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,-1
PA164712908,Monoclonal antibodies,Drug Class,,-1
PA166182229,monoethylglycinexylidide,Metabolite,,-1
PA450546,montelukast,Drug,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,-1
PA164747738,moricizine,Drug,CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4,-1
PA164712909,Morphinan derivatives,Drug Class,,-1
PA450550,morphine,"Drug,""Metabolite""",CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,1
PA166131340,morphine-3-glucuronide,Metabolite,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O)O[C@H]3[C@H](C=C4)O,-1
PA452633,morphine-6-glucuronide,Metabolite,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,-1
PA166118340,motesanib,Drug,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,-1
PA166163260,moviprep,Drug,,-1
PA450555,moxifloxacin,Drug,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,-1
PA140222720,MPP+,Drug,,-1
PA164712910,Mucolytics,Drug Class,,-1
PA164712912,"Multivitamins, Combinations",Drug Class,,-1
PA164712914,"Multivitamins, other combinations",Drug Class,,-1
PA164712913,"Multivitamins, Plain",Drug Class,,-1
PA164712911,Multivitamins with minerals,Drug Class,,-1
PA164712916,Mumps vaccines,Drug Class,,-1
PA164764568,mupirocin,Drug,C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)O)/C)[C@H](C)O,-1
PA162356187,muraglitazar,Drug,,-1
PA164743097,muromonab,Drug,,-1
PA164712917,Muscle Relaxants,Drug Class,,-1
PA164712918,"Muscle Relaxants, Centrally Acting Agents",Drug Class,,-1
PA164712919,"Muscle Relaxants, Directly Acting Agents",Drug Class,,-1
PA452389,"muscle relaxants, peripherally acting agents",Drug Class,,-1
PA164712921,Musculo-skeletal System,Drug Class,,-1
PA165107990,myclobutanil,Drug,,-1
PA450566,mycophenolate mofetil,Drug,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,-1
PA164748728,mycophenolic acid,Drug,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,-1
PA166131525,mycophenolic acid acyl glucuronide,Metabolite,,-1
PA166131524,mycophenolic acid glucuronide,Metabolite,,-1
PA164712922,Mydriatics And Cycloplegics,Drug Class,,-1
PA166131522,n-(2-carboxymethyl)-morpholine,Metabolite,,-1
PA166131347,n-(2-hydroxyethyl)-morpholine,Metabolite,C1COCCN1CCO,-1
PA166131523,n-(2-hydroxyethyl)-morpholine-n-oxide,Metabolite,,-1
PA166170380,N2-methyl lamotrigine,Metabolite,,-1
PA164746998,nabilone,Drug,CCCCCCC(C)(C)C1=CC2=C([C@@H]3CC(=O)CC[C@H]3C(O2)(C)C)C(=C1)O,-1
PA450572,nabumetone,Drug,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,1
PA166271281,N-acetyl-5-aminosalicylic acid,Metabolite,CC(=O)NC1=CC(=C(C=C1)O)C(=O)O,-1
PA164752287,n-acetyl-d-glucosamine,Drug,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O)CO)O)O,-1
PA166163832,n-acetyl fluvoxamine acid,Metabolite,CC(=O)NCCO/N=C(\CCCC(=O)O)/C1=CC=C(C=C1)C(F)(F)F,-1
PA166131547,n-acetyl-gamma-calicheamicin dimethyl hydrazide,Metabolite,,-1
PA140222717,n-acetyl serotonin,Drug,CC(=O)NCCC1=CNC2=C1C=C(C=C2)O,-1
PA166271402,n-acetyl sulfamethoxazole,Metabolite,CC1=CC(=NO1)N(OC(=O)C)S(=O)(=O)C2=CC=C(C=C2)N,-1
PA166271301,N-acetylsulfapyridine,Metabolite,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2,-1
PA450573,nadolol,Drug,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O,-1
PA10815,nadroparin,Drug,,-1
PA166220602,nafamostat,Drug,,-1
PA164754805,nafarelin,Drug,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,-1
PA450576,nafcillin,Drug,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,-1
PA164748617,naftifine,Drug,CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32,-1
PA164745372,nalbuphine,Drug,C1CC(C1)CN2CC[C@]34C5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O,-1
PA164746384,nalidixic acid,Drug,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,-1
PA166176241,nalmefene,Drug,,-1
PA450586,naloxone,Drug,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,-1
PA450588,naltrexone,Drug,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,1
PA164746281,nandrolone,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34,-1
PA165958423,nandrolone decanoate,Drug,,-1
PA165958384,naphazoline,Drug,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,-1
PA154081779,naphthol,Drug,,-1
PA166176067,naphthoxylactic acid,Metabolite,,-1
PA165983954,NAPQI,Metabolite,CC(=O)N=C1C=CC(=O)C=C1,-1
PA450595,naproxen,Drug,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,1
PA166163691,naproxen glucuronide,Metabolite,C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,-1
PA165983957,NAPSQI,Metabolite,CC(=O)NC1=CC=C(C=C1)[O],-1
PA450597,naratriptan,Drug,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,-1
PA151958361,naringenin,Drug,C1[C@H](OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O,-1
PA151958360,naringin,Drug,,-1
PA164712923,Nasal Decongestants For Systemic Use,Drug Class,,-1
PA164712924,Nasal Preparations,Drug Class,,-1
PA164747191,natalizumab,Drug,,-1
PA164744325,natamycin,Drug,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)OC4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O,-1
PA450600,nateglinide,Drug,CC(C)C1CCC(CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O,-1
PA166131372,nateglinide M1,Metabolite,CC(C)(C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O)O,-1
PA166131435,nateglinide M11/M12,Metabolite,C[C@](CO)(C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O)O,-1
PA166131433,nateglinide M2/M3,Metabolite,,-1
PA166131434,nateglinide M4/M5/M6,Metabolite,,-1
PA166131374,nateglinide M7,Metabolite,CC(=C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O,-1
PA164712925,"Natural and semisynthetic estrogens, plain",Drug Class,,-1
PA164712926,Natural opium alkaloids,Drug Class,,-1
PA166185384,navitoclax,Drug,,-1
PA166131470,n-bis-desethyl-amodiaquine,Metabolite,,-1
PA166179301,N-demethylondansetron,Metabolite,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3,-1
PA166270702,n-desethylabemaciclib,Metabolite,CC1=NC2=C(N1C(C)C)C=C(C=C2F)C3=NC(=NC=C3F)NC4=NC=C(C=C4)CN5CCNCC5,-1
PA166131298,n-desethyl-amodiaquine,Metabolite,C1=CC(=C(C=C1NC2=C3C=CC(=CC3=NC=C2)Cl)CN)O,-1
PA166255302,n-desethyl milnacipran,Metabolite,,-1
PA166160639,n-desethyl sunitinib,Metabolite,CCNCCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,-1
PA166183551,N-desisopropyl metoprolol,Metabolite,,-1
PA166183562,n-desisopropylpropranolol,Metabolite,,-1
PA166160753,N-desmethyl-4-hydroxyatomoxetine,Metabolite,,-1
PA166160754,N-desmethyl-4-hydroxyatomoxetine glucuronide,Metabolite,,-1
PA166160751,N-desmethyl atomoxetine,Metabolite,CC1=CC=CC=C1O[C@@H](CCN)C2=CC=CC=C2,-1
PA166160600,n-desmethyl clarithromycin,Metabolite,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)NC)O)(C)OC)C)C)O)(C)O,-1
PA166163659,n-desmethylclozapine,Metabolite,C1CN(CCN1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,-1
PA166131335,n-desmethylflunitrazepam,Metabolite,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3F,-1
PA166131475,n-desmethyl glucuronide rosiglitazone,Metabolite,,-1
PA166131369,n-desmethyl o-hydroxyrosiglitazone,Metabolite,C1=CC(=C(N=C1)NCCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3)O,-1
PA166131477,n-desmethyl o-o-sulfate rosiglitazone,Metabolite,,-1
PA166131478,n-desmethyl p-hydroxyrosiglitazone,Metabolite,,-1
PA166178110,n-desmethyl ponatinib,Metabolite,,-1
PA166131479,n-desmethyl p-o-sulfate rosiglitazone,Metabolite,,-1
PA166278721,n-desmethyl regorafenib n-oxide,Metabolite,C1=CC(=C(C=C1NC(=O)NC2=C(C=C(C=C2)OC3=CC(=[N+](C=C3)[O-])C(=O)N)F)C(F)(F)F)Cl,-1
PA166131282,n-desmethylrosiglitazone,Metabolite,C1=CC=NC(=C1)NCCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,-1
PA166180490,n-desmethyl rosuvastatin,Metabolite,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)NS(=O)(=O)C,-1
PA166261021,n-desmethyl sildenafil,Metabolite,,-1
PA166127651,n-desmethyltamoxifen,Metabolite,CC/C(=C(/C1=CC=CC=C1)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3,-1
PA166131493,n-desmethyltramadol,Metabolite,,-1
PA166260741,n-desmethyl vandetanib,Metabolite,,-1
PA166131537,n-desmethyl venlafaxine,Metabolite,,-1
PA166131480,n-despyridinyl rosiglitazone,Metabolite,,-1
PA151958426,nebivolol,Drug,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,-1
PA450601,nedocromil,Drug,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,-1
PA450603,nefazodone,Drug,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,-1
PA164752425,nelarabine,Drug,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,-1
PA450606,nelfinavir,Drug,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,-1
PA151186253,nemonapride,Drug,,-1
PA450608,neomycin,Drug,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,-1
PA450611,neostigmine,Drug,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,-1
PA165958407,nepafenac,Drug,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N,-1
PA165360204,Nepicastat,Drug,C1CC2=C(C=C(C=C2CC1[NH+]3C(=CNC3=S)CN)F)F,-1
PA165291472,neratinib,Drug,,-1
PA164712927,Nerve depressants,Drug Class,,-1
PA164712928,Nervous System,Drug Class,,-1
PA164781045,nesiritide,Drug,,-1
PA164754913,netilmicin,Drug,CCN[C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]2[C@@H]([C@H]([C@@](CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N,-1
PA164712929,Neuraminidase inhibitors,Drug Class,,-1
PA151958400,neuropsychiatric medications,Drug Class,,-1
PA450616,nevirapine,Drug,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,-1
PA129945760,NG-monomethyl-l-arginine,Drug,,-1
PA166246621,N-hydroxymethyl aripiprazole,Metabolite,,-1
PA450617,niacin,Drug,C1=CC(=CN=C1)C(=O)O,-1
PA450620,nicardipine,Drug,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,-1
PA164743014,nicergoline,Drug,CN1C[C@@H](C[C@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br,-1
PA165958408,niclosamide,Drug,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,-1
PA166184081,nicorandil,Drug,,-1
PA166178637,nicotinamide adenine dinucleotide,Biological Intermediate,,-1
PA166178279,nicotinamide adenine dinucleotide phosphate,Biological Intermediate,,-1
PA450626,nicotine,Drug,CN1CCCC1C2=CN=CC=C2,-1
PA166131310,nicotine glucuronide,Metabolite,CN1CCC[C@H]1C2=C[N+](=CC=C2)[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)[O-])O)O)O,-1
PA166131562,nicotine iminium ion,Metabolite,,-1
PA166131297,nicotine n-oxide,Metabolite,CN1CCCC1C2=C[N+](=CC=C2)[O-],-1
PA164712930,Nicotinic acid and derivatives,Drug Class,,-1
PA450631,nifedipine,Drug,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,-1
PA164746749,niflumic acid,Drug,C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F,-1
PA166228342,nifurtimox,Drug,,-1
PA165958345,nilotinib,Drug,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,-1
PA166164907,nilotinib carboxylic acid,Metabolite,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C(=O)O)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,-1
PA166163686,nilotinib n-oxide,Metabolite,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=C[N+](=CC=C5)[O-],-1
PA450632,nilutamide,Drug,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,-1
PA165958385,nilvadipine,Drug,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,-1
PA137179528,nimesulide,Drug,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,-1
PA450633,nimodipine,Drug,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,-1
PA166249521,nintedanib,Drug,,-1
PA166131610,niraparib,Drug,C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,-1
PA166279883,nirmatrelvir,Drug,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)C(F)(F)F)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C,-1
PA166279921,nirmatrelvir / ritonavir,Drug,,-1
PA450634,nisoldipine,Drug,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,-1
PA164754874,nitazoxanide,Drug,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],-1
PA164777037,nitisinone,Drug,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],-1
PA10242,nitrazepam,Drug,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,-1
PA146096020,nitrendipine,Drug,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,-1
PA450635,nitric oxide,Drug,[N]=O,-1
PA450636,nitrile,Drug,,-1
PA164712932,Nitroferricyanide derivatives,Drug Class,,-1
PA164712933,Nitrofuran derivatives,Drug Class,,-1
PA450640,nitrofurantoin,Drug,C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-],-1
PA164754877,nitrofurazone,Drug,C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N,-1
PA450643,nitrogen,Drug,,-1
PA164712936,Nitrogen mustard analogues,Drug Class,,-1
PA450644,nitroglycerin,Drug,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],-1
PA164712937,Nitroimidazole derivatives,Drug Class,,-1
PA451406,nitroprusside,Drug,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+4],-1
PA164712939,Nitrosoureas,Drug Class,,-1
PA166271441,nitrosulfamethoxazole,Metabolite,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)[N+](=O)[O-],-1
PA450645,nitrous oxide,Drug,,-1
PA164754993,nitroxoline,Drug,C1=CC2=C(C=CC(=C2N=C1)O)[N+](=O)[O-],-1
PA166129522,nivolumab,Drug,,-1
PA166277902,nivolumab / relatlimab,Drug,,-1
PA164752234,nizatidine,Drug,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C,-1
PA166181760,nnal,Metabolite,,-1
PA166131311,"n, n-didesmethyl tamoxifen",Metabolite,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN)/C3=CC=CC=C3,-1
PA166131492,"n,n-didesmethyltramadol",Metabolite,,-1
PA450570,"n,n-dimethylacetamide",Drug,,-1
PA166181759,nnk,Metabolite,,-1
PA166131491,"n,n,o-tridesmethyltramadol",Metabolite,,-1
PA166131495,"n,n,o-tridesmethyl-tramadol conjugates",Metabolite,,-1
PA166131380,"n,n,o-tridesmethyl venlafaxine",Metabolite,C1CCC(CC1)(C(CN)C2=CC=C(C=C2)O)O,-1
PA166131494,"n,o-didesmethyltramadol",Metabolite,CNC[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)O)O,-1
PA166131496,"n,o-didesmethyl-tramadol conjugates",Metabolite,,-1
PA166131539,"n,o-didesmethyl venlafaxine",Metabolite,,-1
PA166131359,"n,o-didesmethyl venlafaxine glucuronide",Metabolite,CNCC(C1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)C3(CCCCC3)O,-1
PA150047156,non-nucleoside reverse transcriptase inhibitors,Drug Class,,-1
PA450648,nonoxynol-9,Drug,CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO,-1
PA164712941,Non-selective beta-adrenoreceptor agonists,Drug Class,,-1
PA164712940,Non-selective Calcium Channel Blockers,Drug Class,,-1
PA10389,non-selective monoamine reuptake inhibitors,Drug Class,,-1
PA164712942,Non-watersoluble X-ray contrast media,Drug Class,,-1
PA166169929,norclobazam,Metabolite,,-1
PA166131386,norcodeine,Metabolite,COC1=C2C3=C(C[C@@H]4[C@H]5[C@]3(CCN4)[C@@H](O2)[C@H](C=C5)O)C=C1,-1
PA166131324,norcotinine,Metabolite,C1CC(=O)NC1C2=CN=CC=C2,-1
PA166131305,nordazepam,Metabolite,C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3,-1
PA166183940,nordextropropoxyphene,Metabolite,,-1
PA166220701,nordihydrocodeine,Metabolite,,-1
PA166220742,nordihydroisomorphine,Metabolite,,-1
PA166220702,nordihydromorphine,Metabolite,,-1
PA164953212,norelgestromin,Drug,CCC12CCC3C(C1CCC2(C#C)O)CCC4=C/C(=N\O)/CCC34,-1
PA166131406,norendoxifen,Metabolite,,-1
PA450649,norepinephrine,"Drug,""Biological Intermediate""",C1=CC(=C(C=C1[C@H](CN)O)O)O,-1
PA450651,norethindrone,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,-1
PA166280421,norfenfluramine,Metabolite,CC(CC1=CC(=CC=C1)C(F)(F)F)N,-1
PA166179852,norfentanyl,Metabolite,CCC(=O)N(C1CCNCC1)C2=CC=CC=C2,-1
PA450654,norfloxacin,Drug,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,-1
PA166131440,norfluoxetine glucuronide,Metabolite,,-1
PA164744346,norgestimate,Drug,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CCC4=C/C(=N/O)/CC[C@H]34,-1
PA450656,norgestrel,Drug,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,-1
PA166220621,norhydrocodone,Metabolite,,-1
PA166220662,norhydromorphone,Metabolite,,-1
PA166186301,normeperidine,Metabolite,,-1
PA166186341,normeperidinic acid,Metabolite,,-1
PA166181133,normetanephrine,"Metabolite,""Biological Intermediate""",COC1=C(C=CC(=C1)C(CN)O)O,-1
PA166131414,normorphine,Metabolite,C1CNC2CC3=C4C15C2C=CC(C5OC4=C(C=C3)O)O,-1
PA166131323,nornicotine,Metabolite,C1CC(NC1)C2=CN=CC=C2,-1
PA166131342,noroxycodone,Metabolite,COC1=C2C3=C(C[C@@H]4[C@]5([C@]3(CCN4)[C@@H](O2)C(=O)CC5)O)C=C1,-1
PA166170879,noroxycodone-glucuronide,Metabolite,,-1
PA166131548,noroxymorphone,Metabolite,,-1
PA166260001,norquetiapine,Metabolite,,-1
PA450657,nortriptyline,Drug,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,1
PA165374638,Noscapine,Drug,,-1
PA164768819,novobiocin,Drug,CC1=C(C=CC2=C1OC(=C(C2=O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O)O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O,-1
PA166178112,n-oxide ponatinib,Metabolite,,-1
PA166131558,NPC,Metabolite,,-1
PA166159659,nppb,Drug,C1=CC=C(C=C1)CCCNC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)O,-1
PA166049196,NS-398,Drug,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2CCCCC2,-1
PA164712943,Nucleoside and nucleotide reverse transcriptase inhibitors,Drug Class,,-1
PA452628,nucleosides and nucleotides excl. reverse transcriptase inhibitors,Drug Class,,-1
PA166182882,nusinersen,Drug,,-1
PA165290931,nutlin-3,Drug,,-1
PA164712944,Nutrients without phenylalanine,Drug Class,,-1
PA450666,nystatin,Drug,C[C@@H]1[C@H]([C@@H]([C@@H](C(O1)OC\2CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C(C(/C=C/C=C/CC/C=C/C=C/C=C/C=C2)C)O)C)C)O)O)O)O)O)O)C(=O)O)O)O)N)O,-1
PA137867605,O6-(4-Bromothenyl)guanine,Drug,,-1
PA164924563,OC144-093,Drug,,-1
PA134711724,ochratoxin A,Drug,,-1
PA450678,octreotide,Drug,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,-1
PA164712945,Ocular Vascular Disorder Agents,Drug Class,,-1
PA166280502,o-demethyl apixaban,Metabolite,C1CCN(C(=O)C1)C2=CC=C(C=C2)N3CCC4=C(C3=O)N(N=C4C(=O)N)C5=CC=C(C=C5)O,-1
PA166280501,o-demethyl apixaban sulfate,Metabolite,C1CCN(C(=O)C1)C2=CC=C(C=C2)N3CCC4=C(C3=O)N(N=C4C(=O)N)C5=CC=C(C=C5)OS(=O)(=O)O,-1
PA166177760,o-demethylmetoprolol,Metabolite,,-1
PA166182233,o-desethyl candesartan,Metabolite,,-1
PA166177869,o-desmethyl carvedilol,Metabolite,,-1
PA166131379,o-desmethyltramadol,Metabolite,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)O)O,-1
PA166131497,o-desmethyltramadol glucuronide,Metabolite,,-1
PA166131538,o-desmethyl venlafaxine glucuronide,Metabolite,,-1
PA166268805,odevixibat,Drug,CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)N1)OCC(=O)N[C@H](C3=CC=C(C=C3)O)C(=O)N[C@@H](CC)C(=O)O)SC)C4=CC=CC=C4)CCCC,-1
PA165291493,ofatumumab,Drug,,-1
PA450684,ofloxacin,Drug,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,-1
PA166131370,o-hydroxyrosiglitazone,Metabolite,,-1
PA450688,olanzapine,Drug,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,-1
PA166164918,olanzapine 10-n-glucuronide,Metabolite,CC1=CC2=C(S1)N(C3=CC=CC=C3N=C2N4CCN(CC4)C)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,-1
PA166164919,olanzapine 4-n-glucuronide,Metabolite,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CC[N+](CC4)(C)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,-1
PA166164915,olanzapine n-oxide,Metabolite,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CC[N+](CC4)(C)[O-],-1
PA164920420,olaparib,Drug,,-1
PA166163434,olaratumab,Drug,,-1
PA166223601,oliceridine,Drug,,-1
PA164742950,olmesartan,Drug,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,-1
PA450698,olopatadine,Drug,CN(C)CC/C=C\1/C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,-1
PA450700,olsalazine,Drug,C1=CC(=C(C=C1N/N=C\2/C=CC(=O)C(=C2)C(=O)O)C(=O)O)O,-1
PA165374637,Oltipraz,Drug,,-1
PA164752253,omalizumab,Drug,,-1
PA166163409,ombitasvir,Drug,CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,-1
PA166163408,ombitasvir / paritaprevir / ritonavir,Drug,CC1=NC=C(N=C1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8.CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)CC([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O.CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,-1
PA450702,omega-3 polyunsaturated fatty acids,Drug Class,,-1
PA450704,omeprazole,Drug,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,1
PA166227322,omeprazole sulfide,Metabolite,,-1
PA166131291,omeprazole sulfone,Metabolite,CC1=CN=C(C(=C1OC)C)CS(=O)(=O)C2=NC3=C(N2)C=C(C=C3)OC,-1
PA166238261,omeprazole sulfone n-oxide,Metabolite,,-1
PA166117241,onartuzumab,Drug,,-1
PA450705,ondansetron,Drug,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,1
PA166179669,ondansetron 6-glucuronide,Metabolite,,-1
PA166179672,ondansetron 6-sulfate,Metabolite,,-1
PA166179545,ondansetron 7-glucuronide,Metabolite,,-1
PA166179671,ondansetron 7-sulfate,Metabolite,,-1
PA166179307,ondansetron 8-glucuronide,Metabolite,CC1=NC=CN1CC2CCC3=C(C2=O)C4=C(N3C)C(=CC=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,-1
PA166179670,ondansetron 8-sulfate,Metabolite,,-1
PA166131472,o-o-glucuronide rosiglitazone,Metabolite,,-1
PA166131473,o-o-sulfate rosiglitazone,Metabolite,,-1
PA166279421,"o,p'-DDA",Metabolite,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(=O)O)Cl,-1
PA166279401,"o,p'-DDE",Metabolite,C1=CC=C(C(=C1)C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,-1
PA164712946,Ophthalmological And Otological Preparations,Drug Class,,-1
PA164712947,Ophthalmologicals,Drug Class,,-1
PA164712948,Opioid anesthetics,Drug Class,,-1
PA452618,opioids,Drug Class,,-1
PA164712949,Opioids in combination with antispasmodics,Drug Class,,-1
PA144614922,opipramol,Drug,,-1
PA164712950,Opium alkaloids and derivatives,Drug Class,,-1
PA164712951,Opium derivatives and expectorants,Drug Class,,-1
PA164747991,oprelvekin,Drug,,-1
PA164712952,Oral rehydration salt formulations,Drug Class,,-1
PA166183405,orange juice,Drug,,-1
PA130619705,orbofiban,Drug,,-1
PA450390,orciprenaline,Drug,CC(C)NCC(C1=CC(=CC(=C1)O)O)O,-1
PA164712953,Organic acids,Drug Class,,-1
PA10472,organic nitrates,Drug Class,,-1
PA164712954,Organophosphorous compounds,Drug Class,,-1
PA164712955,Oripavine derivatives,Drug Class,,-1
PA164776864,orlistat,Drug,CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,-1
PA450715,orphenadrine,Drug,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,-1
PA450721,oseltamivir,Drug,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,-1
PA166131300,OSI-420,Metabolite,COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCO.Cl,-1
PA166131626,osimertinib,Drug,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,-1
PA164712956,Osmotically acting laxatives,Drug Class,,-1
PA164743058,ospa lipoprotein,Drug,,-1
PA166182883,ospemifene,Drug,,-1
PA166281822,ospemifene carboxylic acid,Metabolite,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\C3=CC=C(C=C3)OCC(=O)O)/CCCl,-1
PA151958300,otamixaban,Drug,,-1
PA164712957,Other Agents Acting On The Renin-angiotensin System,Drug Class,,-1
PA164712999,Other agents against amoebiasis and other protozoal diseases,Drug Class,,-1
PA164713000,Other agents against leishmaniasis and trypanosomiasis,Drug Class,,-1
PA164713001,Other agents for local oral treatment,Drug Class,,-1
PA164713002,Other agents for treatment of hemorrhoids and anal fissures for topical use,Drug Class,,-1
PA164712958,Other Alimentary Tract And Metabolism Products,Drug Class,,-1
PA164713003,Other alkylating agents,Drug Class,,-1
PA164713004,Other aminoglycosides,Drug Class,,-1
PA164712960,Other Anabolic Agents,Drug Class,,-1
PA164712961,Other Analgesics And Antipyretics,Drug Class,,-1
PA164713006,Other anterior pituitary lobe hormones and analogues,Drug Class,,-1
PA164713007,Other anti-acne preparations for systemic use,Drug Class,,-1
PA164713008,Other anti-acne preparations for topical use,Drug Class,,-1
PA164713011,Other antiallergics,Drug Class,,-1
PA164712962,Other Antianemic Preparations,Drug Class,,-1
PA164712963,Other Antibacterials,Drug Class,,-1
PA164713014,Other antibiotics for topical use,Drug Class,,-1
PA164713015,Other anticestodals,Drug Class,,-1
PA164713009,Other anti-dementia drugs,Drug Class,,-1
PA164713016,Other antidepressants,Drug Class,,-1
PA164712964,Other Antidiarrheals,Drug Class,,-1
PA164713018,Other antiemetics,Drug Class,,-1
PA164713019,Other antiepileptics,Drug Class,,-1
PA164713020,Other antifungals for topical use,Drug Class,,-1
PA164713021,Other antiglaucoma preparations,Drug Class,,-1
PA164713022,Other antigout preparations,Drug Class,,-1
PA164713023,Other antihistamines for systemic use,Drug Class,,-1
PA164712965,Other Antihypertensives,Drug Class,,-1
PA164713025,Other antihypertensives and diuretics,Drug Class,,-1
PA164713026,Other antiinfectives,Drug Class,,-1
PA164713027,Other antiinfectives and antiseptics,Drug Class,,-1
PA164713028,"Other antiinflammatory and antirheumatic agents, non-steroids",Drug Class,,-1
PA164713030,Other antiinflammatory/antirheumatic agents in combination with other drugs,Drug Class,,-1
PA164713029,Other antiinflammatory therapeutic radiopharmaceuticals,Drug Class,,-1
PA164713031,Other antimalarials,Drug Class,,-1
PA164713032,Other antimigraine preparations,Drug Class,,-1
PA164713033,Other antimycotics for systemic use,Drug Class,,-1
PA164713034,Other antinematodals,Drug Class,,-1
PA164712966,Other Antineoplastic Agents,Drug Class,,-1
PA164713036,Other antiobesity drugs,Drug Class,,-1
PA164713010,Other anti-parathyroid agents,Drug Class,,-1
PA164713037,Other antipruritics,Drug Class,,-1
PA164713038,Other antipsoriatics for systemic use,Drug Class,,-1
PA164713039,Other antipsoriatics for topical use,Drug Class,,-1
PA164713040,Other antipsychotics,Drug Class,,-1
PA164713041,Other antiseptics and disinfectants,Drug Class,,-1
PA164713042,Other antispasmodics in combination with analgesics,Drug Class,,-1
PA164713043,Other antispasmodics in combination with psycholeptics,Drug Class,,-1
PA164713044,Other antithrombotic agents,Drug Class,,-1
PA164713045,Other antithyroid preparations,Drug Class,,-1
PA164713046,Other antitrematodal agents,Drug Class,,-1
PA164713047,Other antivirals,Drug Class,,-1
PA164713048,Other anxiolytics,Drug Class,,-1
PA164713049,Other bacterial vaccines,Drug Class,,-1
PA452159,other beta-lactam antibacterials,Drug Class,,-1
PA164713050,"Other blood glucose lowering drugs, excl. insulins",Drug Class,,-1
PA164713051,Other capillary stabilizing agents,Drug Class,,-1
PA164713052,Other cardiac combination products,Drug Class,,-1
PA164713053,Other cardiac glycosides,Drug Class,,-1
PA164712967,Other Cardiac Preparations,Drug Class,,-1
PA164713055,Other cardiac stimulants,Drug Class,,-1
PA164713056,Other cardiovascular system diagnostic radiopharmaceuticals,Drug Class,,-1
PA164713058,Other centrally acting agents,Drug Class,,-1
PA164713057,Other central nervous system diagnostic radiopharmaceuticals,Drug Class,,-1
PA164713059,Other cephalosporins,Drug Class,,-1
PA164713060,Other chemotherapeutics,Drug Class,,-1
PA164713061,Other cicatrizants,Drug Class,,-1
PA164713062,Other class I antiarrhythmics,Drug Class,,-1
PA164712968,Other Cold Combination Preparations,Drug Class,,-1
PA164713063,Other combinations of nutrients,Drug Class,,-1
PA164713064,Other cough suppressants,Drug Class,,-1
PA164713065,Other cough suppressants and expectorants,Drug Class,,-1
PA164713066,Other cytotoxic antibiotics,Drug Class,,-1
PA164712969,Other Dermatological Preparations,Drug Class,,-1
PA164713067,Other dermatologicals,Drug Class,,-1
PA164712971,Other Diagnostic Agents,Drug Class,,-1
PA164712972,Other Diagnostic Radiopharmaceuticals,Drug Class,,-1
PA164713069,Other diagnostic radiopharmaceuticals for inflammation and infection detection,Drug Class,,-1
PA164713070,Other diagnostic radiopharmaceuticals for tumour detection,Drug Class,,-1
PA164712973,Other Diuretics,Drug Class,,-1
PA164713071,Other dopaminergic agents,Drug Class,,-1
PA164713072,Other drugs affecting bone structure and mineralization,Drug Class,,-1
PA164712974,Other Drugs For Acid Related Disorders,Drug Class,,-1
PA164713073,Other drugs for bile therapy,Drug Class,,-1
PA164712976,Other Drugs For Disorders Of The Musculo-skeletal System,Drug Class,,-1
PA164713075,Other drugs for functional bowel disorders,Drug Class,,-1
PA164712977,"Other Drugs For Obstructive Airway Diseases, Inhalants",Drug Class,,-1
PA164713077,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),Drug Class,,-1
PA164713078,Other drugs for treatment of tuberculosis,Drug Class,,-1
PA164713079,Other drugs used in benign prostatic hypertrophy,Drug Class,,-1
PA164712978,Other Drugs Used In Diabetes,Drug Class,,-1
PA164713080,"Other ectoparasiticides, incl. scabicides",Drug Class,,-1
PA164713081,Other emollients and protectives,Drug Class,,-1
PA164713082,Other estrogens,Drug Class,,-1
PA164713083,Other general anesthetics,Drug Class,,-1
PA164712980,Other Gynecologicals,Drug Class,,-1
PA164712981,Other Hematological Agents,Drug Class,,-1
PA164713085,Other hem products,Drug Class,,-1
PA164713086,Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals,Drug Class,,-1
PA164713087,Other high-ceiling diuretics,Drug Class,,-1
PA164713088,Other hormone antagonists and related agents,Drug Class,,-1
PA164713089,Other hormones,Drug Class,,-1
PA164713090,Other hypnotics and sedatives,Drug Class,,-1
PA164713092,Other immunoglobulins,Drug Class,,-1
PA164713093,Other immunostimulants,Drug Class,,-1
PA164713094,Other immunosuppressants,Drug Class,,-1
PA164713095,Other insecticides and repellents,Drug Class,,-1
PA164713096,Other intestinal adsorbents,Drug Class,,-1
PA164713097,Other intestinal antiinfectives,Drug Class,,-1
PA164713098,Other irrigating solutions,Drug Class,,-1
PA164713091,Other i.v. solution additives,Drug Class,,-1
PA164713099,Other laxatives,Drug Class,,-1
PA164713100,Other lipid modifying agents,Drug Class,,-1
PA164713101,Other local anesthetics,Drug Class,,-1
PA164713102,Other low-ceiling diuretics,Drug Class,,-1
PA164713103,Other magnetic resonance imaging contrast media,Drug Class,,-1
PA164713104,Other mineral products,Drug Class,,-1
PA164712983,Other Mineral Supplements,Drug Class,,-1
PA164713105,"Other muscle relaxants, peripherally acting agents",Drug Class,,-1
PA164713106,Other nasal preparations,Drug Class,,-1
PA164712984,Other Nervous System Drugs,Drug Class,,-1
PA164713108,Other non-selective calcium channel blockers,Drug Class,,-1
PA164713109,Other non-therapeutic auxiliary products,Drug Class,,-1
PA164712986,Other Nutrients,Drug Class,,-1
PA164712987,Other Ophthalmological And Otological Preparations,Drug Class,,-1
PA164713110,Other ophthalmological diagnostic agents,Drug Class,,-1
PA164712988,Other Ophthalmologicals,Drug Class,,-1
PA164713112,Other opioids,Drug Class,,-1
PA164712989,Other Otologicals,Drug Class,,-1
PA164713113,Other oxytocics,Drug Class,,-1
PA164713114,Other parasympathomimetics,Drug Class,,-1
PA164713115,Other peripheral vasodilators,Drug Class,,-1
PA164712990,Other Plain Vitamin Preparations,Drug Class,,-1
PA164713117,Other plant alkaloids and natural products,Drug Class,,-1
PA164713118,Other potassium-sparing agents,Drug Class,,-1
PA164713119,Other psychostimulants and nootropics,Drug Class,,-1
PA164713120,Other quaternary ammonium compounds,Drug Class,,-1
PA164713121,Other quinolones,Drug Class,,-1
PA164713122,Other renal system diagnostic radiopharmaceuticals,Drug Class,,-1
PA164713123,Other respiratory system diagnostic radiopharmaceuticals,Drug Class,,-1
PA164712991,Other Respiratory System Products,Drug Class,,-1
PA164713125,Other sclerosing agents,Drug Class,,-1
PA164713126,Other selective calcium channel blockers with mainly vascular effects,Drug Class,,-1
PA164712993,Other Sex Hormones And Modulators Of The Genital System,Drug Class,,-1
PA164713127,Other specific antirheumatic agents,Drug Class,,-1
PA164713128,Other surgical aids,Drug Class,,-1
PA164712994,Other Systemic Drugs For Obstructive Airway Diseases,Drug Class,,-1
PA164713130,Other systemic hemostatics,Drug Class,,-1
PA164713131,Other therapeutic products,Drug Class,,-1
PA164712995,Other Therapeutic Radiopharmaceuticals,Drug Class,,-1
PA164713132,Other topical products for joint and muscular pain,Drug Class,,-1
PA164713133,Other urologicals,Drug Class,,-1
PA164712996,"Other Urologicals, Incl. Antispasmodics",Drug Class,,-1
PA164712997,Other Vaccines,Drug Class,,-1
PA164713134,Other vasodilators used in cardiac diseases,Drug Class,,-1
PA164713135,Other viral vaccines,Drug Class,,-1
PA164712998,"Other Vitamin Products, Combinations",Drug Class,,-1
PA164713136,Otologicals,Drug Class,,-1
PA163522138,ouabain,Drug,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,-1
PA164713137,"Ovulation stimulants, synthetic",Drug Class,,-1
PA450725,oxacillin,Drug,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,-1
PA131285527,oxaliplatin,Drug,C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2],-1
PA164748782,oxamniquine,Drug,CC(C)NCC1CCC2=CC(=C(C=C2N1)[N+](=O)[O-])CO,-1
PA164749395,oxandrolone,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,-1
PA450730,oxaprozin,Drug,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,-1
PA163522137,oxatomide,Drug,,-1
PA450731,oxazepam,Drug,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,-1
PA166268061,oxazepam glucuronide,Metabolite,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,-1
PA164713139,Oxazolidine derivatives,Drug Class,,-1
PA164713138,"Oxazol, thiazine, and triazine derivatives",Drug Class,,-1
PA450732,oxcarbazepine,Drug,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,1
PA166245981,oxcarbazepine glucuronide,Metabolite,,-1
PA164713140,Oxicams,Drug Class,,-1
PA164754742,oxiconazole,Drug,C1=CC(=C(C=C1Cl)Cl)CO/N=C(/CN2C=CN=C2)\C3=C(C=C(C=C3)Cl)Cl,-1
PA166178638,oxidized nicotinamide adenine dinucleotide,Biological Intermediate,,-1
PA166178646,oxiglutatione,Biological Intermediate,,-1
PA166279941,oxociprofloxacin,Metabolite,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNC(=O)C4)F)C(=O)O,-1
PA166163623,oxonortriptyline,Metabolite,CNCC/C=C/1\C2=CC=CC=C2CC(=O)C3=CC=CC=C31,-1
PA10284,oxprenolol,Drug,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,-1
PA164748137,oxtriphylline,Drug,CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO,-1
PA164742933,oxybenzone,Drug,COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,-1
PA164764617,oxybuprocaine,Drug,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N,-1
PA164746030,oxybutynin,Drug,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,-1
PA450741,oxycodone,Drug,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,1
PA166170878,oxycodone-3-glucuronide,Metabolite,,-1
PA166170880,oxycodone-glucuronide,Metabolite,,-1
PA450744,oxygen,Drug,,-1
PA164748840,oxymetazoline,Drug,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,-1
PA166182885,oxymetazoline and tetracaine,Drug,,-1
PA450748,oxymorphone,Metabolite,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,-1
PA166131363,oxymorphone 3-glucuronide,Metabolite,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@@H]1CC5=C3C(=C(C=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O)O4)O,-1
PA450750,oxyphenbutazone,Drug,CCCCC1C(=O)N(N(C1=O)C2=CC=C(C=C2)O)C3=CC=CC=C3,-1
PA164776910,oxyphencyclimine,Drug,CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O,-1
PA164752252,oxyphenonium,Drug,CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,-1
PA166131330,oxypurinol,Metabolite,C1=C2C(=NC(=O)NC2=O)NN1,-1
PA166211061,oxypurinol 1-riboside,Metabolite,,-1
PA166211042,oxypurinol 7-riboside,Metabolite,,-1
PA450757,oxytetracycline,Drug,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)/C(=C(\N)/O)/C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O,-1
PA164713141,Oxytocics,Drug Class,,-1
PA450760,oxytocin,Drug,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,-1
PA164713142,Oxytocin and analogues,Drug Class,,-1
PA450761,paclitaxel,Drug,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,-1
PA165949675,pactimibe,Drug,CCCCCCCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)CC(=O)O)C,-1
PA164713143,Pain Palliation (bone Seeking Agents),Drug Class,,-1
PA166153469,palbociclib,Drug,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,-1
PA164744014,palifermin,Drug,,-1
PA163518919,paliperidone,"Drug,""Metabolite""",CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,-1
PA164748781,palivizumab,Drug,,-1
PA10352,palonosetron,Drug,C1C[C@H]2CN(C(=O)C3=C2C(=CC=C3)C1)[C@@H]4CN5CCC4CC5,-1
PA166115579,pamaquine,Drug,CCN(CC)CCCC(C)NC1=C2C(=CC(=C1)OC)C=CC=N2,-1
PA450767,pamidronate,Drug,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,-1
PA164713144,Pancreatic Hormones,Drug Class,,-1
PA448428,pancrelipase,Drug,,-1
PA10238,pancreozymin (cholecystokinin),Drug,,-1
PA450771,pancuronium,Drug,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,-1
PA162373091,panitumumab,Drug,,-1
PA166161307,panobinostat,Drug,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO,-1
PA450774,pantoprazole,Drug,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,1
PA166225481,pantoprazole sulfate,Metabolite,,-1
PA166227222,pantoprazole sulfide,Metabolite,,-1
PA166225501,pantoprazole sulfone,Metabolite,,-1
PA450778,papain,Drug,,-1
PA164745550,papaverine,Drug,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,-1
PA164713145,Papaverine and derivatives,Drug Class,,-1
PA164713146,Papillomavirus vaccines,Drug Class,,-1
PA166184497,"Paracetamol, combinations excl. Psycholeptics (Vicks MediNait Sirup)",Drug,,-1
PA450790,paraformaldehyde,Drug,,-1
PA164713147,Paramagnetic contrast media,Drug Class,,-1
PA164748880,paramethadione,Drug,CCC1(C(=O)N(C(=O)O1)C)C,-1
PA164777035,paramethasone,Drug,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@H]3[C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)C)F,-1
PA166162420,paramethoxymethamphetamine,Biological Intermediate,,-1
PA164713148,Parasympathomimetics,Drug Class,,-1
PA164713150,Parathyroid Hormones And Analogues,Drug Class,,-1
PA166049193,parecoxib,Drug,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C,-1
PA450797,pargyline,Drug,CN(CC#C)CC1=CC=CC=C1,-1
PA450798,paricalcitol,Drug,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C,-1
PA166163410,paritaprevir,Drug,CC1=NC=C(N=C1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,-1
PA164784023,paromomycin,Drug,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,1
PA450801,paroxetine,Drug,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,1
PA166131358,paroxetine catechol,Metabolite,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC(=C(C=C3)O)O.Cl,-1
PA166131551,paroxetine M1,Metabolite,,-1
PA166131549,paroxetine M1 sulfate,Metabolite,,-1
PA166131552,paroxetine M2,Metabolite,,-1
PA166131302,paroxetine M3,Metabolite,CN1CC[C@H]([C@@H](C1)CO)C2=CC=C(C=C2)F,-1
PA166131336,paroxetine M3 glucuronide,Metabolite,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)/C)/C,-1
PA166131550,paroxetine polar metabolites,Metabolite,,-1
PA166182884,patisiran,Drug,,-1
PA165291492,pazopanib,Drug,,-1
PA166160967,pazopanib M24,Metabolite,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)CO)C)S(=O)(=O)N,-1
PA166160968,pazopanib M26,Metabolite,CC1=C2C=CC(=CC2=NN1C)N(C)C3=NC(=NC=C3)NC4=CC(=C(C=C4)CO)S(=O)(=O)N,-1
PA166160969,pazopanib M27,Metabolite,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)NC3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,-1
PA166116241,pci-24781,Drug,,-1
PA164742856,pefloxacin,Drug,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,-1
PA450831,pegademase bovine,Drug,,-1
PA164771236,pegaptanib,Drug,,-1
PA164760860,pegaspargase,Drug,,-1
PA164781387,pegfilgrastim,Drug,,-1
PA164749390,peginterferon alfa-2a,Drug,,1
PA164784024,peginterferon alfa-2b,Drug,,1
PA166205561,peginterferon lambda 1a,Drug,,-1
PA165963961,pegloticase,Drug,,-1
PA164749630,pegvisomant,Drug,,-1
PA166124615,pembrolizumab,Drug,,-1
PA10810,pemetrexed,Drug,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,-1
PA166248041,pemigatinib,Drug,,-1
PA164781018,pemirolast,Drug,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,-1
PA450836,pemoline,Drug,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,-1
PA164749474,penbutolol,Drug,CC(C)(C)NC[C@@H](COC1=CC=CC=C1C2CCCC2)O,-1
PA450839,penciclovir,Drug,C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N,-1
PA450840,penicillamine,Drug,CC(C)([C@H](C(=O)O)N)S,-1
PA164713152,Penicillamine and similar agents,Drug Class,,-1
PA450842,penicillin g,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,-1
PA164713153,Penicillins with extended spectrum,Drug Class,,-1
PA164745442,penicillin v,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,-1
PA450849,pentagastrin,Drug,CC(C)COC(=O)NCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N,-1
PA450850,pentamidine,Drug,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,-1
PA450851,pentamidine isethionate,Drug,,-1
PA164744326,pentazocine,Drug,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O,-1
PA450859,pentobarbital,Drug,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,-1
PA164777033,pentolinium,Drug,C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C,-1
PA164774806,pentosan polysulfate,Drug,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O,-1
PA450863,pentostatin,Drug,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O,-1
PA450864,pentoxifylline,Drug,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,-1
PA450868,pepsin,Drug,,-1
PA166230941,perampanel,Drug,,-1
PA162565876,perazine,Drug,,-1
PA164713154,Perchlorates,Drug Class,,-1
PA164781354,perflutren,Drug,C(C(F)(F)F)(C(F)(F)F)(F)F,-1
PA450873,pergolide,Drug,CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC,-1
PA130150436,perhexiline,Drug,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,-1
PA165291471,perifosine,Drug,,-1
PA450877,perindopril,Drug,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,-1
PA164713157,Peripherally acting antiobesity products,Drug Class,,-1
PA164713156,Peripheral Vasodilators,Drug Class,,-1
PA164713158,Peritoneal Dialytics,Drug Class,,-1
PA164743137,permethrin,Drug,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,-1
PA165291546,perospirone,Drug,C1CC[C@H]2[C@@H](C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54.Cl,-1
PA164713159,Peroxides,Drug Class,,-1
PA166178652,peroxynitrite anion,"Ion,""Biological Intermediate""",,-1
PA450882,perphenazine,Drug,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,-1
PA164713160,Pertussis vaccines,Drug Class,,-1
PA165290933,pertuzumab,Drug,,-1
PA128406983,pesticides,Drug Class,,-1
PA152241908,PHA-665752,Drug,CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,-1
PA164745309,phenacemide,Drug,C1=CC=C(C=C1)CC(=O)NC(=O)N,-1
PA450897,phenacetin,Drug,CCOC1=CC=C(C=C1)NC(=O)C,-1
PA166180939,phenazepam,Drug,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3Cl,-1
PA164746899,phenazopyridine,Drug,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,-1
PA128406980,phencyclidine,Drug,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3,-1
PA450902,phendimetrazine,Drug,CC1C(OCCN1C)C2=CC=CC=C2,-1
PA450903,phenelzine,Drug,C1=CC=C(C=C1)CCNN,-1
PA1000,phenformin,Drug,C1=CC=C(C=C1)CCN=C(N)N=C(N)N,-1
PA164750491,phenindamine,Drug,CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4,-1
PA164784031,phenindione,Drug,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,-1
PA164744506,pheniramine,Drug,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2,-1
PA164747188,phenmetrazine,Drug,CC1C(OCCN1)C2=CC=CC=C2,-1
PA450911,phenobarbital,Drug,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,-1
PA450913,phenol,Drug,C1=CC=C(C=C1)O,-1
PA164713161,Phenol and derivatives,Drug Class,,-1
PA450918,phenolsulfonphthalein,Drug,,-1
PA164713162,Phenothiazine derivatives,Drug Class,,-1
PA10478,phenothiazines with aliphatic side-chain,Drug Class,,-1
PA450919,phenoxybenzamine,Drug,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,-1
PA450921,phenprocoumon,Drug,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,-1
PA164771230,phensuximide,Drug,CN1C(=O)CC(C1=O)C2=CC=CC=C2,-1
PA164748099,phentermine,Drug,CC(C)(CC1=CC=CC=C1)N,-1
PA450926,phentolamine,Drug,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,-1
PA165950342,phenylacetic acid,Drug,C1=CC=C(C=C1)CC(=O)[O-].[Na+],-1
PA166182578,phenylacetic acid mustard,Metabolite,,-1
PA164713163,Phenylalkylamine derivatives,Drug Class,,-1
PA450932,phenylbutazone,Drug,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,-1
PA450935,phenylephrine,Drug,CNC[C@@H](C1=CC(=CC=C1)O)O,-1
PA164713165,Phenylpiperidine derivatives,Drug Class,,-1
PA164748965,phenylpropanolamine,Drug,C[C@H]([C@H](C1=CC=CC=C1)O)N,-1
PA450947,phenytoin,Drug,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1
PA166131401,phenytoin arene-oxide,Metabolite,,-1
PA166131402,phenytoin catechol,Metabolite,,-1
PA166131403,phenytoin dihydrodiol,Metabolite,,-1
PA166131404,phenytoin methylcatechol,Metabolite,,-1
PA166131405,phenytoin quinone,Metabolite,,-1
PA10479,phosphates,Drug,,-1
PA166179130,phosphatidylcholine,Biological Intermediate,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,-1
PA166179131,phosphatidylethanolamine,Biological Intermediate,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,-1
PA166179142,phosphatidylinositol diphosphate,Biological Intermediate,CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O[C@@H]1C([C@@H](C(C(C1O)O)OP(=O)(O)O)OP(=O)(O)O)O,-1
PA166179384,phosphatidylinositol trisphosphate,Biological Intermediate,[H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(=O)O[C@H]1C(O)C(OP(O)(O)=O)C(OP(O)(O)=O)[C@@H](OP(O)(O)=O)C1O)OC(=O)CCCCCCCCCCCCCCC,-1
PA164768860,phosphatidylserine,Drug,CCCC(=O)O[C@H](COC(=O)CC)COP(=O)(O)OC[C@@H](C(=O)O)N,-1
PA164713166,Phosphodiesterase inhibitors,Drug Class,,-1
PA450952,phospholipids,Drug,,-1
PA164713167,Phosphonic acid derivatives,Drug Class,,-1
PA166131376,phosphoramide mustard,Metabolite,C(CCl)N(CCCl)P(=O)(N)O,-1
PA166160615,phosphoribosylamine,Biological Intermediate,C([C@@H]1[C@H]([C@H]([C@@H](O1)N)O)O)OP(=O)(O)O,-1
PA166160613,phosphoribosyl pyrophosphate,Biological Intermediate,C([C@@H]1[C@H]([C@H]([C@H](O1)OP(=O)(O)OP(=O)(O)O)O)O)OP(=O)(O)O,-1
PA450953,phosphoric acid,Drug,,-1
PA450954,phosphorus,Drug,,-1
PA165984462,photodynamic therapy,Drug,,-1
PA166247501,p-hydroxymethadone,Metabolite,,-1
PA166170919,p-hydroxy-methylphenidate,Metabolite,,-1
PA166170920,p-hydroxy-ritalinic acid,Metabolite,,-1
PA166170921,p-hydroxy-ritalinic acid glucuoronide,Metabolite,,-1
PA166131382,p-hydroxyrosiglitazone,Metabolite,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=NC=C(C=C3)O,-1
PA450957,physostigmine,Drug,C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C,-1
PA450961,phytonadione,Drug,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,-1
PA164777007,picrotoxin,Drug,CC(=C)[C@@H]1C2[C@@H]3[C@@]4([C@](C1C(=O)O2)(CC5[C@]4(O5)C(=O)O3)O)C.C[C@@]12[C@H]3C4[C@H](C([C@@]1(C[C@@H]5[C@]2(O5)C(=O)O3)O)C(=O)O4)C(C)(C)O,-1
PA450962,pilocarpine,Drug,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C,-1
PA166186035,pilsicainide,Drug,,-1
PA164783790,pimecrolimus,Drug,CC[C@@H]1/C=C(\C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)/C,-1
PA450965,pimozide,Drug,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,-1
PA450966,pindolol,Drug,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,-1
PA450970,pioglitazone,Drug,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,-1
PA165958415,pipazethate,Drug,,-1
PA164764567,pipecuronium,Drug,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CC[N+](CC4)(C)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)N6CC[N+](CC6)(C)C)C,-1
PA450975,piperacillin,Drug,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,-1
PA166228323,piperacillin-tazobactam,Drug,,-1
PA166104279,piperaquine,Drug,C1CN(CCN1CCCN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)C5=C6C=CC(=CC6=NC=C5)Cl,-1
PA450977,piperazine,Drug,C1CNCCN1,-1
PA164713168,Piperazine and derivatives,Drug Class,,-1
PA164713169,Piperazine derivatives,Drug Class,,-1
PA164713170,Piperidinedione derivatives,Drug Class,,-1
PA166165007,piperidine-hydroxy-sirolimus,Metabolite,,-1
PA450980,piperonyl butoxide,Drug,,-1
PA164747673,pipobroman,Drug,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,-1
PA10158,pipotiazine,Drug,CN(C)S(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO,-1
PA450983,pirbuterol,Drug,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,-1
PA10159,pirenzepine,Drug,CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,-1
PA166249581,pirfenidone,Drug,,-1
PA166212681,piritramide,Drug,,-1
PA450985,piroxicam,Drug,CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=CC=CC=C3S1(=O)=O,1
PA166246201,piroxicam glucuronide,Metabolite,,-1
PA142650384,pitavastatin,Drug,,1
PA166256982,pitavastatin acyl glucuronide,Metabolite,,-1
PA166256721,pitavastatin lactone,Metabolite,,-1
PA166185163,pitolisant,Drug,,-1
PA165983754,pitrakinra,Drug,,-1
PA164713171,Pituitary And Hypothalamic Hormones And Analogues,Drug Class,,-1
PA164776912,pivampicillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)OCOC(=O)C(C)(C)C)C,-1
PA164750167,pivmecillinam,Drug,CC1(C(N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C,-1
PA164713172,Plague vaccines,Drug Class,,-1
PA164713173,Plant Alkaloids And Other Natural Products,Drug Class,,-1
PA164713174,Plasters,Drug Class,,-1
PA164713175,Platelet aggregation inhibitors excl. heparin,Drug Class,,-1
PA150595617,platinum,Drug,,-1
PA164713176,Platinum compounds,Drug Class,,-1
PA166228921,plazomicin,Drug,,1
PA165958410,plerixafor,Drug,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,-1
PA165958411,plicamycin,Drug,,-1
PA164713177,Pneumococcal vaccines,Drug Class,,-1
PA450993,podofilox,Drug,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O,-1
PA452642,podophyllotoxin derivatives,Drug Class,,-1
PA10162,podophyllum,Drug,,-1
PA166131474,p-o-glucuronide rosiglitazone,Metabolite,,-1
PA450999,poliomyelitis vaccines,Drug Class,,-1
PA451013,polyethylene glycol,Drug,,-1
PA451018,polyethylene glycol 400,Drug,,-1
PA451020,polyethylene glycol 6000,Drug,,-1
PA451023,polyethylene glycol 8000,Drug,,-1
PA451027,polymyxin b sulfate,Drug,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O,-1
PA164713178,Polymyxins,Drug Class,,-1
PA451038,polysorbate 80,Drug,,-1
PA164749386,polystyrene sulfonate,Drug,C=CC1=CC=CC=C1S(=O)(=O)[O-].[Ca+2],-1
PA164748763,polythiazide,Drug,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F,-1
PA165980594,ponatinib,Drug,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,-1
PA166178111,ponatinib M14,Metabolite,,-1
PA164752658,porfimer,Drug,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O,-1
PA151958574,posaconazole,Drug,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,-1
PA164713179,Posterior Pituitary Lobe Hormones,Drug Class,,-1
PA166131476,p-o-sulfate rosiglitazone,Metabolite,,-1
PA451047,potassium,"Drug,""Ion""",,-1
PA451049,potassium acetate,Drug,,-1
PA451055,potassium chloride,Drug,[Cl-].[K+],-1
PA451057,potassium gluconate,Drug,,-1
PA451060,potassium iodide,Drug,[K+].[I-],-1
PA166190081,potassium oxonate,Drug,,-1
PA451071,"potassium phosphate, incl. comb. with other potassium salts",Drug,,-1
PA164713182,Potassium-sparing Agents,Drug Class,,-1
PA152241909,PP2,Drug,,-1
PA164752820,practolol,Drug,CC(C)NC[C@@H](COC1=CC=C(C=C1)NC(=O)C)O,-1
PA164744926,pralidoxime,Drug,CN\1C=CC=C/C1=C\[NH+]=O,-1
PA166235321,pralsetinib,Drug,,-1
PA164742949,pramipexole,Drug,CCCN[C@@H]1CCC2=C(C1)SC(=N2)N,-1
PA164781394,pramlintide,Drug,,-1
PA134698661,pranlukast,Drug,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC4=C(C=C3)C(=O)C=C(O4)C5=NNN=N5,-1
PA154410481,prasugrel,Drug,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,-1
PA166267762,prasugrel active metabolite R-138727,Metabolite,C1CC1C(=O)C(C2=CC=CC=C2F)N3CCC(/C(=C\C(=O)O)/C3)S,-1
PA451089,pravastatin,Drug,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,1
PA166131390,pravastatin active metabolites; pravastatin inactive metabolites,Metabolite,,-1
PA166247901,pravastatin dihydrodiol,Metabolite,,-1
PA164776668,prazepam,Drug,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,-1
PA164764583,praziquantel,Drug,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,-1
PA451093,prazosin,Drug,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,-1
PA164749394,prednicarbate,Drug,CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC,-1
PA451096,prednisolone,Drug,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,-1
PA166273221,prednisolone glucuronide,Metabolite,C[C@]12C[C@@H]([C@@H]3[C@H]([C@H]1CC[C@]2(C(=O)CO[C@H]4C(C([C@@H](C(O4)C(=O)O)O)O)O)O)CCC5=CC(=O)C=C[C@]35C)O,-1
PA451100,prednisone,Drug,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,-1
PA164754814,pregabalin,Drug,CC(C)C[C@@H](CC(=O)O)CN,-1
PA164713183,Pregnadien derivatives,Drug Class,,-1
PA164713184,Pregnen (4) derivatives,Drug Class,,-1
PA165817938,prenylamine,Drug,,-1
PA165958355,preotact,Drug,,-1
PA164713186,Preparations containing sulfur,Drug Class,,-1
PA164713187,Preparations for biliary tract therapy,Drug Class,,-1
PA164713185,Preparations For Treatment Of Wounds And Ulcers,Drug Class,,-1
PA164713188,Preparations increasing uric acid excretion,Drug Class,,-1
PA164713189,Preparations inhibiting uric acid production,Drug Class,,-1
PA164713190,Preparations with no effect on uric acid metabolism,Drug Class,,-1
PA164713191,Preparations with salicylic acid derivatives,Drug Class,,-1
PA166115441,pridopidine,Drug,CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C,-1
PA451101,prilocaine,Drug,CCCNC(C)C(=O)NC1=CC=CC=C1C,-1
PA451103,primaquine,Drug,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,-1
PA451105,primidone,Drug,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,-1
PA451106,probenecid,Drug,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,-1
PA451107,probucol,Drug,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,-1
PA451108,procainamide,Drug,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,-1
PA451110,procaine,Drug,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,-1
PA451112,procarbazine,Drug,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,-1
PA164748908,procaterol,Drug,CC[C@@H]([C@@H](C1=C2C=CC(=O)NC2=C(C=C1)O)O)NC(C)C,-1
PA451114,prochlorperazine,Drug,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,-1
PA164784001,procyclidine,Drug,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O,-1
PA164748742,proflavine,Drug,C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N,-1
PA164747990,progabide,Drug,C1=CC(=CC=C1/C(=C\2/C=C(C=CC2=O)F)/NCCCC(=O)N)Cl,-1
PA451123,progesterone,Drug,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,-1
PA164713192,Progestogens,Drug Class,,-1
PA164713195,"Progestogens and estrogens, fixed combinations",Drug Class,,-1
PA452359,progestogens and estrogens in combination,Drug Class,,-1
PA164713196,"Progestogens and estrogens, sequential preparations",Drug Class,,-1
PA451124,proguanil,Drug,CC(C)N=C(N)/N=C(\N)/NC1=CC=C(C=C1)Cl,-1
PA164713197,Prolactine inhibitors,Drug Class,,-1
PA451126,promazine,Drug,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,-1
PA451128,promethazine,Drug,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,-1
PA451131,propafenone,Drug,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,-1
PA164746224,propantheline,Drug,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C,-1
PA164776849,proparacaine,Drug,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,-1
PA164781043,propericiazine,Drug,C1CN(CCC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C#N,-1
PA165107991,propiconazole,Drug,,-1
PA164778685,propiomazine,Drug,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C,-1
PA451140,propionic acid derivatives,Drug Class,,-1
PA451141,propofol,Drug,CC(C)C1=C(C(=CC=C1)C(C)C)O,-1
PA166256061,propofol glucuronide,Metabolite,,-1
PA451142,propoxyphene,Drug,CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,-1
PA451145,propranolol,Drug,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,-1
PA166176063,propranolol glucuronide,Metabolite,,-1
PA164713199,Propulsives,Drug Class,,-1
PA165958387,propylhexedrine,Drug,CC(CC1CCCCC1)NC,-1
PA451156,propylthiouracil,Drug,CCCC1=CC(=O)NC(=S)N1,-1
PA166220601,proscillaridin,Drug,,-1
PA164713200,Prostaglandin analogues,Drug Class,,-1
PA166178665,prostaglandin D2,Biological Intermediate,,-1
PA449345,prostaglandin E2,"Drug,""Biological Intermediate""",CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,-1
PA166178991,prostaglandin F2,Biological Intermediate,CCCCCC(/C=C/C1C(CC(C1C/C=C\CCCC(=O)O)O)O)O,-1
PA166178975,prostaglandin G2,Biological Intermediate,CCCCC[C@@H](/C=C/[C@H]1[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)OO2)OO,-1
PA166178660,prostaglandin H2,Biological Intermediate,,-1
PA449479,prostaglandin I2,"Drug,""Biological Intermediate""",CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)O2)O)O,-1
PA452363,prostaglandins,Drug Class,,-1
PA10366,protamine,Drug,,-1
PA451159,protease inhibitors,Drug Class,,-1
PA164713201,Protectives Against Uv-radiation,Drug Class,,-1
PA164713202,Protectives against UV-radiation for systemic use,Drug Class,,-1
PA164713203,Protectives against UV-radiation for topical use,Drug Class,,-1
PA164713205,Proteinase inhibitors,Drug Class,,-1
PA164713204,Protein kinase inhibitors,Drug Class,,-1
PA451465,protein supplements,Drug Class,,-1
PA164713206,Proteolytic enzymes,Drug Class,,-1
PA166131427,protonated proton pump inhibitors,Metabolite,,-1
PA164713207,Proton pump inhibitors,Drug Class,,-1
PA451168,protriptyline,Drug,CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13,-1
PA451170,pseudoephedrine,Drug,C[C@@H]([C@H](C1=CC=CC=C1)O)NC,-1
PA164713208,Psoralens for systemic use,Drug Class,,-1
PA164713209,Psoralens for topical use,Drug Class,,-1
PA164713210,Psychoanaleptics,Drug Class,,-1
PA164713211,Psycholeptics,Drug Class,,-1
PA164713212,Psycholeptics And Psychoanaleptics In Combination,Drug Class,,-1
PA164713214,"Psychostimulants, Agents Used For Adhd And Nootropics",Drug Class,,-1
PA164713213,Psychostimulants in combination with psycholeptics,Drug Class,,-1
PA452634,purine analogues,Drug Class,,-1
PA164713215,Purine derivatives,Drug Class,,-1
PA451182,pyrazinamide,Drug,C1=CN=C(C=N1)C(=O)N,-1
PA166271503,pyrazinoic acid,Metabolite,C1=CN=C(C=N1)C(=O)O,-1
PA164713216,Pyrazolone derivatives,Drug Class,,-1
PA164713217,Pyrazolones,Drug Class,,-1
PA164713218,Pyrethrines,Drug Class,,-1
PA164713219,"Pyrethrines, incl. synthetic compounds",Drug Class,,-1
PA10481,pyrethrins and piperonyl butoxide,Drug,,-1
PA451185,pyridostigmine,Drug,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,-1
PA164749166,pyridoxal,Drug,CC1=NC=C(C(=C1O)C=O)CO,-1
PA164749650,pyridoxal phosphate,Drug,CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O,-1
PA451897,pyridoxine,Drug,CC1=NC=C(C(=C1O)CO)CO,-1
PA165817939,pyrilamine,Drug,CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2,-1
PA451193,pyrimethamine,Drug,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,-1
PA166248741,pyrimethamine / sulfadoxine,Drug,,-1
PA164713220,Pyrimidine analogues,Drug Class,,-1
PA164713221,Pyrimidine derivatives,Drug Class,,-1
PA166131269,pyruvate,"Metabolite,""Biological Intermediate""",CC(=O)C(=O)[O-],-1
PA164778686,pyruvic acid,Drug,CC(=O)C(=O)O,-1
PA1102,qt-prolonging drugs,Drug Class,,-1
PA164713222,Quaternary ammonium compounds,Drug Class,,-1
PA164744373,quazepam,Drug,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,-1
PA166175941,quercetin,Metabolite,,-1
PA451201,quetiapine,Drug,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,-1
PA164745551,quinacrine,Drug,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,-1
PA451205,quinapril,Drug,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O,-1
PA164749042,quinestrol,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5,-1
PA164760863,quinethazone,Drug,CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl,-1
PA451209,quinidine,Drug,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,-1
PA164783957,quinidine barbiturate,Drug,,-1
PA451213,quinine,Drug,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3CC4CCN3C[C@@H]4C=C)O,-1
PA164713223,Quinine and derivatives,Drug Class,,-1
PA164713224,Quinoline derivatives,Drug Class,,-1
PA164713226,Quinoline derivatives and corticosteroids,Drug Class,,-1
PA164713227,Quinoline derivatives and related substances,Drug Class,,-1
PA164713228,Quinolines,Drug Class,,-1
PA164713229,Quinolone Antibacterials,Drug Class,,-1
PA164713230,Quinolone vasodilators,Drug Class,,-1
PA164749647,quinupristin,Drug,CC[C@@H]1C(=O)C2CCC[C@H]2C(=O)N([C@H](C(=O)N3CC(C(=O)CC3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C,-1
PA164924564,R101933,Drug,,-1
PA166246761,R-6-hydroxyacenocoumarol,Metabolite,,-1
PA166246782,R-7-hydroxyacenocoumarol,Metabolite,,-1
PA166267761,R-95913,Metabolite,C1CC1C(=O)C(C2=CC=CC=C2F)N3CCC4C(=CC(=O)S4)C3,-1
PA451216,rabeprazole,Drug,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,1
PA166227261,rabeprazole sulfone,Metabolite,,-1
PA166227241,rabeprazole thioether,Metabolite,,-1
PA10367,rabies immunoglobulin,Drug,,-1
PA451219,rabies vaccines,Drug Class,,-1
PA166122986,radiotherapy,Drug,,-1
PA451221,raloxifene,Drug,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,-1
PA166213481,raloxifene-4-glucuronide,Metabolite,,-1
PA166213482,raloxifene 6-glucuronide,Metabolite,,-1
PA164888966,raltegravir,Drug,,-1
PA131625240,raltitrexed,Drug,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,-1
PA164744896,ramelteon,Drug,CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3,-1
PA451223,ramipril,Drug,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,-1
PA166184558,ramucirumab,Drug,,-1
PA164746012,ranibizumab,Drug,,-1
PA451224,ranitidine,Drug,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C,-1
PA164746007,ranolazine,Drug,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,-1
PA164764584,rasagiline,Drug,C#CCN[C@@H]1CCC2=CC=CC=C12,-1
PA10176,rasburicase,Drug,,1
PA164713231,Rauwolfia alkaloids,Drug Class,,-1
PA164713232,Rauwolfia alkaloids and diuretics in combination,Drug Class,,-1
PA166277861,ravulizumab,Drug,,-1
PA166220441,razuprotafib,Drug,,-1
PA166248841,(r)-citalopram,Drug,,-1
PA166181903,reactive nitrogen species,"Ion,""Biological Intermediate""",,-1
PA166181887,reactive oxygen species,"Ion,""Biological Intermediate""",,-1
PA144614921,reboxetine,Drug,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,-1
PA166247521,R-EDDP,Metabolite,,-1
PA166163820,reduced haloperidol,Metabolite,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(C3=CC=C(C=C3)F)O,-1
PA166181861,reduced haloperidol pyridinium,Metabolite,,-1
PA164755085,reduced nicotinamide adenine dinucleotide,Drug,C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4N=CN=C5N)O)O)O)O,-1
PA166178280,reduced nicotinamide adenine dinucleotide phosphate,"Drug,""Biological Intermediate""",,-1
PA166129536,regadenoson,Drug,CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,-1
PA166114943,regorafenib,Drug,,-1
PA166278801,regorafenib glucuronide,Metabolite,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)N([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C4=CC(=C(C=C4)Cl)C(F)(F)F)F,-1
PA166278742,regorafenib metabolite m3,Metabolite,C1=CC(=C(C=C1NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NCO)F)C(F)(F)F)Cl,-1
PA166278821,regorafenib metabolite m8,Metabolite,CNC(=O)C1=[N+](C=CC(=C1)OC2=CC(=C(C=C2)NC(=O)N([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C4=CC(=C(C=C4)Cl)C(F)(F)F)F)[O-],-1
PA166261061,regorafenib N-oxide,Metabolite,,-1
PA166277901,relatlimab,Drug,,-1
PA166197141,remdesivir,Drug,,-1
PA451232,remifentanil,Drug,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,1
PA164774779,remikiren,Drug,CC(C)(C)S(=O)(=O)C[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@H](CC3CCCCC3)[C@@H]([C@@H](C4CC4)O)O,-1
PA164749051,remoxipride,Drug,CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2OC)Br)OC,-1
PA164713233,Renal System,Drug Class,,-1
PA164713234,Renin-inhibitors,Drug Class,,-1
PA451234,repaglinide,Drug,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,-1
PA166131346,repaglinide M0-OH,Metabolite,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)(C)O)C2=CC=CC=C2N3CCCC(C3)O)C(=O)O,-1
PA166131306,repaglinide M1,Metabolite,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N)C(=O)O,-1
PA166131430,repaglinide M2,Metabolite,,-1
PA166131431,repaglinide M4,Metabolite,,-1
PA166131432,repaglinide M5,Metabolite,,-1
PA164768818,rescinnamine,Drug,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)/C=C/C6=CC(=C(C(=C6)OC)OC)OC,-1
PA451236,reserpine,Drug,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,-1
PA164713237,Respiratory stimulants,Drug Class,,-1
PA164713235,Respiratory System,Drug Class,,-1
PA165291838,Resveratrol,Drug,C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O,-1
PA164749341,retapamulin,Drug,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C,-1
PA164743728,reteplase,Drug,,-1
PA144997862,retigabine,Drug,,-1
PA166177686,retinal,Drug,,-1
PA164713238,Retinoids for topical use in acne,Drug Class,,-1
PA164713239,Retinoids for treatment of acne,Drug Class,,-1
PA164713240,Retinoids for treatment of psoriasis,Drug Class,,-1
PA165110729,rhodamine 123,Drug,,-1
PA451241,ribavirin,Drug,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,1
PA166271882,ribavirin carboxylate,Metabolite,,-1
PA166271861,ribavirin diphosphate,Metabolite,,-1
PA166271841,ribavirin monophosphate,Metabolite,,-1
PA166271881,ribavirin triphosphate,Metabolite,,-1
PA166153470,ribociclib,Drug,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,-1
PA451242,riboflavin,Drug,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](CO)O)O)O,-1
PA166160614,ribose phosphate,Biological Intermediate,C([C@H]([C@H]([C@H](C=O)O)O)O)OP(=O)(O)O,-1
PA166160635,ribosylthioguanine,Metabolite,C1=NC2=C(N1C3C(C(C(O3)CO)O)O)NC(=NC2=S)N,-1
PA166178277,ribulose-5-phosphate,Biological Intermediate,,-1
PA165291475,ridaforolimus,Drug,,-1
PA164746413,ridogrel,Drug,C1=CC(=CC(=C1)C(F)(F)F)/C(=N\OCCCCC(=O)O)/C2=CN=CC=C2,-1
PA451249,rifabutin,Drug,C[C@H]1/C=C/C=C(\C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C6C(=C(C(=C5C2=O)O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)/C,-1
PA451250,rifampin,Drug,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,-1
PA164783809,rifapentine,Drug,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C6CCCC6)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,-1
PA164752443,rifaximin,Drug,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C,-1
PA166256441,rilonacept,Drug,,-1
PA166161159,rilpivirine,Biological Intermediate,,-1
PA451251,riluzole,Drug,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,-1
PA164748038,rimantadine,Drug,CC(C12CC3CC(C1)CC(C3)C2)N,-1
PA166225041,rimegepant,Drug,,-1
PA164752251,rimexolone,Drug,CCC(=O)[C@]1([C@@H](CC2[C@@]1(C[C@@H](C3C2CCC4=CC(=O)C=C[C@]34C)O)C)C)C,-1
PA152407999,rimonabant,Drug,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,-1
PA166203981,rintatolimod,Drug,,-1
PA166182682,riociguat,Drug,,-1
PA166270781,ripretinib,Drug,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,-1
PA166235322,risdiplam,Drug,,-1
PA451255,risedronate,Drug,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,-1
PA451257,risperidone,Drug,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,-1
PA166267881,risperidone m3,Metabolite,,-1
PA166170868,ritalinic acid,Metabolite,,-1
PA451258,ritodrine,Drug,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O,-1
PA451260,ritonavir,Drug,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,-1
PA451261,rituximab,Drug,,-1
PA165958360,rivaroxaban,Drug,,-1
PA451262,rivastigmine,Drug,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,-1
PA451264,rizatriptan,Drug,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,-1
PA166178312,(R)-methadone,Metabolite,,-1
PA166131377,r-norfluoxetine,Metabolite,C1=CC=C(C=C1)[C@@H](CCN)OC2=CC=C(C=C2)C(F)(F)F,-1
PA164754992,rocuronium,Drug,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,-1
PA451268,rofecoxib,Drug,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,-1
PA165948052,roflumilast,Drug,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,-1
PA153906323,rolipram,Drug,COC1=C(C=C(C=C1)[C@H]2CC(=O)NC2)OC3CCCC3,-1
PA164779049,rolitetracycline,Drug,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)/C(=C(\NCN4CCCC4)/O)/C(=O)[C@]3(C(=O)C2=C(C5=C1C=CC=C5O)O)O)N(C)C)O,-1
PA166131375,r-omeprazole,Metabolite,CC1=CN=C(C(=C1OC)C)C[S@@](=O)C2=NC3=C(N2)C=C(C=C3)OC,-1
PA166161306,romidepsin,Drug,C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C,-1
PA166268921,ropeginterferon alfa-2b,Drug,,-1
PA164749035,ropinirole,Drug,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,-1
PA451271,ropivacaine,Drug,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,-1
PA451283,rosiglitazone,Drug,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,-1
PA166131481,rosiglitazone phenoxyacetic acid derivative,Metabolite,,-1
PA164776843,rosoxacin,Drug,CCN1C=C(C(=O)C2=C1C=C(C=C2)C3=CC=NC=C3)C(=O)O,-1
PA166129554,rostafuroxin,Drug,C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@]4(C5=COC=C5)O)O)C)O,-1
PA134308647,rosuvastatin,Drug,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,1
PA166247801,rosuvastatin acyl glucuronide,Metabolite,,-1
PA166180489,rosuvastatin lactone,Metabolite,CC(C)C1=NC(=NC(=C1/C=C/[C@@H]2C[C@H](CC(=O)O2)O)C3=CC=C(C=C3)F)N(C)S(=O)(=O)C,-1
PA164713241,Rota virus diarrhea vaccines,Drug Class,,-1
PA166129566,rotigaptide,Drug,,-1
PA166165149,rotigotine,Drug,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O,-1
PA165958352,rotigotine transdermal patch,Drug,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,-1
PA165958424,roxatidine acetate,Drug,,-1
PA164750505,roxithromycin,Drug,CC[C@@H]1[C@@]([C@@H]([C@H](C(=NOCOCCOC)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,-1
PA164713242,Rubella vaccines,Drug Class,,-1
PA166163418,rucaparib,Drug,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)N2)F,-1
PA166131606,rufinamide,Drug,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,-1
PA165107052,Rupatadine,Drug,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2,-1
PA166123386,ruxolitinib,Drug,C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,-1
PA166176123,ryanodine,Drug,,-1
PA166246742,S-6-hydroxyacenocoumarol,Metabolite,,-1
PA166246781,S-7-hydroxyacenocoumarol,Metabolite,,-1
PA166225061,sacituzumab govitecan-hziy,Drug,,-1
PA166277821,sacrosidase,Drug,,-1
PA166131580,sacubitril,Prodrug,,-1
PA166160618,s-adenosylhomocysteine,Biological Intermediate,C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CSCC[C@@H](C(=O)O)N)O)O,-1
PA164754994,s-adenosylmethionine,"Drug,""Biological Intermediate""",C[S+](CC[C@@H](C(=O)O)N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2N=CN=C3N)O)O,-1
PA448068,salbutamol,Drug,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,-1
PA165958416,salicylamide,Drug,,-1
PA450300,salicylate-magnesium,Drug,,-1
PA451428,salicylate-sodium,Drug,,-1
PA451299,salicylic acid,Drug,C1=CC=C(C(=C1)C(=O)O)O,-1
PA164713243,Salicylic acid and derivatives,Drug Class,,-1
PA164713244,Salicylic acid derivatives,Drug Class,,-1
PA164713245,Salicylic acid preparations,Drug Class,,-1
PA451300,salmeterol,Drug,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,-1
PA448715,salmon calcitonin,Drug,CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO,-1
PA164745462,salsalate,Drug,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,-1
PA164713246,Salt solutions,Drug Class,,-1
PA166128370,salvianolic acid b,Drug,C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C3[C@H]([C@@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O,-1
PA164746338,saprisartan,Drug,CCC1=NC(=C(N1CC2=CC3=C(C=C2)OC(=C3Br)C4=CC=CC=C4NS(=O)(=O)C(F)(F)F)C(=O)N)C5CC5,-1
PA451305,saquinavir,Drug,CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,-1
PA166182626,saquinavir / ritonavir,Drug,,-1
PA165958501,saracatinib,Drug,,-1
PA164748631,sargramostim,Drug,,-1
PA166197221,sarilumab,Drug,,-1
PA166235323,satralizumab,Drug,,-1
PA164745371,satumomab pendetide,Drug,,-1
PA165958362,saxagliptin,Drug,C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N,-1
PA166049195,SC-560,Drug,COC1=CC=C(C=C1)N2C(=CC(=N2)C(F)(F)F)C3=CC=C(C=C3)Cl,-1
PA164713247,Scilla glycosides,Drug Class,,-1
PA164713248,Sclerosing agents for local injection,Drug Class,,-1
PA451308,scopolamine,Drug,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4,-1
PA166170903,scutellarin,Drug,,-1
PA164784035,secobarbital,Drug,CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC=C,-1
PA164713250,Secondary and tertiary amines,Drug Class,,-1
PA164713249,Second-generation cephalosporins,Drug Class,,-1
PA166165009,seco-sirolimus,Metabolite,,-1
PA164760844,secretin,Drug,,-1
PA166177606,S-EDDP,Metabolite,,-1
PA134687887,selective beta-2-adrenoreceptor agonists,Drug Class,,-1
PA164713251,Selective Calcium Channel Blockers With Direct Cardiac Effects,Drug Class,,-1
PA164713252,Selective Calcium Channel Blockers With Mainly Vascular Effects,Drug Class,,-1
PA164713254,Selective estrogen receptor modulators,Drug Class,,-1
PA164713255,Selective immunosuppressants,Drug Class,,-1
PA164713256,Selective serotonin (5HT1) agonists,Drug Class,,-1
PA164713257,Selective serotonin reuptake inhibitors,Drug Class,,-1
PA451316,selegiline,Drug,C[C@H](CC1=CC=CC=C1)N(C)CC#C,-1
PA451319,selenium,Drug Class,,-1
PA164771240,selenium sulfide,Drug,S=[Se],-1
PA10489,selenium supplements,Drug,,-1
PA166281602,selexipag,Drug,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,-1
PA166225084,selpercatinib,Drug,,-1
PA166129529,selumetinib,Drug,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,-1
PA133888890,sematilide,Drug,,-1
PA131887911,semaxanib,Drug,,-1
PA164713258,"Sensitivity tests, discs and tablets",Drug Class,,-1
PA164713259,Sensitizers used in photodynamic/radiation therapy,Drug Class,,-1
PA164713260,Sensory Organs,Drug Class,,-1
PA166104277,sergliflozin,Drug,CCOC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=CC=C2CC3=CC=C(C=C3)OC)O)O)O,-1
PA164749110,sermorelin,Drug,CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N,-1
PA166152901,serotonin,Biological Intermediate,,-1
PA164713261,Serotonin (5HT3) antagonists,Drug Class,,-1
PA164713262,Serotonin antagonists,Drug Class,,-1
PA164713263,Serotonin antagonists and diuretics,Drug Class,,-1
PA164748328,sertaconazole,Drug,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,-1
PA164784002,sertindole,Drug,C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O,-1
PA451333,sertraline,Drug,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,1
PA166180535,sertraline carbamoyl-O-glucuronide,Metabolite,CN([C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl)C(=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,-1
PA166235341,setmelanotide,Drug,,-1
PA164781197,sevelamer,Drug,C=CCN.C1C(O1)CCl,-1
PA451341,sevoflurane,Drug,C(OC(C(F)(F)F)C(F)(F)F)F,1
PA164713264,Sex Hormones And Modulators Of The Genital System,Drug Class,,-1
PA164713265,Short-acting sulfonamides,Drug Class,,-1
PA451344,sibutramine,Drug,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,-1
PA451346,sildenafil,Drug,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,-1
PA166129539,silibinin,Drug,COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,-1
PA451355,silicone products,Drug Class,,-1
PA165291889,silodosin,Drug,,-1
PA166198582,siltuximab,Drug,,-1
PA164713266,Silver compounds,Drug Class,,-1
PA451357,silver nitrate,Drug,,-1
PA164744951,silver sulfadiazine,Drug,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],-1
PA166122590,simeprevir,Drug,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4C(C3)C(=O)N(CCCC/C=C\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,-1
PA451363,simvastatin,Drug,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,1
PA166129446,simvastatin acid,Metabolite,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C,-1
PA166247802,simvastatin acyl glucuronide,Metabolite,,-1
PA166248861,simvastatin / sitagliptin,Drug,,-1
PA166114434,sipoglitazar,Drug,CCOC1=NN(C=C1CCC(=O)O)CC2=CC=C(C=C2)OCC3=CSC(=N3)C4=CC=CC=C4,-1
PA166182736,siponimod,Drug,,-1
PA166246161,siponimod m3,Metabolite,,-1
PA166246141,siponimod m5,Metabolite,,-1
PA451365,sirolimus,Drug,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,-1
PA166203961,sirukumab,Drug,,-1
PA164748978,sitagliptin,Drug,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,-1
PA166115581,sitamaquine,Drug,CCN(CC)CCCCCCNC1=CC(=CC2=C(C=CN=C12)C)OC,-1
PA165958361,sitaxentan,Drug,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,-1
PA162168179,SJG-136,Drug,,-1
PA164713267,Skeleton,Drug Class,,-1
PA166178554,(S)-methadone,Drug,,-1
PA166248681,s-methyldihydroziprasidone,Metabolite,,-1
PA165110775,SN-38,Metabolite,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,-1
PA166131325,SN-38 glucuronide,Metabolite,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,-1
PA166131313,s-norfluoxetine,Metabolite,C1=CC=C(C=C1)[C@H](CCN)OC2=CC=C(C=C2)C(F)(F)F,-1
PA166165069,(s)-norverapamil,Metabolite,CC(C)[C@](CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,-1
PA451368,sodium,Ion,[Na+],-1
PA451369,sodium acetate,Drug,,-1
PA166163262,sodium ascorbate,Drug,C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O.[Na+],-1
PA451374,sodium benzoate,Drug,,-1
PA166176020,sodium benzoate / sodium phenylacetate,Drug,,-1
PA451375,sodium bicarbonate,Drug,C(=O)(O)[O-].[Na+],-1
PA451377,sodium bisulfite,Drug,,-1
PA451379,sodium carbonate,Drug,,-1
PA451382,sodium chloride,Drug,,-1
PA451384,sodium citrate,Drug,,-1
PA166184492,sodium ferulate,Drug,,-1
PA451388,sodium fluoride,"Drug,""Small Molecule""",,-1
PA451398,sodium lauryl sulfate,Drug,CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+],-1
PA166279461,sodium nitrate,Drug,[N+](=O)([O-])[O-].[Na+],-1
PA166115361,sodium nitrite,Drug,N(=O)[O-].[Na+],-1
PA166236501,sodium oxybate,Drug,,-1
PA166114316,sodium phenylbutyrate,Drug,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+],-1
PA451414,sodium phosphate,Drug,,-1
PA451429,sodium selenite,Drug,,-1
PA164743129,sodium stibogluconate,Drug,C(C(C1C2C(O[Sb](O2)(O1)O[Sb]34OC(C(O3)C(CO)O)C(O4)C(=O)[O-])C(=O)[O-])O)O.O.O.O.O.O.O.O.O.O.O.[OH-].[Na+].[Na+].[Na+],-1
PA451434,sodium succinate,Drug,,-1
PA451435,sodium sulfate,Drug,,-1
PA164746759,sodium tetradecyl sulfate,Drug,CCCCCCCCCCCCCCOS(=O)(=O)O,-1
PA166182732,sodium valproate,Drug,,-1
PA166122593,sofosbuvir,Drug,C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,-1
PA166163416,sofosbuvir / velpatasvir,Drug,C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC.C[C@@H](C(=O)OC(C)C)N[P@@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,-1
PA166177517,sofosbuvir / velpatasvir / voxilaprevir,Drug,,-1
PA450787,soft paraffin dressings,Drug Class,,-1
PA164783810,solifenacin,Drug,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.C(CC(=O)O)C(=O)O,-1
PA166165147,solithromycin,Drug,CC[C@@H]1[C@@]2([C@@H]([C@@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@@](C(=O)O1)(C)F)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=N4)C5=CC(=CC=C5)N)C,-1
PA164713268,Solutions affecting the electrolyte balance,Drug Class,,-1
PA164713269,Solutions for parenteral nutrition,Drug Class,,-1
PA164713270,Solutions producing osmotic diuresis,Drug Class,,-1
PA164713271,"Solvents and diluting agents, incl. irrigating solutions",Drug Class,,-1
PA166178990,somatostatin,"Drug,""Biological Intermediate""",CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O,-1
PA164713272,Somatropin and somatropin agonists,Drug Class,,-1
PA451446,somatropin recombinant,Drug,,-1
PA7000,sorafenib,Drug,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,-1
PA166131498,sorafenib M1,Metabolite,,-1
PA166131499,sorafenib M2,Metabolite,,-1
PA166131500,sorafenib M3,Metabolite,,-1
PA166131501,sorafenib M4,Metabolite,,-1
PA166131502,sorafenib M5,Metabolite,,-1
PA166131503,sorafenib M7,Metabolite,,-1
PA166131504,sorafenib M8,Metabolite,,-1
PA451457,sotalol,Drug,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,-1
PA166246441,sotorasib,Drug,,-1
PA166255841,sotrovimab,Drug,,-1
PA451472,sparfloxacin,Drug,C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F,-1
PA452610,sparteine,Drug,,-1
PA164713273,Specific Antirheumatic Agents,Drug Class,,-1
PA164713274,Specific immunoglobulins,Drug Class,,-1
PA164781342,spectinomycin,Drug,C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O,-1
PA164781199,spermine,Drug,C(CCNCCCN)CNCCCN,-1
PA164776913,spirapril,Drug,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3,-1
PA451483,spironolactone,Drug,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,-1
PA166178666,squalene,Biological Intermediate,,-1
PA152408000,SR144528,Drug,,-1
PA165958391,stanozolol,Drug,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C,-1
PA451492,starch,Drug,,-1
PA166131389,statin active metabolites; statin inactive metabolites,Metabolite,,-1
PA165109623,staurosporine,Drug,C[C@]12[C@@H]([C@@H](C[C@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC,-1
PA451494,stavudine,Drug,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,-1
PA164748630,stepronin,Drug,CC(C(=O)NCC(=O)O)SC(=O)C1=CC=CS1,-1
PA164713275,Steroid antibacterials,Drug Class,,-1
PA166175778,stiripentol,Drug,,-1
PA164924486,st. john's wort,Drug,,-1
PA164713276,Stomatological Preparations,Drug Class,,-1
PA164713278,Stomi equipment,Drug Class,,-1
PA164713279,Streptogramins,Drug Class,,-1
PA164754919,streptokinase,Drug,,-1
PA451512,streptomycin,Drug,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,1
PA164713280,Streptomycins,Drug Class,,-1
PA451514,streptozocin,Drug,CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,-1
PA164713281,Strophantus glycosides,Drug Class,,-1
PA164713282,Substituted alkylamines,Drug Class,,-1
PA164713283,Substituted ethylene diamines,Drug Class,,-1
PA451521,succimer,Drug,C(C(C(=O)O)S)(C(=O)O)S,-1
PA166178988,succinate semialdehyde,Biological Intermediate,C(CC(=O)[O-])C=O,-1
PA164747739,succinic acid,Metabolite,C(CC(=O)O)C(=O)O,-1
PA164713284,Succinimide derivatives,Drug Class,,-1
PA451522,succinylcholine,Drug,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,1
PA166178649,succinyl coenzyme A,Biological Intermediate,,-1
PA166131553,succinylmonocholine,Metabolite,,-1
PA451524,sucralfate,Drug,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al].[Al],-1
PA451525,sucrose,"Drug,""Biological Intermediate""",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O,-1
PA451527,sufentanil,Drug,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,1
PA451529,sugar,Drug,,-1
PA451536,sulfacetamide,Drug,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,-1
PA164754808,sulfacytine,Drug,CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA451539,sulfadiazine,Drug,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA165958357,sulfadimethoxine,Drug,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,-1
PA451540,sulfadoxine,Drug,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA164776842,sulfamerazine,Drug,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA451542,sulfamethazine,Drug,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C,-1
PA164781307,sulfamethizole,Drug,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA451544,sulfamethoxazole,Drug,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA166271401,sulfamethoxazole hydroxylamine,Metabolite,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)NO,-1
PA10715,sulfamethoxazole / trimethoprim,Drug,,-1
PA164747038,sulfametopyrazine,Drug,COC1=NC=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA165958417,sulfamoxole,Drug,,-1
PA451545,sulfanilamide,Drug,C1=CC(=CC=C1N)S(=O)(=O)N,-1
PA130231310,sulfaphenazole,Drug,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,-1
PA164779050,sulfapyridine,"Drug,""Metabolite""",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA451547,sulfasalazine,Drug,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,-1
PA165958356,sulfathiazole,Drug,,-1
PA451550,sulfinpyrazone,Drug,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4,-1
PA164748964,sulfisoxazole,Drug,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,-1
PA166279942,sulfociprofloxacin,"Drug,""Metabolite""",C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCN(CC4)S(=O)(=O)O)F)C(=O)O,-1
PA166131317,sulfolane,Metabolite,C1CCS(=O)(=O)C1,-1
PA10772,sulfonamides,Drug Class,,-1
PA164713290,Sulfonamides and corticosteroids,Drug Class,,-1
PA164713291,Sulfonamides and potassium in combination,Drug Class,,-1
PA164713289,Sulfonamides And Trimethoprim,Drug Class,,-1
PA164713293,"Sulfonamides, combinations with other drugs",Drug Class,,-1
PA164713288,Sulfonamides (heterocyclic),Drug Class,,-1
PA10741,"sulfonamides, plain",Drug Class,,-1
PA10390,"sulfonamides, urea derivatives",Drug Class,,-1
PA164713295,Sulfonium derivatives,Drug Class,,-1
PA164776911,sulfoxone,Drug,C1=CC(=CC=C1NCS(=O)O)S(=O)(=O)C2=CC=C(C=C2)NCS(=O)O,-1
PA451558,sulfur,Drug,,-1
PA164713297,Sulfur-containing imidazole derivatives,Drug Class,,-1
PA164713296,Sulfur containing products,Drug Class,,-1
PA451565,sulindac,Drug,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,-1
PA164746343,sulodexide,Drug,,-1
PA164745485,sulpiride,Drug,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,-1
PA166175792,sulthiame,Drug,,-1
PA451566,sumatriptan,Drug,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,-1
PA162372840,sunitinib,Drug,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,-1
PA166178347,sunitinib n-oxide,Metabolite,,-1
PA166131579,superoxide,Ion,[O-][O],-1
PA164713298,Superparamagnetic contrast media,Drug Class,,-1
PA451569,suprofen,Drug,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,-1
PA10292,suramin,Drug,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C,-1
PA164713299,Surgical Aids,Drug Class,,-1
PA164713300,Surgical Dressings,Drug Class,,-1
PA166049191,suxibuzone,Drug,CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)COC(=O)CCC(=O)O,-1
PA164713301,Sympathomimetics,Drug Class,,-1
PA164713305,"Sympathomimetics, combinations excl. corticosteroids",Drug Class,,-1
PA164713302,Sympathomimetics excl. antiglaucoma preparations,Drug Class,,-1
PA164713303,Sympathomimetics in glaucoma therapy,Drug Class,,-1
PA164713306,"Sympathomimetics, labour repressants",Drug Class,,-1
PA164713307,"Sympathomimetics, plain",Drug Class,,-1
PA164713304,Sympathomimetics used as decongestants,Drug Class,,-1
PA164713308,Synthetic anticholinergic agents in combination with analgesics,Drug Class,,-1
PA164713309,Synthetic anticholinergic agents in combination with psycholeptics,Drug Class,,-1
PA164713310,"Synthetic anticholinergics, esters with tertiary amino group",Drug Class,,-1
PA164713311,"Synthetic anticholinergics, quaternary ammonium compounds",Drug Class,,-1
PA164713312,"Synthetic antispasmodics, amides with tertiary amines",Drug Class,,-1
PA166238763,"synthetic conjugated estrogens, A",Drug,,-1
PA164713313,"Synthetic estrogens, plain",Drug Class,,-1
PA164713314,"Systemic Hormonal Preparations, Excl.",Drug Class,,-1
PA166182866,TAC,Drug,,-1
PA451576,tacrine,Drug,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,-1
PA451578,tacrolimus,Drug,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,1
PA10333,tadalafil,Drug,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,-1
PA166184562,tafamidis,Drug,,-1
PA166115580,tafenoquine,Drug,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,-1
PA165958432,tafluprost,Drug,,-1
PA166182740,talazoparib,Drug,,-1
PA164779051,talbutal,Drug,CCC(C)C1(C(=O)N(C(=O)N(C1=O)C)C)CC=C,-1
PA146123005,talinolol,Drug,,-1
PA165109542,talotrexin,Drug,,-1
PA164743464,tamibarotene,Drug,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,-1
PA451581,tamoxifen,Drug,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,1
PA166131308,tamoxifen metabolite E,Metabolite,CC/C(=C(/C1=CC=CC=C1)\C2=CC=C(C=C2)O)/C3=CC=CC=C3,-1
PA166131412,tamoxifen metabolite E glucuronide,Metabolite,,-1
PA166131413,tamoxifen metabolite E sulfate,Metabolite,,-1
PA166131309,tamoxifen metabolite Y,Metabolite,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCO)/C3=CC=CC=C3,-1
PA166131338,tamoxifen-n-glucuronide,Metabolite,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCC[N+](C)(C)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)/C4=CC=CC=C4,-1
PA166131348,tamoxifen-n-oxide,Metabolite,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCC[N+](C)(C)[O-])C3=CC=CC=C3,-1
PA451583,tamsulosin,Drug,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,-1
PA166254764,tamsulosin metabolite M-2,Metabolite,,-1
PA166254765,tamsulosin metabolite M-3,Metabolite,,-1
PA165291490,tanespimycin,Drug,,-1
PA451585,tannic acid,Drug,,-1
PA166179720,tapentadol,Drug,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,-1
PA165282096,Tariquidar,Drug,,-1
PA164713315,Tars,Drug Class,,-1
PA166163227,taselisib,Drug,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,-1
PA164769057,tasosartan,Drug,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,-1
PA451590,taurine,Drug,,-1
PA166131437,taxane metabolite,Metabolite,,-1
PA150481189,taxanes,Drug Class,,-1
PA164746821,tazarotene,Drug,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,-1
PA164764504,tazobactam,Drug,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,-1
PA166277741,tebentafusp,Drug,,-1
PA164713316,Technetium (99mTc) compounds,Drug Class,,-1
PA164713323,"Technetium (99mTc), inhalants",Drug Class,,-1
PA10196,technetium (99mtc) mertiatide,Drug,,-1
PA164713324,"Technetium (99mTc), particles and colloids",Drug Class,,-1
PA164713325,"Technetium (99mTc), particles for injection",Drug Class,,-1
PA10335,technetium (99mtc) sulfur colloid,Drug,,-1
PA164713326,Technical disinfectants,Drug Class,,-1
PA452620,tegafur,Prodrug,,1
PA166115442,tegafur / gimeracil / oteracil,Prodrug,,-1
PA130413154,tegaserod,Drug,CCCCCN=C(N)NN/C=C/1\C=NC2=C1C=C(C=C2)CO,-1
PA164746244,teicoplanin,Drug,CCCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)N[C@H](C7=CC(=CC(=C7C8=C(C=CC(=C8)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]9C1=CC(=CC(=C1)O)OC1=C(C=CC(=C1)[C@H](C(=O)N[C@H](CC1=CC(=C(O3)C=C1)Cl)C(=O)N9)N)O)O)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)C(=O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)C)Cl)CO)O)O,-1
PA165958354,telaprevir,Drug,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5,-1
PA165980595,telatinib,Drug,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,-1
PA164760861,telbivudine,Drug,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,-1
PA131889722,telcyta,Drug,,-1
PA10202,telithromycin,Drug,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,-1
PA451605,telmisartan,Drug,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,-1
PA451608,temazepam,"Drug,""Metabolite""",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,-1
PA166268041,temazepam glucuronide,Metabolite,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)C4=CC=CC=C4,-1
PA451609,temozolomide,Drug,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,-1
PA164746890,temsirolimus,Drug,C[C@@H]1CCC2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,-1
PA164776757,tenecteplase,Drug,,-1
PA166249401,teneligliptin,Drug,,-1
PA451611,teniposide,Drug,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)COC(O7)C8=CC=CS8)O)O,-1
PA10204,tenofovir,Prodrug,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,-1
PA166258723,tenofovir alafenamide,Prodrug,,-1
PA166201941,tenofovir disoproxil fumarate,Drug,,-1
PA131890625,tenoxicam,Drug,CN1/C(=C(/NC2=CC=CC=N2)\O)/C(=O)C3=C(S1(=O)=O)C=CS3,1
PA166211181,tepotinib,Drug,,-1
PA451612,terazosin,Drug,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,-1
PA451614,terbinafine,Drug,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21,-1
PA451616,terbutaline,Drug,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,-1
PA164768834,terconazole,Drug,CC(C)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl,-1
PA451619,terfenadine,Drug,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,-1
PA166256301,teriflunomide,"Drug,""Metabolite""",,-1
PA451620,teriparatide,Drug,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N,-1
PA164781020,terlipressin,Drug,C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,-1
PA165817950,terodiline,Drug,CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C,-1
PA164713327,Tertiary amines,Drug Class,,-1
PA165980596,terutroban,Drug,CC1=C(C2=C(C[C@@H](CC2)NS(=O)(=O)C3=CC=C(C=C3)Cl)C=C1)CCC(=O)[O-].[Na+],-1
PA164743056,testolactone,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)O2)CCC4=CC(=O)C=C[C@]34C,-1
PA451627,testosterone,"Drug,""Biological Intermediate""",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,-1
PA164713328,Testosterone-5-alpha reductase inhibitors,Drug Class,,-1
PA164751373,testosterone propionate,Drug,CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,-1
PA164713329,Tests for allergic diseases,Drug Class,,-1
PA164713330,Tests for bile duct patency,Drug Class,,-1
PA164713331,Tests for diabetes,Drug Class,,-1
PA164713332,Tests for fat absorption,Drug Class,,-1
PA164713333,Tests for fertility disturbances,Drug Class,,-1
PA164713334,Tests for gastric secretion,Drug Class,,-1
PA164713335,Tests for liver functional capacity,Drug Class,,-1
PA164713336,Tests for pancreatic function,Drug Class,,-1
PA164713337,Tests for pituitary function,Drug Class,,-1
PA164713338,Tests for renal function,Drug Class,,-1
PA164713339,Tests for thyreoidea function,Drug Class,,-1
PA451632,tetanus antitoxin,Drug,,-1
PA451636,tetanus toxoid,Drug,,-1
PA451634,tetanus vaccines,Drug Class,,-1
PA140222719,tetrabenazine,Drug,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,-1
PA451638,tetracaine,Drug,,-1
PA451640,tetracycline,Drug,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,-1
PA164713340,Tetracycline and derivatives,Drug Class,,-1
PA164713341,Tetracyclines,Drug Class,,-1
PA161990676,tetrahydrobiopterin,Drug,CC(C(C1CNC2=C(N1)C(=O)N=C(N2)N)O)O,-1
PA164745110,tetrahydrofolic acid,"Drug,""Biological Intermediate""",C1C(NC2=C(N1)NC(=NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,-1
PA164713342,Tetrahydropyrimidine derivatives,Drug Class,,-1
PA166131278,tetrahydrothiophene,Metabolite,C1CCSC1,-1
PA166175754,tezacaftor,Drug,,-1
PA451644,thalidomide,Drug,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,-1
PA451646,theobromine,"Drug,""Metabolite""",CN1C=NC2=C1C(=O)NC(=O)N2C,-1
PA451647,theophylline,"Drug,""Metabolite""",CN1C2=C(C(=O)N(C1=O)C)NC=N2,-1
PA164713343,Therapeutic Radiopharmaceuticals,Drug Class,,-1
PA164746466,thiabendazole,Drug,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,-1
PA451652,thiamine,,,0
PA164746997,thiamylal,Drug,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC=C,-1
PA10432,thiazide derivatives,Drug Class,,-1
PA164713344,Thiazides and potassium in combination,Drug Class,,-1
PA164713345,"Thiazides, combinations with other drugs",Drug Class,,-1
PA164713346,"Thiazides, combinations with psycholeptics and/or analgesics",Drug Class,,-1
PA164713347,"Thiazides, plain",Drug Class,,-1
PA452631,thiazolidinediones,Drug Class,,-1
PA166131438,thienopyridine active metabolite,Metabolite,,-1
PA164748882,thiethylperazine,Drug,CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C,-1
PA10209,thioacetazone and isoniazid,Drug,,-1
PA164713348,Thiocarbamide derivatives,Drug Class,,-1
PA166131566,thioether product,Metabolite,,-1
PA451663,thioguanine,Drug,C1=NC2=C(N1)C(=S)N=C(N2)N,1
PA166160632,thioguanosine diphosphate,Metabolite,C1=NC2=C(N1C3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)NC(=NC2=S)N,-1
PA166160623,thioguanosine monophosphate,Metabolite,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=NC2=S)N,-1
PA166160633,thioguanosine triphosphate,Metabolite,C1=NC2=C(N1[C@@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)NC(=NC2=S)N,-1
PA166160602,thioinosine monophosphate,Metabolite,C1=NC(=S)C2=C(N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)O,-1
PA166160620,thioinosine triphosphate,Metabolite,C1=NC(=S)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,-1
PA166131520,thiol conjugates of valproic acid,Metabolite,,-1
PA451664,thiopental,Drug,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC,-1
PA164754875,thioproperazine,Drug,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C,-1
PA451666,thioridazine,Drug,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,-1
PA164713349,Thiosemicarbazones,Drug Class,,-1
PA451668,thiotepa,Drug,,-1
PA451669,thiothixene,Drug,CN1CCN(CC1)CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C,-1
PA164713350,Thiouracils,Drug Class,,-1
PA166160611,thiouric acid,Metabolite,C12=C(NC(=O)N1)NC(=O)NC2=S,-1
PA10499,thioxanthene derivatives,Drug Class,,-1
PA166163264,thioxanthine,Metabolite,C1=NC2=C(N1)C(=S)NC(=O)N2,-1
PA166160622,thioxanthine monophosphate,Metabolite,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=O)NC2=S,-1
PA164713351,Third-generation cephalosporins,Drug Class,,-1
PA166170176,threohydrobupropion,Metabolite,,-1
PA166170192,threohydrobupropion glucuronide,Metabolite,,-1
PA164713353,Throat Preparations,Drug Class,,-1
PA451674,thrombin,Drug,,-1
PA166178672,thromboxane A2,Biological Intermediate,,-1
PA164748387,thymalfasin,Drug,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)C,-1
PA164754910,thyroglobulin,Drug,,-1
PA164713354,Thyroid,Drug Class,,-1
PA10500,thyroid hormones,Drug Class,,-1
PA451680,thyroid preparations,Drug Class,,-1
PA164713355,Thyroid Therapy,Drug Class,,-1
PA10211,thyrotropin,Drug Class,,-1
PA164746560,thyrotropin alfa,Drug,,-1
PA151070295,thyroxine,Drug,,-1
PA451682,tiagabine,Drug,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C,-1
PA166186040,tianeptine,Drug,,-1
PA164764503,tiaprofenic acid,Drug,CC(C1=CC=C(S1)C(=O)C2=CC=CC=C2)C(=O)O,-1
PA165374673,ticagrelor,Drug,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,-1
PA166267781,ticagrelor O-glucuronide,Metabolite,,-1
PA451684,ticarcillin,Drug,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C,-1
PA451686,ticlopidine,Drug,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,-1
PA164746412,tigecycline,Drug,CC(C)(C)NCC(=O)NC1=C(C2=C(C[C@H]3C[C@H]4[C@@H](C(=O)/C(=C(\N)/O)/C(=O)[C@]4(C(=O)C3=C2O)O)N(C)C)C(=C1)N(C)C)O,-1
PA152132897,Tilarginine Acetate,Drug,,-1
PA166212682,tilidine,Drug,,-1
PA451688,tiludronate,Drug,C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl,-1
PA166222901,timbetasin,Drug,,-1
PA451690,timolol,Drug,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,-1
PA10813,tinidazole,Drug,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,-1
PA451694,tinzaparin,Drug,,-1
PA164746156,tioconazole,Drug,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,-1
PA164769056,tiotropium,Drug,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-],-1
PA165110778,tipifarnib,Drug,,-1
PA166171170,tipiracil hydrochloride,Drug,,-1
PA166184566,tipiracil / trifluridine,Drug,,-1
PA163522473,tipranavir,Drug,CCC[C@]1(CC(=O)C(=C(O1)O)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4,-1
PA166182622,tipranavir / ritonavir,Drug,,-1
PA451698,tirofiban,Drug,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,-1
PA164713356,Tissue adhesives,Drug Class,,-1
PA451701,tizanidine,Drug,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,-1
PA451704,tobramycin,Drug,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N,1
PA451706,tocainide,Drug,CC1=C(C(=CC=C1)C)NC(=O)C(C)N,-1
PA165292659,tocilizumab,Drug,,-1
PA166211901,tofacitinib,Drug,,-1
PA165958428,tofisopam,Drug,,-1
PA164774902,tolazamide,Drug,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,-1
PA451716,tolazoline,Drug,C1CN=C(N1)CC2=CC=CC=C2,-1
PA451718,tolbutamide,Drug,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,-1
PA451720,tolcapone,Drug,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],-1
PA166049189,tolfenamic acid,Drug,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,-1
PA451721,tolmetin,Drug,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,-1
PA164752438,tolnaftate,Drug,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,-1
PA166152940,tolperisone,Biological Intermediate,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,-1
PA164746757,tolterodine,Drug,CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,-1
PA166268821,toluidine blue,Drug,CC1=CC2=C(C=C1N)SC3=CC(=[N+](C)C)C=CC3=N2.[Cl-],-1
PA164713357,Tonics,Drug Class,,-1
PA164713360,Topical Products For Joint And Muscular Pain,Drug Class,,-1
PA451728,topiramate,Drug,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,-1
PA150481186,topoisomerase I inhibitors,Drug Class,,-1
PA451729,topotecan,Drug,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O,-1
PA451733,torasemide,Drug,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,-1
PA145007158,torcetrapib,Drug,,-1
PA451731,toremifene,Drug,CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3,-1
PA164748364,tositumomab,Drug,,-1
PA165958349,trabectedin,Drug,CC1=C(C(=C2[C@@H]3[C@@H]4[C@H]5C6=C([C@@H](N4[C@H]([C@@H](N3C)CC2=C1)O)COC(=O)[C@@]7(CS5)C8=CC(=C(C=C8CCN7)O)OC)C9=C(C(=C6OC(=O)C)C)OCO9)O)OC,-1
PA451735,tramadol,Drug,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,1
PA166115364,trametinib,Drug,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5,-1
PA451737,trandolapril,Drug,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O,-1
PA164750514,tranexamic acid,Drug,C1CC(CCC1CN)C(=O)O,-1
PA131890628,tranilast,Drug,,-1
PA166248981,trans 4-hydroxypraziquantel,Metabolite,,-1
PA166254463,trans-hydroxycilostazol,Metabolite,,-1
PA451741,tranylcypromine,Drug,C1[C@H](C1C2=CC=CC=C2)N,-1
PA451743,trastuzumab,Drug,,-1
PA166190621,trastuzumab deruxtecan,Drug,,-1
PA165958441,trastuzumab emtansine,Drug,,-1
PA164781371,travoprost,Drug,CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)O)O,-1
PA451744,trazodone,Drug,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,-1
PA164768801,treprostinil,Drug,CCCCC[C@H](CC[C@@H]1[C@H](C[C@@H]2[C@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,-1
PA451746,tretinoin,Drug,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,-1
PA165107992,triadimefon,Drug,,-1
PA451749,triamcinolone,Drug,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,-1
PA451752,triamterene,Drug,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,-1
PA451753,triazolam,Drug,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,-1
PA164713361,Triazole derivatives,Drug Class,,-1
PA164752426,trichlormethiazide,Drug,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,-1
PA451755,trichloroacetic acid,Drug,,-1
PA166233721,trichloroacetyl chloride,Metabolite,,-1
PA166115521,trichloroethylene,Drug,C(=C(Cl)Cl)Cl,-1
PA151929741,trichostatin A,Drug,,-1
PA165958661,triciribine,Drug,,-1
PA164746229,tridihexethyl,Drug,CC[N+](CC)(CC)CCC(C1CCCCC1)(C2=CC=CC=C2)O,-1
PA451771,trifluoperazine,Drug,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F,-1
PA166232721,trifluoroacetic acid,Metabolite,,-1
PA166233801,trifluoroacetyl chloride,Metabolite,,-1
PA166280441,trifluoromethylhippuric acid,Metabolite,C1=CC(=CC(=C1)C(F)(F)F)C(=O)NCC(=O)O,-1
PA451773,triflupromazine,Drug,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,-1
PA451775,trifluridine,Drug,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,-1
PA165958430,triflusal,Drug,,-1
PA451776,triglycerides,Drug,,-1
PA164747026,trihexyphenidyl,Drug,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,-1
PA164748507,trilostane,Drug,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C,-1
PA164744009,trimeprazine,Drug,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C,-1
PA164744924,trimethadione,Drug,CC1(C(=O)N(C(=O)O1)C)C,-1
PA451784,trimethaphan,Drug,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,-1
PA164764516,trimethobenzamide,Drug,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,-1
PA451788,trimethoprim,Drug,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,-1
PA164713363,Trimethoprim and derivatives,Drug Class,,-1
PA451790,trimetrexate,Drug,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC,-1
PA451791,trimipramine,Drug,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,1
PA164747186,trioxsalen,Drug,,-1
PA166220603,triparanol,Drug,,-1
PA164764429,tripelennamine,Drug,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2,-1
PA451797,triprolidine,Drug,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC=N3,-1
PA164749164,trisalicylate-choline,Drug,,-1
PA451799,troglitazone,Drug,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,-1
PA127840611,troleandomycin,Drug,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C,-1
PA451802,trometamol,Drug,,-1
PA164749389,tropicamide,Drug,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,-1
PA161925594,tropisetron,Drug,,1
PA166179306,tropisetron 5-glucuronide,Metabolite,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=C3C=C(C=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,-1
PA166179678,tropisetron 5-sulfate,Metabolite,,-1
PA166179673,tropisetron 6-glucuronide,Metabolite,,-1
PA166179679,tropisetron 6-sulfate,Metabolite,,-1
PA166179674,tropisetron 7-glucuronide,Metabolite,,-1
PA166179680,tropisetron 7-sulfate,Metabolite,,-1
PA166179305,tropisetron n-oxide,Metabolite,C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43)[O-],-1
PA164748976,trospium,Drug,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,-1
PA164749184,trovafloxacin,Drug,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,-1
PA451806,trypsin,Drug,,-1
PA166185380,tubastatin A,Drug,,-1
PA152530738,tubercidin,Drug,C1=CN(C2=C1C(=NC=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,-1
PA164713364,Tuberculosis diagnostics,Drug Class,,-1
PA164713365,Tuberculosis vaccines,Drug Class,,-1
PA451811,tubocurarine,Drug,CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC,-1
PA166225141,tucatinib,Drug,,-1
PA164713366,Tumor necrosis factor alpha (TNF-alpha) inhibitors,Drug Class,,-1
PA164713367,Tumour Detection,Drug Class,,-1
PA164743726,tyloxapol,Drug,CN(C1=CC=CC=C1C(=O)NCC2=CC=CO2)C(=O)COC3=CC=CC=C3,-1
PA165958422,tymazoline,Drug,,-1
PA164713368,Typhoid vaccines,Drug Class,,-1
PA164713369,Typhus (exanthematicus) vaccines,Drug Class,,-1
PA164713370,Tyrosine hydroxylase inhibitors,Drug Class,,-1
PA164776753,udenafil,Drug,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C,-1
PA166208561,ulinastatin,Drug,,-1
PA164713371,Ultrasound Contrast Media,Drug Class,,-1
PA166177519,umeclidinium,Drug,,-1
PA166184235,umeclidinium / vilanterol,Drug,,-1
PA166197241,umifenovir,Drug,,-1
PA164713373,Unclassified,Drug Class,,-1
PA166189803,upadacitinib,Drug,,-1
PA451830,uracil mustard,Drug,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,-1
PA451831,urea,Drug,C(=O)(N)N,-1
PA166178378,uric acid,Biological Intermediate,,-1
PA130230921,uridine,Drug,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,-1
PA164713374,Urinary antispasmodics,Drug Class,,-1
PA164713375,Urinary concrement solvents,Drug Class,,-1
PA164713376,Urine Tests,Drug Class,,-1
PA451835,urofollitropin,Drug,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O,-1
PA451836,urokinase,Drug,,-1
PA164713377,Urologicals,Drug Class,,-1
PA451837,ursodeoxycholic acid,Drug,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,-1
PA166048654,ustekinumab,Drug,,-1
PA166205401,UTTR1147A,Drug,,-1
PA164713378,Vaccines,Drug Class,,-1
PA451839,valaciclovir,Drug,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,-1
PA166170051,valbenazine,Drug,,-1
PA10226,valdecoxib,Drug,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,-1
PA10227,valganciclovir,Drug,CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N,-1
PA151917011,valinomycin,Drug,,-1
PA166131364,valproate glucuronide,Metabolite,[2H]C([2H])([2H])CCC(CCC([2H])([2H])[2H])C(=O)O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)C(=O)O)O)O)O,-1
PA451846,valproic acid,Drug,CCCC(CCC)C(=O)O,-1
PA166131510,valproic acid-coenzyme A,Metabolite,,-1
PA166131521,valproic acid-dephosphocoenzyme A,Metabolite,,-1
PA164748616,valrubicin,Drug,CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C3=C(C(=C2C1)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,-1
PA451848,valsartan,Drug,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,-1
PA164924565,Valspodar,Drug,,-1
PA451850,vancomycin,Drug,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,-1
PA166118341,vandetanib,Drug,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,-1
PA451852,vanillin,Drug,,-1
PA166128169,vaniprevir,Drug,CC[C@@H]1C[C@@]1(C(=O)NS(=O)(=O)C2CC2)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C,-1
PA164743146,vapreotide,Drug,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N,-1
PA10229,vardenafil,Drug,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,-1
PA164781343,varenicline,Drug,C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23,-1
PA164713379,Varicella zoster vaccines,Drug Class,,-1
PA164713380,Various,Drug Class,,-1
PA164713381,Various alimentary tract and metabolism products,Drug Class,,-1
PA164713382,Various diagnostic radiopharmaceuticals,Drug Class,,-1
PA164713383,Various pain palliation radiopharmaceuticals,Drug Class,,-1
PA164713384,Various therapeutic radiopharmaceuticals,Drug Class,,-1
PA164713385,Various thyroid diagnostic radiopharmaceuticals,Drug Class,,-1
PA164713386,Vasodilators Used In Cardiac Diseases,Drug Class,,-1
PA451858,vasopressin,Drug,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,-1
PA164713387,Vasopressin and analogues,Drug Class,,-1
PA164713388,Vasopressin antagonists,Drug Class,,-1
PA164713389,Vasoprotectives,Drug Class,,-1
PA7001,vatalanib,Drug,,-1
PA164748865,vecuronium,Drug,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,-1
PA451862,vegetable oil,Drug,,-1
PA166115366,velaglucerase alfa,Drug,,-1
PA166131609,veliparib,Drug,C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,-1
PA166163415,velpatasvir,Drug,C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC,-1
PA165946873,vemurafenib,Drug,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,-1
PA166153473,venetoclax,Drug,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,-1
PA451866,venlafaxine,Drug,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,-1
PA451868,verapamil,Drug,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,-1
PA166165068,verapamil D-617,Metabolite,CC(C)C(CCCNC)(C#N)C1=CC(=C(C=C1)OC)OC,-1
PA166165072,verapamil D-620,Metabolite,CC(C)C(CCCN)(C#N)C1=CC(=C(C=C1)OC)OC,-1
PA166165074,verapamil PR-22,Metabolite,CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)O)OC,-1
PA166165075,verapamil PR-25,Metabolite,CC(C)C(CCCNC)(C#N)C1=CC(=C(C=C1)O)OC,-1
PA166184233,vernakalant,Drug,,-1
PA451871,verteporfin,Drug,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C,-1
PA165290925,Vicodin,Drug,,-1
PA451876,vidarabine,Drug,C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O.O,-1
PA10231,vigabatrin,Drug,C=CC(CCC(=O)O)N,-1
PA165958365,vilazodone,Drug,,-1
PA165958346,vildagliptin,Drug,C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,-1
PA166251581,viloxazine,Drug,,-1
PA166236421,viltolarsen,Drug,,-1
PA451877,vinblastine,Drug,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,-1
PA150481188,vinca alkaloids and analogues,Drug Class,,-1
PA451879,vincristine,Drug,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,-1
PA166131422,vincristine M1,Metabolite,,-1
PA166131423,vincristine M2,Metabolite,,-1
PA166131424,vincristine M4,Metabolite,,-1
PA10232,vindesine,Drug,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O,-1
PA451881,vinorelbine,Drug,CCC1=CC2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,-1
PA452612,vinyl chloride,Drug,,-1
PA164713390,Viral Vaccines,Drug Class,,-1
PA166271941,viramidine,Prodrug,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=N)N,-1
PA164713391,Viscoelastic substances,Drug Class,,-1
PA166048558,Vismodegib,Drug,,-1
PA451884,vitamin a,"Drug,""Biological Intermediate""",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,-1
PA164713392,"Vitamin A And D, Incl. Combinations Of The Two",Drug Class,,-1
PA164713393,Vitamin A and D in combination,Drug Class,,-1
PA164713394,"Vitamin A, plain",Drug Class,,-1
PA449069,vitamin b12 and folic acid,Drug Class,,-1
PA164713403,Vitamin B12 (cyanocobalamin and analogues),Drug Class,,-1
PA164713400,Vitamin B1 in combination with vitamin B6 and/or vitamin B12,Drug Class,,-1
PA164713402,"Vitamin B1, plain",Drug Class,,-1
PA164713401,"Vitamin B1, Plain And In Combination With Vitamin B6 And B12",Drug Class,,-1
PA164713398,"Vitamin B-complex, Incl. Combinations",Drug Class,,-1
PA164713399,"Vitamin B-complex, other combinations",Drug Class,,-1
PA10505,"vitamin b-complex, plain",Drug Class,,-1
PA164713395,Vitamin B-complex with anabolic steroids,Drug Class,,-1
PA164713396,Vitamin B-complex with minerals,Drug Class,,-1
PA164713397,Vitamin B-complex with vitamin C,Drug Class,,-1
PA451898,vitamin c,Drug,C([C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)O,-1
PA451899,vitamin d and analogues,Drug Class,,-1
PA451900,vitamin e,Drug,CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O,-1
PA164713404,Vitamin K,Drug Class,,-1
PA166197681,Vitamin K1,Drug,,-1
PA166179140,vitamin K1 epoxide,Biological Intermediate,CC(C)CCCC(C)CCCC(C)CCC/C(=C/CC12C(=O)C3=CC=CC=C3C(=O)C1(O2)C)/C,-1
PA164713405,Vitamin K And Other Hemostatics,Drug Class,,-1
PA164713406,Vitamin K antagonists,Drug Class,,-1
PA166179141,vitamin K dihydroquinone,Biological Intermediate,CC1=C(C2=CC=CC=C2C(=C1C/C=C(\C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O)O,-1
PA164713407,Vitamins,Drug Class,,-1
PA164713410,"Vitamins, other combinations",Drug Class,,-1
PA164713409,Vitamins with minerals,Drug Class,,-1
PA165958347,voacamine,Drug,CC[C@H]1C[C@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=CC(=C(C=C45)OC)[C@H]6C[C@@H]\7C([C@@H](CC8=C6NC9=CC=CC=C89)N(C/C7=C/C)C)C(=O)OC)C(=O)OC,-1
PA164752433,voglibose,Drug,C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO,-1
PA166131630,volatile anesthetics,Drug,,-1
PA166250441,vonoprazan,Drug,,-1
PA10233,voriconazole,Drug,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,1
PA166159251,voriconazole n-oxide,Metabolite,C[C@@H](C1=NC=[N+](C=C1F)[O-])[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,-1
PA164748224,vorinostat,Drug,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,-1
PA166122595,vortioxetine,Drug,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,-1
PA166255241,vortioxetine benzoic acid,Metabolite,,-1
PA166255242,vortioxetine sulfoxide,Metabolite,,-1
PA166255281,vortioxetine sulfoxide glucuronide,Metabolite,,-1
PA166189802,voxelotor,Drug,,-1
PA166171182,voxilaprevir,Drug,,-1
PA166220605,voxtalisib,Drug,,-1
PA166277621,vutrisiran,Drug,,-1
PA451906,warfarin,Drug,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,1
PA164713411,Wart and anti-corn preparations,Drug Class,,-1
PA164713412,Washing agents etc.,Drug Class,,-1
PA166178627,water,"Biological Intermediate,""Small Molecule""",,-1
PA164713413,"Watersoluble, hepatotropic X-ray contrast media",Drug Class,,-1
PA164713414,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",Drug Class,,-1
PA164713415,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",Drug Class,,-1
PA166248061,wee1 inhibitor,Drug,,-1
PA166182517,wuzhi capsule,Drug,,-1
PA152432579,xanomeline,Drug,,-1
PA166178628,xanthine,Biological Intermediate,,-1
PA164713418,Xanthine derivatives,Drug Class,,-1
PA166179134,xanthine monophosphate,Biological Intermediate,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=O)NC2=O,-1
PA164713420,Xanthines,Drug Class,,-1
PA164713421,Xanthines and adrenergics,Drug Class,,-1
PA164748318,xanthophyll,Drug,CC1=C(C(CC(C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C2C(=CC(CC2(C)C)O)C)/C)/C,-1
PA166182864,XELOX,Drug,,-1
PA452604,xenobiotics,Drug Class,,-1
PA451935,xenon,Drug,,-1
PA161748474,ximelagatran,Drug,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)/C(=N/O)/N,-1
PA166114484,XK469,Drug,CC(C(=O)O)OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl,-1
PA164924566,XR9051,Drug,,-1
PA164713416,"X-ray Contrast Media, Iodinated",Drug Class,,-1
PA164713417,"X-ray Contrast Media, Non-iodinated",Drug Class,,-1
PA165958368,xylometazoline,Drug,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C,-1
PA164713422,Yellow fever vaccines,Drug Class,,-1
PA451946,yohimbine,Drug,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,-1
PA164713423,Yttrium (90Y) compounds,Drug Class,,-1
PA451949,zafirlukast,Drug,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,-1
PA451950,zalcitabine,Drug,C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N,-1
PA451952,zaleplon,Drug,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,-1
PA164740891,zanamivir,Drug,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N,-1
PA166204001,zanubrutinib,Drug,,-1
PA451954,zidovudine,Prodrug,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],-1
PA166184503,zidovudine / lamivudine / abacavir,Drug,,-1
PA451955,zileuton,Drug,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,-1
PA451956,zinc,Drug,[Zn],-1
PA451961,zinc acetate,Drug,,-1
PA164713425,Zinc bandages,Drug Class,,-1
PA451965,zinc oxide,Drug,,-1
PA164713426,Zinc products,Drug Class,,-1
PA451971,zinc sulfate,Drug,,-1
PA451974,ziprasidone,Drug,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,-1
PA166248704,ziprasidone sulfone,Metabolite,,-1
PA166248682,ziprasidone sulfoxide,Metabolite,,-1
PA10235,zoledronate,Drug,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,-1
PA451975,zolmitriptan,Drug,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@@H]3COC(=O)N3,-1
PA451976,zolpidem,Drug,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,-1
PA166049188,zomepirac,Drug,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,-1
PA451978,zonisamide,Drug,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,-1
PA10236,zopiclone,Drug,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,-1
PA164924567,Zosuquidar,Drug,,-1
PA452606,zoxazolamine,Drug,,-1
PA452629,zuclopenthixol,Drug,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,-1
